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1. INTRODUCTION 
 
This present dissertation explores the expression patterns of members of the ADAM and 
cadherin gene families in the chicken embryo. Section 1.1 of the Introduction introduces 
the chicken embryo as an experimental system in developmental biology. Section 1.2 is an 
outline about the superfamily of cell adhesion molecules, which includes the ADAM and 
cadherin families. Sections 1.3 and 1.4 give an overview on the functions of ADAMs and 
cadherins in cell adhesion and related developmental processes, especially during nervous 
system development. Section 1.5 describes the molecular interactions between ADAMs 
and cadherins and underlines the motivation to study both families of genes in this work. 
Section 1.6 outlines the aim and experimental approach of the present dissertation.  
 
1.1 The chicken as an experimental model organism 
The chicken (Gallus gallus) is an important model organism for biomedical research, 
embryonic development, and molecular biology (Hamburger and Hamilton, 1951; Bellairs 
and Osmond, 2005). The chicken embryo has served as one of the most widely used 
experimental animals for both teaching and research for more than a century, for the 
following reasons: (1) fertilized eggs are cheap and available in large numbers at any time; 
(2) chicken embryonic development is fast in comparison with most mammalian embryos, 
lasting only 21 days, which is similar to that of the mouse; (3) the physiology of the 
chicken embryo is not complicated by the presence of a placenta; (4) chicken genetics are 
known well, both for normal embryos and for different mutant forms; and (5) as an 
amniote, chicken development resembles that of mammals in its broad outline (Bellairs 
and Osmond, 2005). The recent completion of the sequencing of the chicken genome has 
enhanced the importance of this species in embryology and developmental biology 
(http://www.ncbi.nlm.nih.gov/projects/genome/guide/chicken/). More recently, the chicken 
embryo has also been used broadly in the field of molecular biology and has provided an 
important model system for studies of gene regulation. Although chicken gene “knock out” 
is impractical because embryonic stem cells are elusive and generation times in the hen’s 
reproductive organ are long (Brown et al., 2003), the application of plasmid-based RNA 
interference (RNAi) in conjunction with in vivo (in ovo or ex ovo) electroporation makes 
loss-of-function studies possible (Das et al., 2006). In conjunction with gene 
overexpression (gain-of-function) mediated by the in ovo or ex ovo electroporation of 
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recombinant plasmids, the chicken embryo allows to fully explore gene function regionally 
and temporally (Muramatsu et al., 1997, 1998; Luo and Redies, 2004, 2005).  
The Redies laboratory has extensive experience in chicken embryonic development, 
especially in the development of the central nervous system (CNS), both in the context of 
descriptive studies (Arndt et al., 1998; Fushimi et al., 1997; Redies et al., 1997, 2001, 
2002a, b; Arndt and Redies, 1996, 1998; Gänzler-Odenthal and Redies, 1998; Wöhrn et al., 
1998, 1999; Gerhardt et al, 1999, 2000a, b; Becker and Redies, 2003; Kovjanic and Redies, 
2003; Heyers et al., 2003, 2004; Müller et al., 2004; Ju et al., 2004) and experimental 
research using in vivo electroporation (Treubert-Zimmermann et al., 2002; Luo and 
Redies, 2004, 2005; Luo et al., 2004, 2006). For these reasons, I chose the chicken embryo 
as the experimental animal model in my doctoral research. 
 
1.2 Developmental processes mediated by cell adhesion molecules (CAMs) 
The development of an organism like the chicken embryo is a highly complex process. 
Vertebrate embryos share fundamentally similar developmental mechanisms during early 
embryogenesis. Multiple cleavage divisions generate a large number of cells from the 
fertilized oocyte. In a temporally and spatially highly orchestrated fashion, different genes 
regulate the proliferation, differentiation, migration, adhesion, fate determination and 
apoptosis of cells (Bellairs and Osmond, 2005).  
In developmental processes, cell adhesion molecules (CAMs) play an important 
role. Many CAMs are glycoproteins located on the external surface of the cytoplasmic 
membrane. These proteins interact either with other CAMs on adjacent cells or with 
proteins of the extracellular matrix, to mediate cell-cell and cell-extracellular matrix 
adhesion, respectively. There are a number of classifications for CAMs. Initially, they were 
named after the tissue, in which they were first identified. It is now clear that most CAMs 
are expressed rather widely and not limited to single tissues or organs. For example, N-
cadherin (N-Cdh), which was first discovered in the neural tissues, is also found in diverse 
epithelia and mesenchymal cells; E-cadherin (E-Cdh), which was initially discovered in the 
epithelium, has also been localized to non-epithelial tissues (Takeichi, 1988; Redies, 
2000); and R-cadherin (R-Cdh), which was confirmed in the retina at first, is also 
expressed strongly in brain (Arndt and Redies, 1996). Later, based on homologies and 
phylogenetic comparisons, CAMs were separated into several superfamilies, which each 
contain a number of smaller subgroups. The superfamilies of CAMs include the 
immunoglobulins, cadherins, integrins, selectins, proteoglycans (including the syndecan 
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subfamily of adhesion molecules) (Kerrigan et al., 1998). ADAMs (a disintegrin and 
metalloproteases) can also be viewed as a subfamily of CAMs because of their disintegrin 
domain, which can bind integrin to mediate cell-cell or cell-extracelluar matrix interaction 
(Lu et al., 2007). Moreover, ADAMs contain a cysteine-rich domain and an epidermal 
growth factor (EGF)-like domain, both of which are able to mediate cell-cell adhesion as 
well (Zhao et al., 2004; Zigrino et al., 2007). In addition, some ADAMs can shed other 
trans-membrane proteins through their metalloprotease activity. For example, ADAM10 
sheds N-Cdh, E-Cdh, protocadherin (Pcdh)-C3 and vascular endothelial cadherin (VE-
Cdh), to regulate their functions (Reiss et al., 2005, 2006; Maretzky et al., 2005, 2008; 
Schulz et al., 2008). The current project focuses mainly on the expression patterns and 
possible functions of ADAMs and cadherins during chicken embryonic development. 
 
1.3 ADAMs play versatile roles during embryonic development 
1.3.1 Structure and potential functions of ADAMs 
ADAMs belong to type I trans-membrane proteins. Some members of the ADAM family 
have also been named MDC, which stands for metalloprotease/disintegrin/cysteine-rich. 
Members of this protein family possess a multi-domain structure and are composed of a 
signal peptide, a prodomain, a metalloprotease domain, a disintegrin domain, a cysteine-
rich domain, an EGF-like domain, a trans-membrane domain and a cytoplasmic tail (Black 
and White, 1998; Schlöndorff and Blobel, 1999; Stone et al., 1999; Primakoff and Myles, 
2000; Lu et al., 2007). The possession of these multiple domains suggests that ADAMs are 
potentially involved in proteolysis, adhesion, cell fusion and cell signaling (Blobel, 2002, 
2005). The domain structure and the potential function of each domain are shown in Figure 
1. Specific biological processes, in which ADAMs have been implicated, include sperm- 
 
 
Fig. 1. A schematic diagram for the domain structure and potential functions of ADAMs. EGF, EGF-like 
domain; TM, trans-membrane domain. Revised after Black and White (1998), Duffy et al. (2003), and Seals 
and Courtneidge (2003).  
 
Signal Pro Metalloprotease Disintegrin Cysteine-rich EGF TM Cytoplasmic tail
Latency Proteolysis Adhesion Adhension/Fusion Signaling
Domain 
Structure 
Potential  
Funtions 
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egg fusion, somatic cell-cell adhesion, ectodomain shedding, and developmental processes, 
for example, myoblast fusion and neurogenesis. 
Emerging data suggest that ADAMs are probably synthesized in the rough 
endoplasmic reticulum (ER) and processed to produce their mature form in the Golgi 
compartment; maturation involves the removal of the prodomain from the ADAM 
precursor protein (Seals and Courtneidge, 2003; see Fig. 3 in Part 1.5). Most ADAMs 
possess a putative furin recognition sequence between the prodomain and the 
metalloprotease domain, which agrees with the finding that ADAMs are possibly activated 
by a furin-like protein convertase enzyme (Anders et al., 2001; Duffy et al., 2003).  
ADAMs have been found in vertebrates, as well as in Caenorhabditis elegans (C. 
elegans) and Drosophila. However, they are not present in Escherichia coli, 
Saccharomyces cerevisiae, or plants. So far, more than 35 members of the ADAM family 
have been cloned and confirmed in different species. Not every ADAM family member 
possesses proteolytic function, though all of them have a metalloprotease domain. Only 
those members, which contain the remarkably conserved sequence HExxHxxGxxHD in 
the metalloprotease domain, are predicted to have catalytic activation. This is the case for 
approximately half of all members of the ADAM family. The presently known ADAMs 
and their potential functions and characteristics are listed in Table 1.1 
(http://people.virginia.edu/~jw7g/ Table_of_the_ ADAMs.html).  
 
Table 1.1. Members of the ADAM family 
ADAM Other name Characteristics and potential functions Organism 
ADAM1 PH-30 alpha; Fertilin 
alpha 
Spermatogenesis, sperm-egg fusion Human, mouse, rat 
ADAM2 PH-30 beta; Fertilin beta Sperm-egg binding via integrins, testis-specific Human, mouse, rat 
ADAM3 Cyritestin; tMDC I Sperm-egg adhesion and fusion, testis-specific Human, mouse, rat 
ADAM4 tMDC V Primarily expressed in testis Mouse, rat 
ADAM5 tMDC II Primarily expressed in testis Mouse  
ADAM6 tMDC IV Primarily expressed in testis Human, mouse, rat 
ADAM7 EAP I, GP-83 Sperm maturation, androgen-regulated Human, mouse, rat 
ADAM8 MS2, CD156 Neutrophil infiltration, osteoclast stimulating factor Human, mouse 
ADAM9 MDC9, meltrin gamma Cleaves HB-EGF, APP, secretase activity, myogenesis Human,mouse,Xenopus,chicken 
ADAM10 MADM; kuzbanian Neurogenesis, alpha-secretase activity, axon extension Many including chicken 
ADAM11 MDC Candidate tumor suppressor for breast cancer Human, mouse, xenopus 
ADAM12 Meltrin alpha Myoblast fusion, osteogenesis, cleaves IGFBP-3 Human, mouse, chicken 
ADAM13  Neural crest cell migration Xenopus, chicken 
ADAM14 adm-1, UNC-71 Expressed on sperm Caenorhabditis elegans 
ADAM15 Metargidin; MDC 15 Blood vessel function, binds integrin  Human, mouse, rat 
ADAM16 MDC 16 Spermatogenesis, fertilization, testis-specific Xenopus 
ADAM17 TACE Cleaves pro-TNF-alpha , TNF receptor, L-selectin, Human, mouse, rat, chicken 
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APP 
ADAM18 tMDC III Expressed on sperm, testis-specific Human, mouse, rat 
ADAM19 Meltrin beta Myogenesis, osteoblast differentiation Human, mouse 
ADAM20  Spermatogenesis, testis-specific Human  
ADAM21 ADAM31 Spermatogenesis, testis-specific Human, mouse 
ADAM22 MDC 2 Expressed predominantly in brain Human,mouse,Xenopus,chicken 
ADAM23 MDC 3 Expressed predominantly in brain Human, mouse, chicken 
ADAM24 Testase-1 Testis-specific Mouse  
ADAM25 Testase-2 Testis-specific Mouse 
ADAM26 Testase-3 Testis specific Mouse  
ADAM27 ADAM18 Expressed on sperm, testis-specific Human, mouse, rat 
ADAM28 eMDCII, MDC-Ls Expressed in human lymphocytes Human, mouse, rat 
ADAM29 svph1 Testis-specific Human, mouse 
ADAM30 svph4 Testis-specific Human, mouse 
ADAM31 ADAM21 Spermatogenesis testis-specific Human, mouse 
ADAM32  Testis-predominent Human, mouse, rat 
ADAM33  Asthma susceptibility gene, airway remodeling Human, mouse 
ADAM34  Testase-4 Testis-specific Mouse  
ADAM35 Meltrin epsilon Expressed in epithelial tissues Chicken  
 
Note: This table was derived from data originating in the White laboratory and was referenced in recent 
publications (Duffy, et al., 2003; Watabe-Uchida et al, 2004; Publication 1). Underlined ADAMs possess the 
consensus metalloprotease sequence HExGHxxGxxHD that indicates potential metalloprotease activity. 
"Chicken" highlights the ADAMs that have been identified in chicken. For abbreviations, see the list of 
abbreviation on page III-V.  
 
ADAMs have been confirmed to play a critical role during fertilization and 
embryonic development. Altered expression of individual ADAMs has been associated 
with a number of diseases including inflammation, asthma, arthritis, Alzheimer’s disease, 
atherosclerosis and cancer (Wolfsberg et al., 1995a,b; Primakoff and Myles, 2000; 
Kheradmand and Werb, 2002; Duffy et al., 2003; Novak, 2004; Yang et al., 2006). From 
our own results, it is clear that some ADAMs are expressed in a highly restricted pattern in 
particular types of tissues or cells whereas other ADAMs are expressed more widely 
throughout the developing organism.  
 
1.3.2 Expression and role of ADAMs in embryonic development  
In embryonic development, ADAMs were shown to play a role in spermatogenesis, 
fertilization, myogenesis and morphogenesis. The processes mediated by ADAMs in 
embryonic development include ectodomain shedding of cell membrane-binding proteins 
via the metalloprotease domain, cell-cell and cell-matrix adhesion via the disintegrin and 
the cysteine-rich domain, and direct or indirect intracellular signaling through the 
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cytoplasmic domain (Blobel, 2002, 2005). For example, ADAM1 and ADAM2 (also called 
fertilin-alpha and -beta) are sperm-surface proteins and participate in sperm migration into 
the oviduct, the dispersal of cumulus cells, and sperm binding to the zona pellucida 
(Wolfsberg et al., 1993; Nishimura et al., 2004). ADAM24-ADAM27 mRNAs are 
transcribed in spermatogenic cells in a regulated pattern at a specific developmental stage 
(Zhu et al., 1999). ADAM12 shows strong expression in neonatal skeletal muscle, bones, 
nervous system, and is involved in myoblast fusion and differentiation (Yagami-Hiromasa 
et al., 1995; Gilpin et al., 1998; Bernstein et al, 2004), in pathological processes of 
muscular dystrophy (Kronqvist et al., 2002), and in adipogenesis (Kawaguchi et al., 2002). 
Moreover, ADAM12 is expressed in a restricted fashion in the developing chicken brain 
(Publication 4). Chicken ADAM10 is expressed in the developing dermatome and 
myotome, in epidermis, endoderm, the epithelial tissues of the kidney, liver, heart, and in 
neural crest cells. The expression patterns and protein distribution of ADAM10 suggest 
that it may play a significant role in the morphogenesis of several epithelial tissues (Hall 
and Erickson, 2003). Moreover, by shedding the Notch ligand Delta from the cell surface 
in Drosophila, ADAM10 (also named Kuzbanian in Drosophila) is involved in the Notch 
signaling pathway that regulates numerous cell fate decisions in invertebrates and 
vertebrates (Sotillos et al., 1997; Hartmann et al., 2002; Six et al., 2003). ADAM15 has a 
role in neovascularization in mice under pathological conditions (Horiuchi et al., 2003, 
2005), whereas ADAM19 is essential for cardiovascular morphogenesis (Kurohara et al., 
2004; Zhou et al., 2004). Xenopus ADAM13 is expressed in somitic mesoderm and cranial 
neural crest cells during gastrulation and neurulation (Alfandari et al., 1997; Gunn et al., 
2002). Alteration of its expression in cranial neural crest cells results in the failure of their 
migration along the branchial pathways (Alfandari et al., 2001). The expression of 
ADAM13 in the chicken embryo was shown to be temporally and spatially regulated in 
different organs and tissues (Publication 1). ADAM35 is also expressed in epithelial 
tissues during chicken embryogenesis (Watabe-Uchida et al., 2004). ADAM17 (also called 
TNF-alpha converting enzyme or TACE) shows a restricted expression in embryonic 
development. The absence of ADAM17 activity in mouse allows the generation of cells 
with an osteoclastic phenotype, but prevents their migration into the core of the diaphysis 
and the subsequent formation of a marrow cavity (Boissy et al., 2003). ADAM17 is the 
only ADAM described so far to be expressed in human skin, and its expression was seen 
throughout all layers of the epidermis, the hair follicles, eccrine ducts and glands, and 
sebaceous glands (Kawaguchi et al., 2004). 
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1.3.3 ADAMs in the developing nervous system 
To date, 17 members of ADAMs have been identified in the CNS (Novak, 2004). Table 
1.2 lists these ADAMs and their metalloprotease characteristics. During nervous system 
development, ADAMs play versatile roles in neurogenesis, neuronal migration, axonal 
extension and plasticity, through mediating signal transduction, cell-cell adhesion, and 
ectodomain shedding. Some ADAM knock-out mice have been shown to cause defects in 
the structure and/or function of the central nervous system. For example, ADAM10-mutant 
mice die at embryonic day 9.5 (E9.5) because of major and multiple morphological defects 
in the cardiovascular system and in the developing brain, such as growth retardation, 
shortened forebrain primordium, abnormal hindbrain flexure, and an irregular 
neuroepithelial wall (Hartmann et al., 2002). In ADAM11-deficient mice, brain or spinal 
cord is apparently normal with no major histological abnormalities, but learning and motor 
coordination are affected (Takahashi et al., 2006). In ADAM22-deficient mice, ataxia and 
prominent hypomyelination of the peripheral nerves was observed (Sagane et al., 2005). 
ADAM23-deficient mice suffer from tremor and ataxia and die during early postnatal 
times (Mitchell et al., 2001). ADAM17- and ADAM19-deficient mice die at birth because 
of multiple cardiovascular defects (Horiuchi et al., 2005), but an analysis of their nervous 
system has not been reported. In contrast, ADAM8-mutant mice have no major defects in 
the CNS during development or in adult tissues, despite the fact that this molecule is 
expressed prominently in the developing brain and spinal cord (Kelly et al., 2005). 
ADAM9 and ADAM15 knock-out mice also do not exhibit obvious morphological deficits 
in the nervous system (Weskamp et al., 2002; Horiuchi et al., 2003), despite their wide 
expression in the brain. Possibly, other ADAMs compensate for the absence of these 
ADAMs.  
 
 Table 1.2. ADAMs present in the nervous system and their known substrates  
ADAMs Location in the nervous system References Substrate  
ADAM1 Pyramidal neurons of the hippocampus Gerst et al., 2000 Unknown  
ADAM2 Pyramidal neurons of the hippocampus, ependymal cells Gerst et al., 2000; 
Yang et al., 2005 
Inactive 
ADAM3 Astrocytes around the third ventricle Yang et al., 2005 Inactive  
ADAM4 mRNA detected in the brain Wolfsberg et al., 
1995a,b 
Inactive  
ADAM5 mRNA detected in the brain Wolfsberg et al., 
1995a,b 
Inactive  
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ADAM8 Neurons, astrocytes, and oligodendrocytes Chantry et al., 1992; 
Schlomann et al., 2000 
APP, CHL1, CD16, CD23, 
CX3CL1, L-selectin, MBP, 
PSGL-1, TGF-alpha, CD163, 
IL-1-RII, TNFR1 
ADAM9 Ubiquitous expression in the CNS, with higher expression 
in the hippocampus, hypothalamus, and cerebellum 
Weskamp et al., 2002 
Hotoda et al., 2002 
APP, pro-HB-EGF 
ADAM10 Neurons in cerebral cortex, hippocampus, ventral 
hypothalamus, and cerebellar cortex, oligodendrocytes 
Kärkkäinen et al., 2000; 
Marcinkiewicz and 
Seidah, 2000; Ortiz et 
al., 2005; Reiss et al., 
2005, 2006 
APP, pro-HB-EGF, pro-EGF, 
Notch, Delta, ephrins, L1, 
type-IV collagen, cellular 
prion precursor, CD44, N-
Cdh,E-Cdh,Pcdh-C3,VE-Cdh 
ADAM11 Neurons throughout the cerebrum, hippocampus, 
cerebellum, and spinal cord, as well as sensory ganglia 
Rybnikova et al., 2002; 
Sagane et al., 1999 
Inactive 
ADAM12 Pyramidal neurons and oligodendrocytes Bernstein et al., 2004 Pro-HB-EGF, insulin-like 
growth factor binding 
proteins 3 and 5, S 
carboxymethylated 
transferrin 
ADAM15 Neurons in the brain and spinal cord, Schwann cells in 
the peripheral nerve 
Bosse et al., 2000 Type-IV collagen, gelatine, 
CD23 
ADAM17 Astrocytes and endothelial cells or neurons Goddard et al., 2001; 
Skovronsky et al., 2001 
APP, pro-TNF-alpha, pro-
HB-EGF, pro-androgen 
receptor, Notch, EGFR 
ligand, TNF receptor I and II, 
pro-amphiregulin, cellular 
prion precursor… 
ADAM19 Ventral horn of the spinal cord and the dorsal root ganglia Kurisaki et al., 1998; 
Tanabe et al., 2007 
APP, pro-neuroregulin-1 
ADAM21 Ependyma, tanycytes, growing neurons and processes Yang et al., 2005 Unknown  
ADAM22 Neurons throughout the brain and spinal cord Sagane et al., 2005 Inactive  
ADAM23 Neurons throughout the brain, with higher expression in 
the hippocampal formation, basal ganglia and Purkinje 
and granule cells of the cerebellum 
Goldsmith et al., 2004; 
Leighton et al., 2001; 
Mitchell et al., 2001 
Inactive  
ADAM33 Granule neurons of the dentate gyrus and cerebellum Gunn et al., 2002 Unknown  
 
Note: Revised after Yang et al. (2006). For abbreviations, see the list of abbreviation on page III-V. 
 
Various functions of different ADAMs have been identified in the nervous system. 
ADAMs play a role not only in axon guidance, but also in neural crest cell migration. The 
axon pathways in Drosophila embryos with a loss-of-function mutation of 
ADAM10/Kuzbanian exhibit dramatic defects with many axons stalling and failing to 
extend through the nerve cord. These data suggest that proteolysis by the 
ADAM10/Kuzbanian metalloprotease activity is required at the growth cone for axon 
extension (Fambrough et al., 1996). ADAM10 was confirmed to regulate the guidance of 
retinal axons in Xenopus laevis (Chen et al., 2007). Moreover, ADAM10/Kuzbanian 
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induces the shedding of ephrin-A2 from the cell surface, which results in axon repulsion 
(Hattori et al., 2000). In C. elegans, UNC-71, a homolog of human ADAM14, regulates 
motor axon guidance and probably functions in a combinatorial manner with integrins and 
UNC-6/netrin (Huang et al., 2003). ADAM13 is expressed in the somitic mesoderm and 
neural crest cells during development of Xenopus laevis (Alfandari et al., 1997). The 
protease activity of ADAM13 plays a critical role in neural crest cell migration along 
defined pathways. It has been proposed that the ADAM13-dependent modification of 
extracellular matrix and/or other guidance molecules is a key step in the directed migration 
of the neural crest cells (Alfandari et al., 2001). Recently, it was reported that ADAM2 
promotes the migration of neuroblasts in the rostral migratory stream to the olfactory bulb 
(Murase et al., 2008). 
ADAMs are expressed widely in the adult nervous system. In adult rodent CNS, at 
least 17 ADAM mRNAs are expressed in strikingly different expression patterns (Table 
1.2). For example, it has been shown that ADAM10 mRNA expression is widespread, 
while ADAM17 shows a spatially more restricted expression pattern. The wide and 
differential expression of ADAM mRNAs suggests versatile roles for ADAMs in the adult 
CNS (Kärkkäinen et al, 2000). However, little is known about the expression of ADAMs 
during development, especially during the embryonic development of the nervous system. 
In order to provide a basis for experimental studies on the role of ADAMs in CNS 
development, I analyzed the spatiotemporal expression pattern of five ADAMs in detail in 
the embryonic chicken brain (Publication 4). I also show that the overexpression of 
ADAM17 in the chicken tectum causes an enlargement of blood vessels due to an 
increasing number of pericytes (Additional Results). 
 
1.4 Cadherins are important to embryonic development 
1.4.1 Structure and functions of cadherins  
Cadherins are a family of trans-membrane proteins, which are composed of an 
extracellular domain, a trans-membrane domain and a cytoplasmic domain. The main 
characteristics of this protein family are about 100 amino acid-long “cadherin repeats” or 
“cadherin domains” in the extracellular domain. So far, more than 100 members of the 
cadherin superfamily were confirmed from vertebrate to invertebrate species (Drosophila 
and C. elegans). These members were classified into several subfamilies according to 
conserved amino acid motifs in their extracellular domain as well as cytoplasmic domain. 
The subfamilies are the classic cadherins, desmosomal cadherins, Flamingo cadherins, fat-
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like cadherins and protocadherins (Hirano et al., 2003; Redies et al., 2005; Takeichi, 2007; 
Suzuki and Takeichi, 2008; see Fig. 2 for models on the molecular structure of cadherins, 
cited after Hirano et al., 2003).  
 
 
 
Fig. 2. Members of the cadherin family. Shown are the domain structures of representative members of the 
cadherin family of vertebrates. Note that, in most cases, the cytoplasmic domains are completely different 
from each other. This feature suggests that members of different cadherin subfamilies participate in distinct 
signaling pathways and protein interactions. Reproduced from Hirano et al. (2003).  
 
The present thesis project mainly focuses on classic cadherins (Cdh). Classic 
cadherins are composed of five conserved extracellular domains, of which the fifth domain 
shows lower homology than the other domains. On basis of characteristic amino acid 
sequences in the cytoplasmic domain, classic cadherins can be further divided into type I 
and type II classic cadherins. Type I classic cadherins, which share five extracellular 
cadherins repeats, have been named according to the organ or tissue, in which they were 
first identified. For example, E-Cdh is expressed in epithelia, N-Cdh in neural tissue, P-
Cdh in the placenta, and R-Cdh in the retina. The expression of these cadherins, however, 
is not restricted to these tissues (see above). Type II classic cadherins, which differ from 
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type I cadherins in specific amino acid sequences, were numbered by the order of their 
discovery (Hirano et al., 2003). So far, type II cadherins include Cdh5 (VE-Cdh), Cdh6, 
Cdh7, Cdh8, Cdh9, Cdh10, Cdh11, Cdh12, Cdh18, Cdh19, and Cdh20; these genes were 
identified in human, mouse, rat, chicken, or Xenopus. 
As adhesion molecules, the principal function of cadherins is in cell-cell adhesion. 
Cadherins preferentially bind to the same cadherin subtype (homophilic adhesion). For 
example, E-Cdh interacts with E-Cdh, whereas N-Cdh interacts with N-Cdh (Hirano et al., 
2003). This binding specificity is thought to provide a molecular basis for the sorting of 
cells and/or their processes during embryonic development (Takeichi, 1995; Redies et al., 
1997, 2000; Hirano et al., 2003). The strength of cadherin-mediated adhesion can be 
regulated by a number of proteins, including catenins, which serve to bind cadherins to the 
cytoskeleton (Hirano et al., 2003; Takeichi, 2007). Apart from cell-cell adhesion, cadherins 
have been implicated in a number of signaling pathways, as well as in cell proliferation and 
differentiation.  
Cadherins play an important role in the morphogenesis of many organs and tissues. 
Abnormal alteration of cadherin function results in malformation and tumorgenesis 
(Takeichi, 1995; Vleminckx and Kemler, 1999; Peinado et al., 2004). The differential 
expression of cadherins has been considered as a potential marker for epithelial to 
mesenchymal transformation during tumor progression (Agiostratidou et al., 2007).  
 
1.4.2 Cadherins in embryonic development  
Cadherins play various roles during embryonic development and are major players for 
regulating morphogenesis. Developmental mechanisms, which are mediated by cadherins, 
include epithelial-mesenchymal transition, gastrulation movements, tubulogenesis, somite 
morphogenesis, morphogenesis of the heart and neural tube, vasculogenesis, as well as 
neurogenesis (Thiery, 2003). E-Cdh and N-Cdh are of critical importance as adhesive 
molecules in early development. N-Cdh-deficient mouse embryos die around E10.5 with 
multiple defects, including malformed somites and neural tube, although the death is 
caused mainly by severe heart defects (Luo et al., 2001). The heart phenotype can be 
rescued partially by expressing either N-Cdh or E-Cdh under the control of muscle-specific 
promoters (Luo et al., 2001; Thiery, 2003).  
A number of organs express multiple classic cadherins in spatiotemporally highly 
regulated patterns that reflect complex tissue morphogenesis, for example the brain 
(Redies, 2000; Hirano et al., 2003) and the kidney (Perantoni, 1999). Several cadherins are 
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also expressed in the developing inner ear, for instance, N-Cdh, R-Cdh and Cdh11 exhibit 
distinct spatiotemporal patterns of expression during otic vesicle morphogenesis of 
zebrafish (Novince et al., 2003), but the spatial relationship of their expression patterns and 
their relation to cochlear morphogenesis remains largely unclear. I therefore investigated 8 
classic cadherins (N-Cdh, R-Cdh, Cdh6, Cdh7, Cdh8, Cdh11, Cdh19 and Cdh20) in the 
developing chicken cochlea, and demonstrated that most of these cadherins show 
differential and restricted expression profiles during chicken cochlear development 
(Publication 2). 
 
1.4.3 Cadherins in the developing and adult CNS  
Development of the nervous system is the process, during which the relatively simple 
neuroepithelium of the neural tube is transformed into a highly complex set of divisions 
that become functionally connected to form neural circuits. During this process, a large 
number of cadherins are expressed in a regionally restricted fashion in the embryonic and 
functional subdivisions of the CNS (Redies, 2000; Hirano et al., 2003). The vast majority 
of cadherins are expressed during the formation, regionalization, and maintenance of brain 
segments, brain nuclei, gray matter, and cortical layers (Redies and Takeichi, 1996; 
Redies, 2000; Hirano et al., 2003). In the nervous system, cadherins were shown to be 
involved in cell proliferation, differentiation, and migration (Winklbauer et al., 1992; 
Nakagawa and Takeichi, 1998; Goichberg and Geiger, 1998), in axonal outgrowth, 
fasciculation, and pathfinding (Riehl et al., 1996; Treubert-Zimmermann et al., 2002), as 
well as in synaptogenesis and synaptic plasticity (Fannon and Colman, 1996; Tanaka et al., 
2000; Suzuki et al., 2007; Takeichi, 2007). Cadherin-mediated adhesive specificity may 
thus provide a molecular code for early embryonic CNS regionalization as well as for the 
development and maintenance of functional structures in the CNS (Redies, 2000; Redies et 
al., 2003; Hertel et al., 2008; Krishna et al., 2008). In the adult CNS, some cadherins seem 
to be involved in synapse formation and plasticity and neuronal survival. However, the 
biological role of most cadherins in the adult remains largely unknown (Takeichi, 2007). 
The vast complexity of developing brain structures is reflected in a similarly 
complex expression of genes, such as cadherins (Redies, 2000; Hirano et al., 2003). 
Complex molecular expression patterns can be established not only by the expression of 
multiple genes, but also by the expression of multiple mRNA isoforms of the same 
molecule. In contrast to some protocadherins, for example δ-protocadherins (Vanhalst et 
al., 2005; Redies et al., 2005), which possess numerous isoforms, there are only single or 
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very few isoforms for most classic cadherins. With few exceptions (rat Cdh8, Kido et al., 
1998; chicken Cdh7, Kawano et al., 2002; and chicken Cdh20, Shirabe et al., 2005), little 
is known about the spatiotemporal expression patterns of these mRNA isoforms. In this 
work, I identified three isoforms of Cdh8 in chicken and studied their temporal and spatial 
expression patterns during development of the embryonic chicken brain (Publication 3). 
 
1.5 Interaction between ADAMs and cadherins  
The principal function of cadherins is in cell-cell adhesion. One of the mechanisms, which 
regulates adhesiveness, is the release of the extracellular cadherin domain. The ectodomain 
cleavage of cadherins can be inhibited with the matrix metalloproteinase (MMP) inhibitors, 
including the tissue inhibitors of metalloproteinases (TIMPs; Ho et al., 2001). This finding 
suggests that a metalloprotease is responsible for the ectodomain shedding of cadherins. 
Because about half of all ADAMs possess a predicted metalloprotease activity, ADAMs 
have been considered candidate proteases to shed cadherins and thereby regulate cadherin-
mediated cell-cell adhesion. This notion was confirmed by demonstrating that ADAM10  
 
Fig. 3. The structure and function of ADAMs and cadherins as well as their interaction. Revised after Seals 
and Courtneidge (2003) and Reiss et al. (2005, 2006) 
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can shed N-Cdh, E-Cdh, Pcdh C3 and VE-Cdh (Reiss et al., 2005, 2006; Maretzky et al., 
2005, 2008; Schulz et al., 2008). The postulated interaction between members of the 
ADAM family and the cadherin family is illustrated in Figure 3. 
ADAM10 and N-Cdh are co-localized in different regions of the embryo, such as in 
the somites, heart and neural tube, giving support for the notion that both proteins are 
functionally linked. ADAM10 is the major protease responsible for N-Cdh ectodomain 
cleavage in fibroblasts and neuronal cells. The cell-cell adhesion mediated by N-Cdh is 
upregulated in ADAM10-deficient fibroblasts. Therefore, ADAM10 is responsible for the 
initial and crucial proteolytic processing of N-Cdh, leading to the generation of the C-
terminal fragment (CTF1) and thereby modulating cell-cell adhesion as well as signal 
transduction through influencing the cytoplasmic β-catenin pool (Reiss et al., 2005). The 
coordinated interaction of ADAM10 and N-Cdh may be significant for the coordinated 
interplay between cell-cell adhesion, cell detachment, cell proliferation and cell survival 
during embryogenic development (Reiss et al., 2005). ADAM10 is responsible for the 
shedding of not only N-Cdh, but also E-Cdh in fibroblasts and keratinocytes. ADAM10-
mediated E-Cdh shedding affects epithelial cell-cell adhesion as well as cell migration 
(Maretzky et al., 2005). The shedding of E-Cdh by ADAM10 modulates β-catenin 
subcellular localization and downstream signaling (Maretzky et al., 2005). Moreover, the 
release of ADAM10-mediated E-Cdh is regulated by proinflammatory cytokinase and 
modulates keratinocyte cohesion in eczematous dermatitis (Maretzky et al., 2008). Also, 
ADAM10 was confirmed to shed γ-protocadherin C3 (Pcdh-C3) and Pcdh-B4 and to 
regulate their function in fibroblasts and neuronal cells (Reiss et al., 2006). In contrast to 
N-Cdh that was activated by N-methyl-D-aspartic acid receptor activation in neuronal 
cells, γ-Pcdh shedding was induced by alpha-amino-3-hydroxy-5-methylisoxazole-4-
propionic acid hydrate stimulation, which suggests that the regulatory mechanism of 
cadherin-mediated function at the synapse differs for the two types of cadherins (Reiss et 
al., 2006). VE-Cdh, which plays an essential role in the regulation of endothelial 
permeability, vascular integrity, leukocyte transmigration, and angiogenesis, is the major 
adhesion molecule at the endothelial adherence junction. Recently, it was reported that VE-
Cdh is specifically cleaved by ADAM10 (Schulz et al., 2008). Interestingly, similar to the 
case of N-Cdh, the cleavage of other cadherins or protocadherins by ADAM10 releases a 
soluble fragment and generates a carboxyl-terminal membrane-bound stub (see the model 
of ADAM10-induced shedding of N-Cdh in Figure 4; cited after Reiss et al., 2005).  
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Fig. 4. Schematic representation of the N-Cdh cleavage sites and different antibody binding regions (for 
antibodies GC4, MNCD2 and C32). Full-length 135 kDa N-Cdh is cleaved by metalloprotease activity into 
an N-terminal 95 kDa fragment (NTF) and a C-terminal 40 kDa fragments (CTF1), which can be further 
processed by gamma-secretase-like activity into a soluble 35kDa fragment (CTF2). It was confirmed that the 
metalloprotease is ADAM10. Reproduced from Reiss et al. (2005). 
 
Moreover, ADAM15 co-localizes with VE-Cdh at the cell-cell boundaries between 
endothelial cells. VE-Cdh can drive surface expression of ADAM15, which suggests that 
ADAM15 may be a novel component of adherence junctions and thus could play a role in 
endothelial adhesive function (Ham et al., 2002). It is likely that many other interactions 
between ADAMs and cadherins remain unexplored. 
                                                              
1.6 Aims of the study and experimental approach  
The expression of members of the ADAM and the cadherin superfamilies can vary 
considerably. A more precise picture of their spatiotemporal expression profiles would be 
very useful to explore their possible interactions and functions. The expression patterns of 
classic cadherins and protocadherins have been studied well in the nervous system of 
different vertebrate species, such as the rat, the mouse, and the chicken (for reviews, see 
Redies, 2000; Hirano et al., 2003). Nevertheless, the expression of many members of this 
trans-membrane protein family remains unexplored, especially in organs other than the 
brain, for example, the cochlea. 
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Compared to cadherins, the expression patterns of ADAMs are much less explored 
during embryonic development. In particular, virtually no details on expression patterns 
are known for the chicken. ADAM expression during vertebrate development remains 
poorly documented. Amongst the few studies published in this area are the work by 
Asayesh et al. (2005) that described the restricted expression of ADAM9, ADAM10, and 
ADAM17 in divergent pancreatic compartments of the mouse, and the work by 
Kärkkäinen et al (2000) who found strikingly different expression patterns for individual 
ADAM mRNAs in the adult mouse CNS. 
 
The aims and the experimental approaches of my study are as follows: 
1. Cloning of cDNA fragments, ORFs, or full-length cDNAs of some ADAMs and 
cadherins from chicken, according to the predicted chicken sequences or homologous 
sequences from other vertebrate species. The cDNA fragments or ORF of selected 
ADAMs and cadherins of chicken are cloned into pCR-II vector that will be used to 
synthesize cRNA probes for in situ hybridization (ISH) of sections through the chicken 
embryo.  
2. The expression patterns of members of the ADAM family and cadherin family 
are investigated during chicken embryonic development, especially in the CNS and in the 
cochlea (Publications 1, 2, 3 and 4). 
3. For selected ADAM and cadherin genes, the ORFs are subcloned into a suitable 
vector for gene overexpression (gain-of-function studies) by in ovo or ex ovo 
electroporation in the chicken embryo, in order to investigate the possible function of these 
genes during the development. In particular, ADAM17 is overexpressed by ex ovo 
electroporation in the developing chicken tectum (Additional Results).   
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2. PUBLICATION OVERVIEW 
 
2.1 Regionalized expression of ADAM13 during chicken embryonic development. Juntang 
Lin, Christoph Redies, Jiankai Luo. Developmental Dynamics, 2007, 236:862-870. 
 
The full-length cDNA of chicken ADAM13 was cloned in this study. The temporal 
expression profile of chicken ADAM13 was studied by semi-quantitative RT-PCR, and its 
expression pattern was investigated by section and whole mount in situ hybridization 
during chicken embryonic development. Our results extend the previous results from 
Xenopus for early stages of development and show in detail that ADAM13 is expressed 
temporally and spatially at later stages of embryonic development as well. 
 
Own contribution to the manuscript: 
1. Cloning and identification of chicken ADAM13 
2. Analysis of the temporal expression profile of ADAM13 during chicken embryonic 
development with semi-quantitative RT-PCR 
3. Analysis of the temporal and spatial expression pattern of ADAM13 during chicken 
embryonic development by section and whole-mount in situ hybridization 
4. Data evaluation, and interpretation and representation of the results 
 
 
2.2 Cadherin expression in the developing chicken cochlea. Jiankai Luo, Hong Wang, 
Juntang Lin, Christoph Redies. Developmental Dynamics, 2007, 236:2331-2337.  
 
In this study, we focused on the chicken embryo as the experimental animal model to 
investigate the expression patterns of eight classic cadherins (N-Cdh, R-Cdh, Cdh6B, 
Cdh7, Cdh8, Cdh11, Cdh19 and Cdh20) in the cochlea during late stages of embryonic 
development with in situ hybridization and fluorescence immunostaining. We also cloned 
and identified the full-length sequences of Cdh8 and Cdh19, and the open reading frame of 
Cdh20. Our results show that each cadherin is expressed in one or more cochlear regions, 
and reversely, two or three cadherins can be co-distributed in one region. These results 
suggest that cadherins play a role in the development of the cochlea, for example, in the 
formation of hair cells or in the guidance of neurites from the acoustic ganglion to the hair 
cells. 
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Own contribution to the manuscript: 
1. Cloning and identification of chicken Cdh8, Cdh19 and Cdh20 
2. Bioinformatics analysis of chicken Cdh8 and Cdh19 
3. Participation in probes synthesis, section preparation, and the performance of some in 
situ hybridization experiments on sections  
4. Participation in data evaluation and in the interpretation and representation of the results 
 
 
2.3 Molecular cloning and expression analysis of three cadherin-8 isoforms in the 
embryonic chicken brain. Juntang Lin, Jiankai Luo, Christoph Redies. Brain Research, 
2008, 1201:1-14. 
 
We cloned three types of full-length cDNAs of chicken cadherin-8 by the RACE method in 
this study. Semi-quantitative RT-PCR with type-specific primers showed that the 
transcription of the three isoforms was temporally and spatially regulated in different parts 
of the embryonic chicken brain. In situ hybridization results for the long isoform showed 
that Cdh8 expression is restricted to a subset of brain nuclei, regions and layers in all major 
parts of the brain. The spatiotemporally regulated restriction of gene expression suggests 
that the three Cdh8 isoforms likely play different roles during brain development.  
 
Own contribution to the manuscript: 
1. Cloning and identification of the three isoforms of chicken Cdh8 
2. Analysis of the temporal and regional expression profile of the three Cdh8 isoforms 
during chicken embryonic brain development with semi-quantitative RT-PCR  
3. Analysis of the regional and temporal expression profile of the long Cdh8 isoform in 
developing chicken brain by in situ hybridization  
4. Data evaluation and interpretation and representation of the results 
 
 
2.4 Differential expression of five members of the ADAM family in the developing 
chicken brain. Juntang Lin, Jiankai Luo, Christoph Redies. Neuroscience, 2008 (in press). 
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In this study, we cloned the open reading frames of ADAM9, ADAM10 and ADAM23 by 
RT-PCR, and the full-length cDNAs of ADAM12 and ADAM22 by the RACE method, 
from chicken embryonic brain. We analyzed their evolutionary relationship by 
bioinformatics analysis, and investigated their expression patterns in the embryonic 
chicken brain by in situ hybridization for the first time. Our results show that each of the 
five ADAMs investigated is expressed in a spatially restricted and temporally regulated 
expression pattern, but the general types of structures that express the individual ADAMs 
are rather different. This result suggests that different ADAMs play versatile roles during 
brain development. 
 
Own contribution to the manuscript: 
1. Cloning and identification of the ORFs of ADAM9, ADAM10 and ADAM23 by RT-
PCR, and the full-length cDNAs of ADAM12 and ADAM22 by RACE 
2. Brain section preparation and in situ hybridization for the five investigated ADAMs in 
the developing chicken brain 
3. Anatomical analysis of the in situ results for the five investigated ADAMs 
4. Data evaluation and interpretation and representation of the results 
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Regionalized expression of ADAM13 during chicken embryonic development 
 
Juntang Lin, Christoph Redies, Jiankai Luo 
 
Developmental Dynamics, 2007, 236:862-870. 
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PATTERNS & PHENOTYPES
Regionalized Expression of ADAM13 During
Chicken Embryonic Development
Juntang Lin, Christoph Redies, and Jiankai Luo*
ADAMs are a family of membrane proteins possessing a disintegrin domain and a metalloprotease domain,
which have functions in cell–cell adhesion, cell–matrix adhesion, and protein shedding, respectively.
ADAMs are involved in morphogenesis and tissue formation during embryonic development. In the present
study, chicken ADAM13 was cloned and identiﬁed, and its expression was investigated by semiquantitative
reverse transcriptase-polymerase chain reaction and in situ hybridization during chicken embryonic
development. Our results show that ADAM13 expression is temporally and spatially regulated in chicken
embryos. At early developmental stages, ADAM13 is expressed in the head mesenchyme, which later
develops into the craniofacial skeleton, in the branchial arches, and in the meninges surrounding the brain.
Furthermore, ADAM13 mRNA was also detected in several tissues and organs, such as the somites and their
derived muscles, the meninges surrounding the spinal cord, the dorsal aorta, the developing kidney, and
several digestive organs. Developmental Dynamics 236:862–870, 2007. © 2007 Wiley-Liss, Inc.
Key words: ADAM; gene expression pattern; neural crest; somite; dorsal aorta; branchial arch; meninges; limb; kidney;
esophagus; proventriculus; gizzard; intestine; development
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INTRODUCTION
Members of the ADAM (a disintegrin
and metalloprotease) family are mem-
brane-anchored metalloproteases that
are expressed widely in many organs,
tissues, and cells (Wolfsberg et al.,
1995). ADAMs have multiple domains
as well as multiple functions. Their
metalloprotease domain can shed
other transmembrane proteins and
cleave matrix proteins. The disintegrin
domain as well as the cysteine-rich do-
main have adhesive activities in cell–
cell and cell–matrix interaction. The
cytoplasmic domain of ADAMs is in-
volved in intracellular signal trans-
duction. ADAMs are candidates for
modulating proteolysis, cell adhesion
and fusion, and for cell signaling
(Seals and Courtneidge, 2003; White,
2003; Blobel, 2005; Huang et al., 2005;
Maretzky et al., 2005; Reiss et al.,
2006).
The meltrin subfamily of ADAMs
comprises ADAM9, 12, 19, and 35.
These genes are involved in muscle
development (Yagami-Hiromasa et
al., 1995; Weskamp et al., 1996; Lewis
et al., 2004; Watabe-Uchida et al.,
2004). The expression of some mem-
bers of the meltrin subfamily has been
described in avian embryos (Lewis et
al., 2004; Watabe-Uchida et al., 2004).
In the quail, ADAM12 is expressed in
the cranial ganglia, in the mesen-
chyme of the limb bud, and in the mes-
enchyme surrounding the dorsal
aorta, whereas ADAM19 is expressed
in the cranial and dorsal root ganglia
and in the allantois (Lewis et al.,
2004). ADAM35 is expressed in the
chicken myotome and several epithe-
lial tissues, such as the otic vesicles
and gut epithelia (Watabe-Uchida et
al., 2004). The full-length sequence of
chicken ADAM9 was reported, but its
expression pattern has not been de-
scribed to date (Caldwell et al., 2005).
Xenopus ADAM13, which is similar
to members of the meltrin subfamily
and to ADAM33, is expressed in
somitic mesoderm and cranial neural
crest cells during gastrulation and
neurulation of Xenopus (Alfandari et
al., 1997; Gunn et al., 2002). Alter-
ation of its expression in cranial neu-
ral crest cells results in the failure of
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their migration along the branchial
and hyoid pathways (Alfandari et al.,
2001). In the present study, a cDNA
encoding an ortholog of Xenopus
ADAM13 was identiﬁed in the chicken
embryo. Its expression pattern was
analyzed during embryonic develop-
ment by semiquantitative reverse
transcriptase-polymerase chain reac-
tion (RT-PCR) and, in detail, by in situ
hybridization in different tissues and
organs.
RESULT AND DISCUSSION
Cloning and Sequence
Analysis of a cDNA
Encoding Chicken ADAM13
To obtain a cDNA encoding the
chicken ortholog of Xenopus ADAM13,
RT-PCR was performed using a pair of
speciﬁc primers. A cDNA fragment of
1,278 bp was obtained. Based on the
sequence of this fragment, a rapid am-
pliﬁcation of cDNA ends (RACE) reac-
tion was performed and a molecule
with a full-length sequence encoding
947 amino acids was obtained (see
Supplementary Figure S1, which can
be viewed at http://www.interscience.
wiley.com/jpages/1058-8388/suppmat).
This chicken cDNA sequence was an-
alyzed in three steps. First, we
searched for highly similar sequences
with the NCBI BLAST program (http://
www.ncbi.nlm.nih.gov/BLAST). The
BLAST result demonstrated that, on
the nucleotide level, the chicken
cDNA sequence shares a high similar-
ity with the predicted sequence of
chicken ADAM13 published in Gen-
Bank (NCBI GenBank accession no.
XM_420886). On the amino acid
level, the protein sequence deduced
from the full-length cDNA sequence
shows highest similarity to Xenopus
ADAM13 protein (57% identities and
70% positives; NCBI GenBank acces-
sion no. U66003). Second, based on
the alignment of the chicken and Xe-
nopus amino acid sequences of
ADAM13, the chicken protein pos-
sesses domains that are characteristic
of the ADAM family, such as a signal
peptide (38% identity to Xenopus
ADAM13), a prodomain (48% iden-
tity), a metalloprotease domain (80%
identity), a disintegrin domain (77%
identity), a cysteine-rich domain (62%
identity), an EGF-like domain (77%
identity), a transmembrane domain
(27% identity), and a cytoplasmic do-
main (36% identity; see Supplemen-
tary Figure S1). Third, the amino acid
sequence deduced from the obtained
chicken cDNA was compared with
other meltrin subfamily members and
to ADAM33. The obtained chicken
gene shares a relatively high identity
with ADAM33 and ADAM19, respec-
tively (Fig. 1A). Based on the sequence
analysis described above, we desig-
nated the obtained molecule as
chicken ADAM13. The complete se-
quence has been submitted to Gen-
Bank (NCBI GenBank accession no.
EF136663).
Expression Analysis of
ADAM13 at Different Stages
by RT-PCR
To study ADAM13 transcription, we
performed semiquantitative RT-PCR
from stage 10, when the neural crest
begins to develop, to stage 45. Our
results showed that ADAM13 began
to be transcribed weakly at stage 10
(Fig. 1B). As the embryo developed,
the transcription of ADAM13 in-
creased gradually, reaching the high-
est level at around stage 36, and then
decreased gradually until stage 45,
when ADAM13 was still detectable
(Fig. 1B). This result suggested that
the expression of ADAM13 was tem-
porally regulated during chicken em-
bryonic development.
Expression of ADAM13 in
Structures Derived From
Cranial Neural Crest
To study the expression pattern of
ADAM13 in detail, we performed in
situ hybridization at different stages
(from stage 10 to 36) during chicken
development using antisense cRNA
probes. Sense cRNA probe was used
as a negative control for in situ hy-
bridization (data not shown). At stage
10, weak ADAM13 expression was de-
tected in the dorsal cranial area (ar-
rowhead in Fig. 2A) but not in the
trunk region. At stage 13, ADAM13
transcript was revealed in the mesen-
chyme surrounding the brain and the
eyes, and also in the branchial arches
(Fig. 2D,J–L). Note that, at this stage,
the ADAM13-positive neural crest
cells were still in migration from dor-
sal to ventral in the area around the
Fig. 1. Phylogenetic tree and semiquantitative reverse transcriptase-polymerase chain reaction
(RT-PCR) of ADAM13. A: Phylogenetic tree illustrating the relationship between chicken ADAM13
and Xenopus ADAM13, the other members of the meltrin subfamily of ADAMs, and ADAM33. The
numbers below indicate the percentage difference between the various amino acid sequences.
B: Detection of ADAM13 expression using semiquantitative RT-PCR at different stages of chicken
embryonic development. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an
internal control to monitor the amount of RNA.
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pharynx, where the branchial arches
are forming (Fig. 2L). At stage 17,
ADAM13 transcription was strong
with clear boundary between the dif-
ferent migratory streams in the
branchial arches (Fig. 2G); expression
was maintained until stage 26 at least
(Figs. 2M–O, 3K). The neural crest at
the level from the mesencephalon to
rhombomere 2 contributes to the mes-
enchyme around the brain and the
eyes and will later develop into parts
of the craniofacial skeleton, and into
the ﬁrst branchial arch. The neural
crest at the level of rhombomeres 3 to
7 and their adjacent paraxial meso-
derm gives rise to branchial arches 2,
3, and 4 (Lumsden et al., 1991; Le
Douarin et al., 2004; Noden and
Trainor, 2005). In the branchial
arches, ADAM13-expressing cells
were located more peripherally and
enveloped the branchial myogenic
cores derived from the paraxial meso-
Fig. 2. ADAM13 transcript in structures derived from cranial neural crest cells. A–I: Whole-mount in situ hybridization at stage 10 (A–C), stage 13
(D–F), and stage 17 (G–I) using antisense probes for ADAM13 (A,D,G), Pax1 (B,E,H), and Pax3 (C,F,I). The arrows indicate the somites. The arrowheads
in A, B, and F indicate the dorsal cranial area, head mesenchyme, and neural tube, respectively. J–R: ADAM13 is transcribed in the mesenchyme
(arrows in J–O) derived from head cranial neural crest around the forebrain and the eyes, in the branchial arches 1–4 (ba1-4; J, M–P), and in the
meninges surrounding the diencephalon (di) and telencephalon (tel; arrowheads in P–R) at different stages (marked). J shows the magniﬁcation of the
area boxed in D. The arrowheads in N point to branchial arch arteries (aa). K, L, P show transverse sections, and Q and R frontal sections. M–O
represent lateral views. ms, mesencephalon; pg, pharynx. Scale bars  200 m in K,L,M, in N (applies to N–P); 500 m in Q,R; 1.2 mm in A (applies
to A–C); 2.0 mm in D (applies to D–F); 2.5 mm in G (applies to G–I).
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derm (Fig. 2D,G,M–O; Noden and
Trainor, 2005). Therefore, compared
with the expression patterns of the
myogenic regulatory genes Myf5,
MyoD, and Pax1, the transcript of
ADAM13 in the branchial arches was
more widespread (Fig. 2D,E,G,H; Bar-
nes et al., 1996; Hacker and Guthrie,
1998; Noden and Trainor, 2005). The
ectoderm and the endoderm of the
head did not express ADAM13. In the
prospective craniofacial skeleton at
Fig. 3. ADAM13, Pax1, and Pax3 transcription in somites and in somite-derived musculature. A,D,F–L,N,O,Q: ADAM13 is expressed in the somites
(A,D,F,G; transverse sections), in the meninges around the spinal cord (sp) and spinal ganglia (sg; arrows in F–H, transverse section; in I and J,
parasagittal sections), and by muscles (arrows in K,L,N,O,Q) at different stages (marked). B,E: Pax1 is expressed in the sclerotome at stage 13 (B) and
stage 20 (E). C,M,P: Pax3 is transcribed in the dermomyotome (dm; C) and in muscles (arrows in M, P) at stage 13 (C), stage 28 (M), and stage 36
(P). The arrowheads in G indicate ADAM13-expressing neural crest cells. The arrowheads in H, O, and Q show chondroblasts around the vertebrae
(v) and the ribs, respectively. carti, cartilage; co, coelom; da, dorsal aorta; em, epaxial myotome; hm, hypaxial myotome; me, mesonephros; nc,
notochord; ncc, neural crest cell; sc, sclerotome; tel, telencephalon. Scale bars  50 m in L (applies to L,M,O,P); 200 m in A (applies to A–E,H);
in F (applies to F,G) and in I,N; 500 m in J,Q; 5 mm in K.
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stage 36, ADAM13 mRNA was tran-
scribed in the prospective premaxilla,
maxilla, nasal conchae, and mandibu-
lar cartilage (data not shown). A sim-
ilar expression pattern was seen in
Xenopus where ADAM13 is expressed
in the structures of the mandibular
crest segment, the hyoid crest, and the
anterior and posterior branchial crest
(Alfandari et al., 1997). In chicken, we
found ADAM13 to be expressed also in
the mesenchyme around the brain
and the eyes, which develops later
into parts of the craniofacial skeleton.
The expression of ADAM13 in cranial
neural crest cells suggested that
ADAM13 might play a role in cranial
neural crest cell migration and differ-
entiation.
Expression of ADAM13 in
the Meninges
During development, the meninges
around the forebrain originate from
the cranial neural crest, whereas the
meninges around the mesencephalon
and the more caudal CNS, including
the spinal cord, derive from meso-
derm-originated mesenchymal cells
(Halata et al., 1990; Le Douarin et al.,
2004). At stage 24 of chicken develop-
ment, ADAM13 mRNA was expressed
in a thin layer of mesenchyme that
condensated around the forebrain and
corresponded to the prospective me-
ninges (arrowheads in Fig. 2P). At
stage 28, strong expression of
ADAM13 was maintained around the
forebrain (arrowheads in Fig. 2Q). Ex-
pression then decreased gradually but
was still visible at stage 36 (arrow-
heads in Fig. 2R). At stage 28,
ADAM13 transcript was also found
surrounding the mesencephalon and
hindbrain (data not shown). In the
meninges around the spinal cord and
spinal ganglia, ADAM13 mRNA was
expressed from stage 24 (arrows in
Fig. 3F,I) and expression persisted at
stage 28 (Fig. 3G,J) and stage 36 (Fig.
3H).
Expression of ADAM13 in
the Somites and Derived
Structures
In whole-mount embryos, ADAM13
mRNA was detected in the somites
along the entire cranial–caudal axis at
stage 13 (Fig. 2D) and was expressed
strongly at stage 17 (Fig. 2G). Expres-
sion was absent at stage 10 (Fig. 2A). In
transverse sections of stage 13 embryos,
ADAM13 transcription was prominent
in the dermomyotome and the scle-
rotome, where Pax3 and Pax1 were also
expressed, respectively (Fig. 3A–C). As
the somites differentiated, the expres-
sion of ADAM13 remained strong in the
dermomyotome, but it became more
widespread and diffuse around the scle-
rotome at stage 20 (Figs. 3D, 4A). From
stage 24 to 28, ADAM13 was expressed
strongly in the epaxial and hypaxial
myotome and weakly in the sclerotome
(Fig. 3F,G).
Because the epaxial and hypaxial
myotomes develop into skeletal mus-
culature, and the sclerotome gives rise
to the skeleton of the trunk, we also
investigated the expression patterns
of ADAM13 in their derivatives. From
stage 26, ADAM13 transcript was
found in the limb buds (arrows in Fig.
3K) where it was expressed by devel-
oping muscles, which coexpressed
Pax3 (arrows in Fig. 3L–N; Bendall et
al., 1999). At stage 36, ADAM13
mRNA was transcribed widely in
muscles, e.g., of the limbs, the thorax,
and the abdominal wall (arrows in
Fig. 3O,Q). The muscles of the thorax
and the abdominal wall also coex-
pressed Pax3 (arrow in Fig. 3P; Ben-
dall et al., 1999). Furthermore, at
stage 36, ADAM13 mRNA was found
also in condensed sheets of chondro-
blasts around cartilage, e.g., around
the vertebrae (arrowheads in Fig. 3H)
and the ribs and the sternum (arrow-
heads in Figs. 3O,Q, 4K), but it was
not observed in the perichondrium of
limb skeleton elements (Fig. 3Q). Ex-
pression of ADAM13 in somitic meso-
derm was also described in Xenopus,
but only at early stages of develop-
ment and not in somite-derived struc-
tures (Alfandari et al., 1997). In the
present study, we demonstrate ex-
pression of ADAM13 also at relatively
late stages. Our data show that the
skeletal muscles of the limbs and the
trunk also expressed ADAM13
mRNA.
ADAM13 Expression in
Dorsal Aorta and Developing
Kidney
During the initial phase of blood ves-
sel formation, nascent endothelial
tubes are established from mesoder-
mal precursor cells. During aortic de-
velopment, the endothelia of the aorta
originate from two different precursor
pools: the splanchnopleura and the
somite. After fusion of the paired aor-
tae, the vessels are renewed by replac-
ing the initial endothelium derived
from the splanchnopleural cells by the
cells derived from the somites (Pouget
et al., 2006). Furthermore, cells de-
rived from the somites differentiate
into smooth muscle cells of the aorta
(Pouget et al., 2006). At stages 20 and
24 of chicken development, ADAM13
mRNA was detected in the wall of the
dorsal aorta, including the epithelium
and the surrounding mesenchyme
(Fig. 4A,B). The boundaries of
ADAM13 expression between the dor-
sal aorta and adjacent structures,
such as the nephrogenic ridges (meso-
nephros) and the scleromyotome, were
vague (Fig. 4A,B). At stages 28 and 36,
the expression of ADAM13 in the wall
of the dorsal aorta persisted (Fig.
4C,D). At stage 36, aortic expression
was stronger dorsally than ventrally
at thoracic levels (insert in Fig. 4E).
The ADAM13-expressing cells may
correspond to cardiac neural crest
cells, which contribute to the forma-
tion of the cardiac ganglion and the
aortico-pulmonary septum (Verberne
et al., 1998). Moreover, in transverse
sections at cervical levels, ADAM13
mRNA was expressed strongly
throughout the wall of the carotid ar-
teries (Fig. 4E).
During vertebrate development, the
intermediate mesoderm forms the
nephrogenic mesenchyme, which ex-
tends down the trunk and contributes
to the developing kidneys (prone-
phros, mesonephros, and metane-
phros). At stage 20, ADAM13 mRNA
was expressed in the primordia of the
glomeruli and in the mesenchyme
around the mesonephric tubules (Fig.
4A). As the kidney develops (stages 24
to 36), the expression of ADAM13 be-
came restricted gradually to the glo-
meruli, the mesenchyme around the
mesonephric tubules, and the nephric
duct (Fig. 4B–D,F). The glomeruli,
which express ADAM13 strongly,
were located in the dorsal and medial
side of the mesonephros (Fig.
4B–D,F). At the hindlimb level,
ADAM13 mRNA was strongly tran-
scribed in the mesenchyme of the met-
866 LIN ET AL.
anephros, which was located at the
caudal and dorsal side of the mesone-
phros (Fig. 4G). At stage 36, the ex-
pression of ADAM13 was restricted to
the glomeruli and the mesenchyme
around the mesonephric tubules and
the nephric duct (Fig. 4D and insert).
Note that the expression of ADAM13
in the glomeruli seemed to be related
to the vascular tuft. Whether
ADAM13 expression in the mesen-
chyme around the mesonephric tu-
bules and the nephric duct is associ-
ated with blood vessels, remains to be
studied.
Expression of ADAM13 in
Digestive Organs
At around stage 28, the gut of the
chicken has developed into several
parts, such as the esophagus, the
proventriculus, the gizzard, and the
intestines. Each of these organs con-
sists of an epithelium and a surround-
ing mesenchyme (connective tissue
and smooth muscle layers), which are
derived from endoderm and meso-
derm, respectively. From stage 28,
weak expression of ADAM13 in the
digestive organs can be detected in the
mesenchymal layer (Fig. 4G; data not
shown). At stage 36, ADAM13 mRNA
Fig. 4. Expression of ADAM13 in the dorsal aorta, the developing kidney, and digestive organs. A–G: ADAM13 is expressed in the dorsal aorta (da,
arrows in A–E, transverse sections) and the developing kidneys (arrowheads in A–D,G) at different stages (marked). Note that the boundary of ADAM13
expression between the dorsal aorta and the adjacent sclerotome (sc) and the mesonephros (me) was not clear (A,B). The arrowhead in the insert of
E points to the mesenchyme at the dorsal side of the dorsal aorta. The insert in D shows a magniﬁcation of the area boxed in D. H–L: ADAM13 is
transcribed in the epithelium (arrowheads) of the proventriculus (I) and the gizzard (J) and in the mesenchymal layer (arrows) of several digestive organs
at stage 36. Transverse sections are shown. ca, carotid artery; dm, dermomyotome; es, esophagus; gi, gizzard; glo, glomerulus; li, large intestine; mc,
mesenchyme of the mesonephric tubules; mn, metanephros; ms, mesenchyme; mt, mesonephric tubules; nc, notochord; nd, nephric duct; pv,
proventriculus; si, small intestine; sp, spinal cord; st, sternum. Scale bars  50 m in A; 100 m in F (applies to F,G); 200 m in B–D; and E (applies
to E,H–J,L); 500 m in K.
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was transcribed distinctly in the
esophagus, the proventriculus, the
gizzard, and the intestines, with
slightly different expression patterns
(Fig. 4H–L). In the esophagus,
ADAM13 was expressed in mesoderm-
derived tissues only, including the
connective tissue and the muscle lay-
ers (Fig. 4H). In the proventriculus,
ADAM13 was transcribed in scattered
epithelial cells and, more weakly, in
the surrounding mesenchyme (Fig.
4I). In the gizzard, ADAM13 was ex-
pressed in the epithelium and the
muscle layers, especially in the latter
(Fig. 4J,K). During chicken develop-
ment, the proventricular epithelium
invades the surrounding mesenchyme
and begins to form proventricular
glands, which later secrete pepsin and
hydrochloric acid. This differentiation
of gland epithelium depends on an in-
teraction between epithelial cells and
mesenchyme and may involve genes
such as BMP2, Sox2, and GATA5
(Fukuda and Yasugi, 2005). Whether
the restricted expression of ADAM13
in the gizzard epithelial cells plays a
role in this interaction remains to be
elucidated. In the small and large in-
testines, the expression of ADAM13
mRNA was restricted to mesenchymal
cells and the muscle layers (Fig. 4K,L,
and insert in 4L).
Concluding Remarks
In conclusion, during chicken embry-
onic development, ADAM13 expres-
sion is temporally and spatially regu-
lated in different organs and tissues,
most of which are of mesenchymal or-
igin. In the head, expression is prom-
inent in the mesenchymal components
of the branchial arches, the craniofa-
cial skeleton, and the meninges. In the
trunk, ADAM13 is expressed in the
somites and several tissues of somitic
origin, for example, by the skeletal
and intestinal musculature, by the
mesoderm-derived components of the
kidney and digestive organs, by the
meninges of the spinal cord, and by
the dorsal aorta. Our results extend
previous results from Xenopus for
early stages of development (Alfan-
dari et al., 1997, 2001) and show in
detail that ADAM13 is expressed also
at later stages of development.
EXPERIMENTAL
PROCEDURES
Animals
Fertilized eggs of White Leghorn
chicken (Gallus domesticus) were ob-
tained from a local farm and incu-
bated in a forced-draft incubator
(Ehret, Emmendingen, Germany) at
37°C and 65% humidity. Embryos
were studied at stages 10, 12, 13, 15,
17, 20, 24, 26, 28, 34, 36, 38, 40, 42, 44,
and 45 (according to Hamburger and
Hamilton, 1951; at least 3 embryos for
each stage). After deep anesthesia
was induced by cooling on ice, the em-
bryos were removed from the eggs.
For RT-PCR analysis, the embryos
were quickly immersed in liquid nitro-
gen and stored in a80°C freezer. For
in situ hybridization of sections, em-
bryos were ﬁxed in 4% formaldehyde
solution on ice for 6 to 24 hr, depend-
ing on the size of the embryo. For
whole-mount in situ hybridization,
embryos were dehydrated in a graded
series of methanol solutions (25%,
50%, 75% [v/v] in phosphate buffered
saline [PBS]) and stored in 100%
methanol at 20°C until further use.
cDNA Cloning, RACE, and
Sequences Analysis
To obtain chicken ADAM13 cDNA, to-
tal RNA of chicken brain at stage 40
was extracted with TRIzol reagent
(Invitrogen, Karlsruhe, Germany).
First-strand cDNA was synthesized in
vitro using the SuperScript First-
Strand Synthesis System (Invitro-
gen). For PCR performance, a pair of
speciﬁc primers was designed with the
Lasergene software (DNASTAR, Inc.,
Madison, WI), based on the compari-
son of the Xenopus ADAM13 sequence
with the predicted ADAM13 sequence
of chicken from GenBank (NCBI Gen-
Bank accession no. XM_420886). The
sequence of the forward primer was
A13-F: 5-CGATGCCAACGCCACG-
CTCTG-3 and that of the reverse
primer was A13-R: 5-ATGCTGCA-
CGGGGCCACTGTCC-3. The PCR
template was denatured for 2 min at
94°C, followed by 35 cycles of ampliﬁ-
cation (denaturing for 20 sec at 94°C,
annealing for 30 sec at 64°C, and ex-
tension for 2 min at 68°C). After the
last cycle, the reaction product was
extended ﬁnally for 15 min at 68°C.
The PCR fragment obtained was
cloned into pCR II-TOPO vector with
the TA-cloning kit (Invitrogen). The
plasmid was puriﬁed using the Plas-
mid Maxi Kit (Qiagen, Hilden, Ger-
many) and sequenced by a commercial
company (SeqLab, Go¨ttingen, Ger-
many).
To obtain the full-length sequence
of chicken ADAM13, 5- and 3-end
RACE reactions were performed with
the SMART RACE cDNA Ampliﬁca-
tion Kit (Takara Bio Europe/Clontech,
Saint-Germain-en-Laye, France). The
speciﬁc primers for RACE were cho-
sen from the obtained 1,278-bp frag-
ment according to the instructions of
the RACE Kit User Manual. The
primers for 5-end RACE PCR were as
follows: 5-GCGTCTCAGTATAGCCT-
GGTGCCAGCA-3 (A13-antisense-1),
and 5-TGCAGATGGTCCCAGCCAC-
CTTCAGC-3 (A13-antisense-2). The
primers used for 3-end RACE PCR
were 5-GTTGGGCTCCTCCATACT-
GCGAGAAGC-3 (A13-sense-1) and
5-GGACCTGGTGGTGGGACGGAA-
ATGTG-3 (A13-sense-2). The touch-
down PCR for 5- and 3-end RACE
ampliﬁcation was performed using the
A13-antisense-1 and A13-sense-1
primers together with the Universal
Primer Mix, respectively. For the ﬁrst
5 cycles, the touchdown PCR was per-
formed at 94°C for 30 sec, at 72°C for
3 min, then for second 5 cycles at 94°C
for 30 sec, at 70°C for 30 sec, and at 72
for 3 min. At last, for further 27 cycles,
PCR was performed at 94°C for 30 sec,
at 68°C for 30 sec, and at 72°C for 3
min. To get more speciﬁc bands,
nested PCR was subsequently carried
out with the primers A13-antisense-2
and A13-sense-2 together with the
Nested Universal Primer for 5- and
3-end cDNA ampliﬁcation, respec-
tively. The PCR template was dena-
tured for 1 min at 95°C, followed by 20
cycles of ampliﬁcation (denaturing for
30 sec at 95°C, annealing and exten-
sion for 3 min at 68°C). After the last
cycle, the reaction product was ex-
tended ﬁnally for 3 min at 68°C. The
PCR products were cloned into pCR
II-TOPO vector (Invitrogen) and se-
quenced by a commercial company
(MWG, Ebersberg, Germany). The
full-length nucleotide sequence encod-
ing 947 amino acids was obtained by
splicing both the 5- and 3-end se-
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quences together with the previously
obtained 1,278-bp fragment.
Chicken cDNAs encoding Pax1
(NCBI GenBank accession no.
NM_204269) and Pax3 (NCBI Gen-
bank accession no. U22046) were ob-
tained using the same method de-
scribed as above (RT-PCR). The
forward primer for Pax1 was 5-AG-
ATCCTGGCCCGCTACAACGAGA-3,
and the reverse primer was 5-
TGGGCGGAAGGGAAGGCAGTC-3.
The forward primer of Pax3 was 5-
GCATCCGGCCCTGTGTCATCTC-3,
and the reverse primer was 5-GCTC-
CTGCCTGCTTCCTCCATCT-3.
Semiquantitative RT-PCR
Total RNA of chicken embryos (stages
10, 12, 15, 20, 24, 26, 28, 34, 36, 38, 40,
42, 44, and 45) were extracted with
TRIzol reagent (Invitrogen). For early
embryonic stages (stage 10 to stage
24), whole embryos were homogenized
directly in TRIzol reagent. For later
stages, the embryos were ground in
liquid nitrogen and total mRNA was
extracted from the resulting powder.
The glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) was used as an
internal control to monitor the
amount of RNA in the semiquantita-
tive RT-PCR. The forward primer for
GAPDH was 5-GGGCTCATCTGA-
AGGGTGGTGCTA-3 and the reverse
primer was 5-GTGGGGGAGACAGA-
AGGGAACAGA-3. The semiquanti-
tative RT-PCR was performed using
the One Step RT-PCR Kit (Qiagen) by
adding ADAM13 primers (A13-F and
A13-R) together with the primers for
GAPDH in one tube. The ratio of
primer concentration of ADAM13 and
GAPDH was 6:1. The one-step RT-
PCR reaction was started at 50°C for
30 min for reverse transcription and
at 95°C for 15 min for denaturing, fol-
lowed by 30 cycles of ampliﬁcation (de-
naturing for 45 sec at 94°C, annealing
for 45 sec at 62°C, and extension for
1.5 min at 72°C). The RT-PCR frag-
ments were analyzed on agarose gels.
In Situ Hybridization
Digoxigenin-labeled sense and anti-
sense cRNA probes were transcribed
using plasmids containing cDNA frag-
ments for ADAM13, Pax1, and Pax3
as templates, according to the manu-
facturer’s instructions for probe syn-
thesis (Roche, Mannheim, Germany).
Sense cRNA probe was used as a neg-
ative control for in situ hybridization.
The protocol for in situ hybridization
on cryosections was according to
Redies et al. (1993). In brief, 20-m-
thick cryostat sections were ﬁxed with
4% formaldehyde in PBS and were
pretreated with proteinase K and ace-
tic anhydride. Sections were hybrid-
ized overnight with cRNA probe at a
concentration of 3 ng/l at 70°C in
hybridization solution (50% form-
amide, 3 standard saline citrate, 1
Denhardt’s solution, 250 g/ml yeast
transfer RNA, and 250 g/ml salmon
sperm DNA). After the sections were
washed and the unbound cRNA was
removed by RNAse, the sections were
incubated with alkaline phosphatase–
coupled anti-digoxigenin Fab frag-
ments (Roche) at 4°C overnight. For
visualization of the labeled mRNA, a
substrate solution of nitroblue tetra-
zolium salt and 5-bromo-4-chloro-3-in-
doyl phosphate was added. The sec-
tions were viewed and photographed
under a microscope (Olympus BX40,
Hamburg, Germany) equipped with a
digital camera (Olympus DP70).
Whole-mount in situ hybridization
was performed on chicken embryos as
described by Riddle et al. (1993) using
the digoxigenin-labeled cRNA probes
described above.
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PATTERNS & PHENOTYPES
Cadherin Expression in the Developing
Chicken Cochlea
Jiankai Luo,1,2* Hong Wang,3 Juntang Lin,1 and Christoph Redies1
In this study, we demonstrate that eight classic cadherins are differentially expressed in distinct
anatomical regions of the cochlea during late stages of chicken embryonic development. Cadherin-6B is
expressed in hair cells and spindle-shaped cells, while cadherin-8 mRNA is found only in supporting cells.
Cadherin-11 is widely expressed not only in mesenchymal cell around the cochlea, but also in supporting
cells and homogene cells. N-cadherin is found in the sensory epithelium, the neurons of the acoustic
ganglion and on their neurites that target the hair cells. Three closely related cadherins (cadherin-7,
cadherin-19, and cadherin-20) are expressed in a partially complementary manner in spindle-shaped cells
and acoustic ganglion cells. R-cadherin is observed in homogene cells, acoustic ganglion cells, and their
projections to hair cells. The expression of classic cadherins in the developing cochlea suggests a role for
cadherins in the development of the cochlea. Developmental Dynamics 236:2331–2337, 2007.
© 2007 Wiley-Liss, Inc.
Key words: cadherin; cochlea; gene expression pattern; chicken development
Accepted 31 May 2007
INTRODUCTION
The inner ear is a complex sensory
organ that is responsible for sound de-
tection and body balance. It arises
from a simple embryonic structure,
the otic vesicle, which originates in a
transient epithelial thickening of cra-
nial ectoderm at the level of the hind-
brain. During embryonic develop-
ment, the epithelium of the otic vesicle
differentiates into distinct anatomical
domains of the mature inner ear (Co-
hen and Fermin, 1978). The ventro-
medial part of the otic epithelium
gives rise to the cochlea and the lat-
erodorsal region to the vestibular or-
gan (Torres and Giraldez, 1998). The
formation of the mature inner ear is
regulated by a combinatorial action of
genes (Brigande et al., 2000) and a
balanced interplay between different
signaling mechanisms acting from in-
side and outside the otic vesicle (Ric-
comagno et al., 2002, 2005; Bok et al.,
2003; Ozaki et al., 2004). Remarkably,
the mutation of many genes (at least
35 known genes) can lead to hearing
loss in hereditary deafness (Holme
and Steel, 1999).
Cell adhesion molecules, including
cadherins, are suggested to be in-
volved in the genesis of the cochlea
(Richardson et al., 1987; Raphael et
al., 1988; Kelley, 2003; Novince et al.,
2003). Cadherins are Ca2-dependent
adhesion molecules and play impor-
tant roles in the regulation of morpho-
genesis and tissue formation during
embryo development (Redies, 1995,
2000; Takeichi, 1995). Several cad-
herins were found to be expressed
during the development of the cochlea.
In the zebraﬁsh, cadherin-2 (Cad2 or
N-Cad) and cadherin-4 (Cad4 or R-
Cad) are transcribed only in the sen-
sory patches and in the statoacoustic
ganglion, while cadherin-11 (Cad11)
mRNA is expressed widely in the
early otic placode and restricted later
to a subset of cells, including hair cells
(Novince et al., 2003). In the chicken,
N-Cad and E-cadherin (E-Cad) are co-
expressed ﬁrst in the epithelium of the
otic vesicle and subsequently, N-Cad
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is maintained in the sensory epithelia
of the basilar papilla, whereas E-Cad
is detected in the nonsensory epithelia
(Richardson et al., 1987; Raphael et
al., 1988). During rat cochlear ontog-
eny, truncated-cadherin (T-Cad) is
present in ﬁbrocytes and in the subdo-
mains of the pillar cells. E-Cad is ex-
pressed in cochlear epithelial cells ex-
cept for the inner hair cells (IHCs).
N-Cad appears ﬁrst in the developing
IHCs and then in the neighboring
Ko¨lliker’s organ (Simonneau et al.,
2003). Furthermore, protocadherin-15
(Pcdh15) and cadherin-23 (Cad23) are
involved in the formation of the ste-
reociliary bundles of the hair cells
during mouse cochlear development
and may regulate the mechanoelectri-
cal transduction in the hair cells (Ala-
gramam et al., 2001a,b; Siemens et
al., 2004). Mutation of the Pcdh15 and
Cad23 genes results in defects of the
hair cells and causes a recessive deaf-
ness in mice (Hampton et al., 2003;
Noben-Trauth et al., 2003; Adato et
al., 2005; El-Amraoui and Petit, 2005).
The distribution and function of cad-
herins in the developing cochlea have
still remained largely unexplored. In
the present study, we investigated the
relationship between cadherin expres-
sion patterns and developing cochlear
structures at late embryonic stages in
the chicken. Our results show that the
expression of each of eight different
classic cadherins is restricted to distinct
parts and cell types of the cochlea, al-
though the expression patterns overlap
partially.
RESULTS
Cloning and Sequence
Analysis of Chicken cDNAs
Encoding Cadherins
To obtain cDNAs encoding chicken
Cad8, Cad11, Cad19, and Cad20, re-
verse transcriptase-polymerase chain
reaction (RT-PCR) was performed us-
ing pairs of speciﬁc or degenerate
primers under optimal parameters
(see Table 1). The PCR fragments
were subcloned into pBluescript-
SK() or pCRII-TOPO vectors, and
the clones were sequenced. A search of
the NCBI GenBank database (http://
www.ncbi.nlm.nih.gov) using the
BLAST program revealed that two
fragments of 2,850 bp and 2,055 bp,
respectively, had the same nucleotide
sequences as the published chicken
Cad11 (GenBank accession no.
NM_001004371) and Cad20 (Gen-
Bank accession no. NM_204134). Two
other fragments of 1,759 bp and 1,407
bp, respectively, shared highest simi-
larity with the predicted sequence
Cad8 (GenBank accession no.
XM_425125) and Cad19 (GenBank ac-
cession no. XM_419115) of chicken. To
identify whether these two fragments
were chicken Cad8 and Cad19, rapid
ampliﬁcation of cDNA ends (RACE)
was carried out using different prim-
ers (see Table 1). Two full-length se-
quences encoding 799 amino acids
(see Supplementary Figure S1, which
can be viewed at http://www.inter
science.wiley.com/jpages/1058-8388/
suppmat) and 776 amino acids (see
Supplementary Figure S2) were ob-
tained, respectively. On the nucleotide
level, these two full-length sequences
share highest similarity with the pre-
dicted chicken Cad8 and Cad19 se-
quences, respectively. On the amino
acid level, the proteins deduced from
the two full-length sequences show
highest similarity to human Cad8
(90% identity; GenBank accession no.
BC113416) and to human Cad19 (57%
identity; GenBank accession no.
AJ007607), respectively. Alignment of
the amino acid sequences between the
obtained chicken molecules and known
cadherins revealed that the deduced
chicken proteins possess the domains
characteristic of the classic cadherin
family (see Supplementary Figures S1
and S2). Taken together, the two mole-
cules obtained were identiﬁed as
chicken Cad8 and Cad19, respectively.
The complete sequences of chicken
Cad8 (accession no: EF608154) and
Cad19 (accession no: EF608155) have
been submitted to NCBI GenBank.
Expression of Cadherins in
the Developing Cochlea
We investigated the gene expression
patterns of eight classic cadherins in
TABLE 1. Primers of PCR or RACE and the PCR Parameters for Different Cadherinsa
Name Primer (PCR or RACE) PCR parameter
Cad8 5-aacaaacctctggagcctc-3 30 sec at 94°C, 30 sec at 50°C
5-cggaattctcrtanggnggngcngt-3 3 min at 68°C
Cad11 5-gctctagagatgctgccgcctctgct-3 15 sec at 94°C, 30 sec at 55°C
5-gctctagacctgcttacatttcttctggattc-3 3.5 min at 68°C
Cad19 5-aatgcccggctgctttaca-3 30 sec at 94°C, 30 sec at 54°C
5-ctcaccacctccttcatcatcata-3 2 min at 68°C
Cad20 5-ggaattcgtktggaaycarttytt-3 15 sec at 94°C, 30 sec at 51°C
5-ggaattcrtabctctgsagggartc-3 2.5 min at 68°C
Cad8-anti-1 5-gaatgttggctgcttctaccttcagag -3
Cad8-anti-2 5-ggcttctctgtccatgttgggaagagc-3
Cad19-anti-1 5-ggtggattgtcattgacgtcagagagg-3
Cad19-anti-2 5-gctcctgcttgtccaaccatatctttgg-3
Cad8-sense-1 5-cctcctaagtttgcgcagagtctgtatc-3
Cad8-sense-2 5-gaaccacagtcaagtgtcccgggtgc-3
Cad19-sense-1 5-ctgtcactgtctgtgactgtgatactg-3
Cad19-sense-2 5-gcataagacagcagaggaagaagactc-3
aPCR, polymerase chain reaction; RACE, rapid ampliﬁcation of cDNA ends.
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transverse sections through midre-
gions of the cochlea from 11 days of
incubation (E11; stage 37), when
hearing in chicken embryo begins
(Saunders et al., 1973; Jackson and
Rubel, 1978; Jones et al., 2006), to the
prehatching stage (E18). At E11, dif-
ferent types of cells in distinct ana-
tomical regions can be recognized in
the embryonic cochlea (Cohen and
Fermin, 1978; Tanaka and Smith,
1978). For example, sensory hair cells
and supporting cells are located in the
basilar papilla, and ganglion cells in
the acoustic ganglion (Fig. 1A,B). The
three cell types can be visualized by
their Islet-1 expression (Li et al.,
2004) (Fig. 1C). Homogene cells are
found adjacent to the superior ﬁbro-
cartilaginous plate and spindle-
shaped cells are distributed between
the acoustic ganglion cells and the
sensory epithelium (Fig. 1A). In the
following paragraphs, we will describe
the expression of each cadherin in the
different cell types and tissues associ-
ated with the cochlea.
Cad6B mRNA was detectable at
E11 and E14 (Fig. 1D,E) in the spin-
dle-shaped cells and the acoustic gan-
glion cells, but disappeared at E18
(Fig. 1F). From E14, Cad6B began to
be expressed in the tall hair cells (Fig.
1E–G). Cad8 mRNA was extremely
abundant in the supporting cells at
the inferior edge of the basilar papilla
at E11 and E14 (Fig. 1H,I) and was
distributed homogeneously at E18
(Fig. 1J).
For Cad11, previous studies have
indicated that this molecule is ex-
pressed widely by neural cells as well
as by mesenchymal cells. Cad11 is in-
volved in various morphogenetic
events, e.g., neurogenesis and chon-
drogenesis, during embryonic devel-
opment (Simonneau et al., 1995; Si-
monneau and Thiery, 1998; Vallin et
al., 1998). In our study, strong expres-
sion of Cad11 was found in the chon-
droblast cells and the mesenchymal
cells around the cochlea. Further-
more, Cad11 was found in the sup-
porting cells and the homogene cells
from E11 to E18 (Fig. 1K–M). N-Cad
was expressed abundantly in the hair
cells, in the supporting cells of the
sensory epithelium, and in acoustic
ganglion cells at E11 and E14 (Figs.
1N,O, 3F,J) and was retained at E18
(Fig. 1P).
Cad7 was expressed in the spindle-
shaped cells and the acoustic ganglion
cells at both the mRNA and protein
level from E11 to E18 (Figs. 2A–D,
3C,D). Cad19 mRNA was found in the
spindle-shaped cells (Fig. 2E–G),
while Cad20 transcript was present in
the acoustic ganglion cells (Fig. 2H–J).
R-Cad expression was present in
the homogene cells and the acoustic
ganglion cells at E11 and E14 (Figs.
2K,L, 3I) and was reduced in the ho-
mogene cells and disappeared in the
acoustic ganglion cells at E18 (Fig. 2M).
In summary, the expression of each
of the eight cadherins was restricted
to different types of cells and distinct
anatomic structures of the cochlea,
with partial overlap (Fig. 2N).
Furthermore, the neurites of the
acoustic ganglion were also studied. By
immunostaining against neuroﬁlament
(NF), a speciﬁc marker for differenti-
ated neurons and their processes (Hatta
Fig. 1. Expression of Islet-1 and cadherins in transverse sections through the midregion of the
developing chicken cochlea. A: Hematoxylin and eosin (HE) staining at embryonic day (E) 11. B,C:
Nuclear stain using dye Hoechst 33258 (Nuc, B) and immunostaining for Islet-1 for revealing hair
cells (hc), supporting cells (sp), and acoustic ganglion cells (sg) at the same section of E11 (C). D–P:
In situ hybridization (D–F,H–P) and immunostaining (G) for Cad6B (D–G), Cad8 (H–J), Cad11 (K–M),
and N-Cad (N–P) at different stages (marked). Adjacent sections are shown in D, H, K, and N, and
in E, I, L, and O, respectively. ho, homogene cells; me, mesenchymal cells; se, sensory epithelium;
ssc, spindle-shaped cells; tv, tegmentum vasculosum. Scale bars  50 m in A, 100 m in B
(applies to B,C,F,G,J,M,P), 200 m in D (applies to D,E,H,I,K,L,N,O).
CADHERINS IN THE CHICKEN COCHLEA 2333
et al., 1987), and -tubulin III (Tuj-1), a
marker for neurons, axons, and chicken
hair cells (Cheng et al., 2003), the neu-
rites of the acoustic ganglion cells (nf in
Fig. 3B,E) and their terminals that con-
tact the hair cells (arrows in Fig. 3B,E
and insert in 3E) were visualized. The
neurites of the acoustic ganglion cells
expressed Cad7 (nf in Figs. 2D, 3C,D),
N-Cad (nf in Fig. 3F), and R-Cad (nf in
Fig. 3I). Moreover, N-Cad and R-Cad
were coexpressed in the contact areas
between the neurite terminals and the
hair cells (arrows in Fig. 3F,G,I,J).
DISCUSSION
Cadherins in the Sensory
Epithelia and the
Differentiation of Hair Cells
and Supporting Cells
In the present study, expression of
Cad6B and N-Cad was demonstrated
in the hair cells (Fig. 1E–G,N–P),
while Cad8, Cad11, and N-Cad mR-
NAs were present in the supporting
cells of the basilar papilla (Fig. 1H–P).
During chicken cochlear development,
hair cells and supporting cells share a
common progenitor cell (Weisleder et
al., 1995; Fekete et al., 1998). Sup-
porting cells can differentiate into
hair cells when hair cells are de-
stroyed by acoustic noise or ototoxic
drugs (Girod et al., 1989; Adler and
Raphael, 1996; Roberson et al., 2004;
Yamagata et al., 2006). It is remark-
able that N-Cad signaling can induce
cell proliferation of both hair cells and
supporting cells. Blocking the function
of N-Cad results in an inhibition of the
proliferation of both hair cells and
supporting cells (Warchol, 2002).
Therefore, the expression of cadherins
in the supporting cells and the hair
cells may have an effect on the differ-
entiation of the supporting cells and
the hair cells during normal chicken
cochlear development.
Cadherins in Homogene
Cells, Spindle-Shaped Cells,
and Acoustic Ganglion Cells
Cad11 and R-Cad were exclusively ex-
pressed by the homogene cells of the
chicken cochlea (Figs. 1K–M, 2K–M),
which are involved in the formation of
the tectorial membrane during chicken
cochlear development (Tanaka and
Smith, 1975; Cohen and Fermin, 1985).
The temporal proﬁle of Cad11 and R-
Cad expression in the homogene cells
may relate to the generation of the tec-
torial membrane.
The human homologues of Cad7,
Cad19, and Cad20 are closely related
and found at the same chromosomal
location of the human genome (Kools
et al., 2000). Of interest, they were
expressed in an overlapping manner
during cochlear development in the
chicken. Cad19 was transcribed by the
spindle-shaped cells, Cad20 in the
acoustic ganglion cells, and Cad7 in
both of them (Fig. 2A–J). This result
suggests that the regulation of gene
expression for the three cadherins is
only partially diverged in the cochlea
and may coregulate the development
of the spindle-shaped cells and the
acoustic ganglion cells.
In the cochlea, the projection of pe-
ripheral receptive regions onto audi-
tory structures of the central nervous
system is tonotopically organized. The
guidance of the nerve ﬁbers mediating
this tonotopic projection is therefore of
special interest. Several cell adhesion
Fig. 2. Expression of cadherins in transverse sections through the midregion of the developing
chicken cochlea. A–M: In situ hybridization (A–C,E–M) and immunostaining (D) for Cad7 (A–D),
Cad19 (E–G), Cad20 (H–J), and R-Cad (K–M) at different stages (marked). Adjacent sections are
shown in A, E, H, and K, and in B, F, I, and L, respectively. N summarizes schematically the
expression of cadherins in the cochlea at E14. ho, homogene cells; nf, neural ﬁbers; sg, acoustic
ganglion cells; sp, supporting cells; ssc, spindle-shaped cells. Scale bars  50 m in D, 100 m
in C (applies to C,G,J), 200 m in A (applies to A,B,E,F,H,I,K–M).
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molecules have been found to be in-
volved in the guidance of the exten-
sion of the neurites from the acoustic
ganglion to their target hair cells (Ri-
chardson et al., 1987; Kajikawa et al.,
1997). The present study reveals that
Cad7, N-Cad, and R-Cad are coex-
pressed by the neurites of the acoustic
ganglion axons (nf in Figs. 2D, 3F,I)
and that N-Cad and R-Cad are also
coexpressed in the areas of contact be-
tween the neurite terminals and the
hair cells (arrows in Fig. 3I–K). Previ-
ous studies have demonstrated that
Cad7, N-Cad, and R-Cad play an im-
portant role in neurite outgrowth
and fasciculation, in synaptogenesis
and/or in synaptic plasticity during
embryonic development (Redies et al.,
1992, Redies, 1995; Fannon and Col-
man, 1996; Riehl et al., 1996; Tanaka
et al., 2000; Treubert-Zimmermann et
al., 2002). Therefore, the three cad-
herins may be involved in the guid-
ance of neurites from the acoustic gan-
glion to the sensory epithelium and in
synaptogenesis with the target cells.
EXPERIMENTAL
PROCEDURES
Animals, Antibodies, and
cRNA Probes
Eggs fromWhite Leghorn chicken (Gal-
lus domesticus) were incubated in a
forced-draft incubator (BSS160, Ehret,
Germany) at 37°C under 60% humidity.
Chicken embryoswere staged according
to Hamburger and Hamilton (1951). Af-
ter the embryos were deeply anesthe-
tized by cooling on ice, they were re-
moved from the shell and perfused
through the heart with 4% formalde-
hyde in 0.1 M cacodylate buffer (Roth,
Karlsruhe, Germany; containing 1 mM
Ca2 and 1mM Mg2). Cochleae were
separated and collected for this study at
E11, E14, and E18 (stages 37, 40, and
44, respectively; at least six cochleae for
each stage). The experiments were car-
ried out under an approved institu-
tional protocol according to the Na-
tional Institutes of Health Guide for the
Care and Use of Laboratory Animals.
For immunohistochemistry, primary
mouse and rat monoclonal antibodies
raised against Cad6B (CCD6B-1) and
Cad7 (CCD7-1; Nakagawa and Takei-
chi, 1998), N-Cad (NCD-2; Hatta and
Takeichi, 1986), R-Cad (RCD-2; Redies
et al., 1992), Islet-1 (Li et al., 2004),
neuroﬁlament (Hatta et al., 1987), and
-tubulin III (Tuj-1; Sigma) were used.
CCD6-1, CCD7-1, NCD-2, RCD-2, and
neuroﬁlament antibodies were kind
gifts of Dr. S. Nakagawa and Dr. M.
Takeichi (RIKEN Center for Develop-
mental Biology, Kobe, Japan). Antibod-
ies against Islet-1 were obtained from
the Developmental Studies Hybridoma
Bank developed under the auspices of
the NICHD and maintained by The
University of Iowa, Department of Bio-
logical Sciences (Iowa City, IA 52242).
For in situ hybridization, puriﬁed
plasmids containing the full-length
sequences encoding chicken Cad6B,
Cad7, N-Cad, and R-Cad (kind gifts of
Dr. S. Nakagawa and Dr. M. Takei-
chi), and the RT-PCR fragments en-
coding chicken Cad8, Cad11, Cad19,
and Cad20 were used as templates for
the in vitro synthesis of cRNA probes.
Digoxigenin-labeled sense and anti-
sense cRNA probes were transcribed
according to the manufacturer’s in-
structions (Roche, Mannheim, Ger-
many). Sense cRNA probes were ap-
plied as a negative control for in situ
hybridization.
RT-PCR and RACE Reaction
To obtain chicken cDNAs encoding
cadherins (Cad8, Cad11, Cad19, and
Cad20), mRNA from E14 (stage 40)
Fig. 3. Expression of cadherins in transverse sections through the midregion of the developing
chicken cochlea. A,B: Nuclear stain using dye Hoechst 33258 (Nuc; A) and immunostaining for
neuroﬁlament (NF; B) to reveal nerve ﬁbers (nf) targeting the sensory epithelium. The arrow indicates the
neurites at the bottom of the hair cells. C,D: Cad7 is expressed in the acoustic ganglion cells (sg) and
their projections (nf). The arrow points to spindle-shaped cells. E–H: Double immunostaining for
-tubulin III (Tuj-1; green, E) and N-Cad (red, F) in the cochlea at embryonic day (E) 11. G: The merged
image of E and F is shown. H: A nuclear stain using dye Hoechst 33258. The arrows indicate the bottom
of the hair cells, where the neurites contact the hair cells to form synapses. The insert in E shows a
magniﬁcation of a sensory epithelial region. The arrowhead indicates the hair cells (hc). The nuclei of the
hair cells and the supporting cells (sp) are represented by the violet color. I–L: Double immunostaining
of R-Cad (green, I) and N-Cad (red, J) in the cochlea at E11. K: The merged image of I and J is shown.
L: A nuclear stain. The arrows indicate the bottom of the hair cells. ho, homogene cells; tm, tectorial
membrane. Scale bars  50 m in C, 100 m in A (applies to A,B,D–L).
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chicken brain was puriﬁed using Mi-
cro-FastTrack 2.0 mRNA Isolation Kit
(Invitrogen, Karlsruhe, Germany) and
ﬁrst-strain cDNA was synthesized in
vitro with the SuperScript First-
Strand Synthesis System (Invitro-
gen). Then PCR was performed with a
pair of speciﬁc or degenerate primers
(see Table 1). The PCR templates were
denatured for 2 min at 94°C, followed
by 35 cycles of ampliﬁcation with op-
timal denaturing, annealing, and ex-
tension conditions for each cadherin
(see Table 1). After the last cycle, the
reaction was extended ﬁnally for 15
min at 72°C. The PCR fragments ob-
tained were cloned into pBluescript-
SK() vector (for Cad8, Cad11, and
Cad20) or into pCR II-TOPO vector
using the TA-cloning kit (Invitrogen;
for Cad19). The plasmids were puri-
ﬁed using the Plasmid Maxi Kit (Qia-
gen, Hilden, Germany) and sequenced
by a commercial company (MWG,
Ebersberg, Germany).
To obtain the full-length se-
quences of chicken Cad8 and Cad19,
5- and 3-end RACE reactions were
performed with the SMART RACE
cDNA Ampliﬁcation Kit (Takara Bio
Europe/Clontech, Saint-Germain-
en-Laye, France). The speciﬁc prim-
ers for RACE were chosen from the
obtained PCR fragments according
to the instructions of the RACE Kit
User Manual. The primers for 5-end
RACE PCR (Cad8-anti-1 and Cad8-
anti-2 for chicken Cad8; Cad19-
anti-1 and Cad19-anti-2 for chicken
Cad19) and 3-end RACE PCR (Cad8-
sense-1 and Cad8-sense-2 for Cad8;
Cad19-sense-1 and Cad19-sense-2 for
Cad19) are shown in Table 1. The
touch-down PCR for 5- and 3-end
RACE ampliﬁcation was performed
using the 5- and 3-end RACE PCR
primers (Cad8-anti-1 and Cad19-an-
ti-1 for 5-end RACE; Cad8-sense-1
and Cad19-sense-1 for 3-end RACE,
respectively) together with the Uni-
versal Primer Mix. For the ﬁrst 5 cy-
cles, the touch-down PCR was per-
formed at 94°C for 30 sec and at 72°C
for 3 min. The next 5 cycles were per-
formed at 94°C for 30 sec, 70°C for 30
sec, and 72°C for 3 min. At last, an-
other 27 cycles were performed at
94°C for 30 sec, at 68°C for 30 sec, and
at 72°C for 3 min. To obtain more spe-
ciﬁc bands, nested PCR was per-
formed following the touch-down PCR
for 5- and 3-end cDNA ampliﬁcation
with the primers (Cad8-anti-2 and
Cad19-anti-2 for 5-end RACE; Cad8-
sense-2 and Cad19-sense-2 for 3-end
RACE) together with the Nested Uni-
versal Primer, respectively. The PCR
templates were denatured for 1 min at
95°C, followed by 20 cycles of ampliﬁ-
cation (denaturing for 30 sec at 95°C,
and annealing and extension for 3 min
at 68°C). The PCR products were
cloned into pCR II-TOPO vector (In-
vitrogen) and sequenced by a commer-
cial company (MWG). After ligating
the RACE sequences with the ob-
tained RT-PCR fragment sequences,
two molecules with the full-length nu-
cleotide sequences were obtained.
Immunohistochemistry
To detect the expression of cadherins in
the cochlea, ﬂuorescent immunostain-
ing was performed on sections of
chicken cochleae according to the proto-
col described previously (Luo and
Redies, 2004). In brief, after post-ﬁxa-
tion with 4% formaldehyde, cryostat
sections of 20 m thickness were prein-
cubated with blocking solution (5%
skimmed milk, 0.3% Triton X-100 in
TBS) at room temperature for 60 min.
Then the sections were incubated over-
night at 4°C with the primary antibody
against cadherin, followed by Alexa
488-labeled or Cy3-labeled secondary
antibody against mouse or rat IgG (Di-
anova, Hamburg, Germany) at room
temperature for 1 hr. Finally, cell nuclei
were counterstained with dye Hoechst
33258 (Molecular Probes, Eugene, OR).
Fluorescence was imaged under a ﬂuo-
rescence microscope (BX40, Olympus,
Hamburg, Germany) equipped with a
digital camera (DP70, Olympus).
For double-label ﬂuorescent im-
munohistochemistry, sections were
ﬁrst immunostained with antibodies
against R-Cad or -tubulin III using
the method described above. Subse-
quently, immunostaining for N-Cad
was performed.
In Situ Hybridization
In situ hybridization on cryosections
was performed according to the proto-
col described previously (Redies and
Takeichi, 1993). In brief, after post-
ﬁxation with 4% formaldehyde in
phosphate-buffered saline, cryostat
sections of 20 m thickness were pre-
treated with proteinase K and acetic
anhydride and hybridized overnight
with cRNA probe at a concentration of
approximately 1–5 ng/l at 70°C in
hybridization solution (50% form-
amide, 3 SSC, 1 Denhardt’s solu-
tion, 250 g/ml yeast transfer RNA,
and 250 g/ml salmon sperm DNA).
After the unbound cRNA was removed
by RNAse, the sections were incu-
bated with alkaline phosphatase-con-
jugated anti-digoxigenin Fab frag-
ments (Roche) at 4°C overnight. For
visualization of the labeled mRNA, a
substrate solution of nitroblue tetra-
zolium salt (NBT) and 5-bromo-4-
chloro-3-indoyl phosphate (BCIP) was
added. The color reactions were ana-
lyzed under a microscope (BX40,
Olympus) and photographed with a
digital camera (DP70, Olympus).
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isoforms in the embryonic chicken brainJuntang Lina, Jiankai Luoa,b, Christoph Rediesa,⁎
aInstitute of Anatomy I, Friedrich Schiller University Jena, Teichgraben 7, D-07743 Jena, Germany
bNeurobiological Laboratory, Department of Neurology, University of Rostock, Gehlsheimerstrasse 20, D-18147 Rostock, GermanyA R T I C L E I N F O⁎ Corresponding author. Fax: +49 3641 938512
E-mail address: redies@mti.uni-jena.de (C
Abbreviations: Cdh, cadherin; EC, extracellu
saline; ORF, open reading frame; RACE, rapid
0006-8993/$ – see front matter © 2008 Elsevi
doi:10.1016/j.brainres.2008.01.071A B S T R A C TArticle history:
Accepted 26 January 2008
Available online 9 February 2008Three types of full-length cDNAs encoding chicken cadherin-8 (Cdh8) were identified and their
expression in the embryonic chicken brain was investigated. The longest type of cDNA is
closely similar to that of other classic cadherins, and the predicted protein shows a high
similarity to rat and human Cdh8. The second type of cDNA is considerably shorter. The
deduced protein lacks the cytoplasmic tail and the transmembrane domain, and contains a
truncated fifth cadherin repeat in the extracellular domain (EC5; 68 amino acids), suggesting
that it is a soluble isoform. The third type resembles the secondone but is even shorter (only 30
amino acids in EC5). All types contain unique short sequences at their C terminus. Genomic
analysis demonstrated that all of the three Cdh8 isoforms are located on chromosome 11, and
consist of 12, 10, and 9 exons, respectively. Semi-quantitative RT-PCR with type-specific
primers showed that the transcription of the threeCdh8 isoformswas temporally and spatially
regulated in different parts of the embryonic chicken brain. The distinct regulation of gene
expression suggested that the three isoforms likely play different roles during brain
development. Northern blot analysis revealed that the transcription of the long isoform was
much stronger than that of the two shorter ones. In situ hybridization showed that the long
isoformof Cdh8 is expressed by a specific subset of brain nuclei, regions and layers in allmajor
parts of the brain.
© 2008 Elsevier B.V. All rights reserved.Keywords:
Cadherin
RACE
Isoform
Expression pattern
Brain development
In situ hybridization1. Introduction
Cadherins are a large family of transmembrane proteins that
mediateCa2+-dependent cell–cell adhesion.Theyplay important
roles in regulating morphogenesis and tissue formation during
embryonic development, also in the central nervous system
(CNS) (for reviews, see Redies (2000); and Takeichi (2007)). Cad-
herin subfamilies are the classic cadherins (type I and type II),
the protocadherins, the desmosomal cadherins, etc. (Nollet
et al., 2000). So far, more than a dozen classic cadherins have.
. Redies).
lar domain; GAPDH, glyc
amplification of cDNA e
er B.V. All rights reservedbeen reported in various tissues of different organisms. In gen-
eral, classic cadherinssharecommonproperties. For example, at
theN-terminal side, theextracellulardomain iscomposedof five
so-called cadherin repeats. Following the transmembrane
domain, there is a highly conserved cytoplasmic domain at the
C-terminal side. The expression of most classic cadherins, for
example, of N-cadherin, R-cadherin, cadherin-6 (Cdh6), Cdh7,
Cdh8, Cdh11, and Cdh20, is restricted to specific developing gray
matter regions, fiber tracts and synapses in theCNS (for reviews,
see Redies (2000); and Hirano et al. (2003)).eraldehyde-3-phosphate dehydrogenase; PBS, phosphate-buffered
nds
.
2 B R A I N R E S E A R C H 1 2 0 1 ( 2 0 0 8 ) 1 – 1 4Cdh8, a type II classic cadherin, has been identified in human
(Shimoyamaetal., 2000),mouse (KorematsuandRedies, 1997a,b),
rat (Kido et al., 1998) and chicken (Luo et al., 2007). The expression
of this cadherin has been studied in detail in the mouse brain
(Korematsu and Redies, 1997a,b; Korematsu et al., 1998).
An analysis of Cdh8 knock-out mice revealed that Cdh8 is es-
sential for establishing the physiological coupling between cold-
sensitive sensory neurons and their target dorsal horn neurons
(Suzuki et al., 2007).
Itwasalso reported that rat Cdh8 is expressed in two forms, a
complete form and a truncated formwithout a transmembrane
domain and a cytoplasmic tail (Kido et al., 1998). Splicing
variants of type II cadherins have been reported also for Cdh22
(PB-cadherin; Sugimoto et al., 1996), Cdh11 (Kawaguchi et al.,
1999), andCdh7 (Kawano et al., 2002). The variant forms of these
cadherins represent truncated transmembrane proteins with a
short cytoplasmic domain that differs from the full-length
forms. In contrast, the short variant of Cdh20 (MN-cadherin)
lacks the EC1 and EC2 domains in the extracellular region
(Shirabe et al., 2005). The function of these short variants re-
mains to be elucidated. Variant forms of some protocadherins
have been reported as well (Makarenkova et al., 2005; Vanhalst
et al., 2005).
Little is known about variant Cdh8 forms and the expres-
sion of Cdh8 in chicken. In the present study, we have suc-
cessfully cloned and identified two novel truncated isoforms
of chicken Cdh8 by RACE (rapid amplification of cDNA ends).
The two isoforms lack the transmembrane domain and the
cytoplasmic tail, but both have short unique sequences at the
C terminus. The gene and protein structures of the three Cdh8
isoforms were analyzed by appropriate bioinformatics soft-
ware. The expression of the three isoforms was studied at dif-
ferent developmental stages and in various parts of the brain by
semi-quantitative RT-PCR. Our results show that the expres-
sion of the Cdh8 isoforms is temporally and spatially regulated
during brain development. The expression pattern of the long
isoform was mapped by in situ hybridization in the embryonic
chicken brain.Fig. 1 – A. Visualization of the unique PCR products that
correspond to the three isoforms of Cdh8. 1, Cdh8-1 (466 bp);
2, Cdh8-2 (575 bp); 3, Cdh8-3 (697 bp); M, DNA molecular
weight marker; mix, mixture of all three unique PCR
products. B. ORFs of the three Cdh8 isoforms. 1, Cdh8-1
(1585 bp); 2, Cdh8-2 (1697 bp); 3, Cdh8-3 (2400 bp); M, DNA
molecular weight marker; mix, mixture of all three ORF.
C. Results from Northern blot analysis showing the relative
transcript amounts of the three Cdh8 isoforms (Cdh8-1,
2.5 kb; Cdh8-2, 2.8 kb; and Cdh8-3, 3.6 kb) at E18. D. The
measured intensity values of the bands are normalized to the
Cdh8-3 value. The error bars represent means +/−s.e.m.
(n=3).2. Results
2.1. Cloning and identification of novel chicken
Cdh8 isoforms
Based on the predicted sequence of chicken Cdh8 (GenBank
accession No. XM_425125), a 1759 bp fragment was cloned
previously (Luo et al., 2007). By nested RACE PCR, one band of
about 1500 bp in length was obtained from the 5 end and two
bands of about 600 bp and 750 bp in length from the 3 end,
respectively. After sequencing and alignment of these RACE
products with the 1759 bp fragment, two full-length sequences
with polyadenylation sites were obtained. The length of one
sequence was 2570 bp, and of the other sequence was 2771 bp.
An alignment of these two sequences with Cdh8 from other
animals revealed a very high similarity with Cdh8 from human
(NM_001796), mouse (NM_007667) and rat (NM_053393) (more
than 80% sequence identity), but they were much shorter than
the complete Cdh8 sequences of the other species. Therefore,
these two sequences represented truncated isoforms of chickenCdh8, and were named Cdh8-1 and Cdh8-2. The long Cdh8
isoformthat includeda3676bpsequencewithapolyadenylation
site was similar in length to human, mouse or rat Cdh8. It was
confirmed as chicken Cdh8 (Luo et al., 2007) and named Cdh8-3.
The sequences of these three isoforms of chicken Cdh8 have
been submitted to NCBI GenBank (Cdh8-1, GenBank accession
No. EU035636; Cdh8-2, GenBank accession No. EU035637; and
Cdh8-3, GenBank accession No. EF608154).
Next, primers were designed to amplify unique fragments
of the three isoforms for use in semi-quantitative RT-PCR,
Northern blotting and in situ hybridization (ISH). Bands of
466 bp length (for Cdh8-1), 575 bp length (for Cdh8-2) and 697 bp
length (for Cdh8-3) were obtained (Fig. 1A) and cloned into
3B R A I N R E S E A R C H 1 2 0 1 ( 2 0 0 8 ) 1 – 1 4Topo II vector. The position of the primers and the unique
fragments is shown in the alignment of the three isoforms
(Suppl. Fig. S1).
To confirm the existence of the three Cdh8 isoforms, their
ORFswereclonedbyRT-PCR (Fig. 1B). Bandsof thepredictedsize
were obtained (Cdh8-1, 1585 bp; Cdh8-2, 1697 bp; and Cdh8-3,
2400 bp).
Northern blot was performed to confirm the existence of
three Cdh8 isoforms in the E18 chicken brain. Results revealed
three bandsof 2.5 kb, 2.8 kb and 3.6 kb in length corresponding to
Cdh8-1, Cdh8-2 andCdh8-3, respectively (Fig. 1C).These findings
are compatible with results from RACE and RT-PCR. The
intensity of the bands was quantifiedwith appropriate software
(ImageQuant TL). Result showed that the expression levels of
Cdh8-1 and Cdh8-2 were similar. Expression of Cdh8-3 was
about 15 times stronger than that of the two shorter isoforms
(Fig. 1D). Similar results were obtained for chicken brain at E7
and E12 (data not shown).
2.2. Gene structure and characterization of the
three isoforms
The three sequences of chicken Cdh8 were blasted against the
chicken genome (http://www.ncbi.nlm.nih.gov/blast). Results
showed that Cdh8-1 has 9 exons, Cdh8-2 has 10 exons, and
Cdh8-3 has 12 exons, respectively (Fig. 2A). The 8 exons of the 5
end are identical in the three isoforms. The remaining exons at
the 3 end differ from each other, especially in the UTR. The
lengths of the exons and introns are shown in Table 1. Cdh8 is
located on chromosome 11 of the chicken genome in a region
that represents a synteny block on chromosome 16 in the
human genome (Martin et al., 2004). Chicken Cdh8 and human
Cdh8 both have 12 exons. The exon sizes and the intron/exon
boundaries for chicken Cdh8 are very similar, if not identical,
compared to those of human Cdh8. Differences exist only in the
first exon and in the last exon; the 3-UTR and 5-UTR of chicken
Cdh8 both are much longer than in human Cdh8. However, theFig. 2 – A. Genomic organization of chicken Cdh8 and exon/intro
represent exons and horizontal lines represent introns between t
(2) consists of 10 exons and 9 introns, and Cdh8-3 (3) consists of
putative chicken Cdh8 products. Cdh8-1 (1) lacks the transmembra
extracellular repeat (EC5; only 30 aa). Cdh8-2 (2) is similar to Cdh
complete isoform of chicken Cdh8.length of the introns shows large differences between chicken
and human Cdh8 (Table 1).
A comparison of the unique sequences of Cdh8-1, Cdh8-2
and the truncated isoform of rat Cdh8 indicates that there is a
consensus sequence (AA[G]ATAT) at the boundary between the
complete type of Cdh8 and the truncated ones (Suppl. Fig. S1).
This result suggests that these truncated types are produced by
alternative mRNA splicing (Kido et al., 1998). The possible
alternative splicing sites are indicated by arrowheads in Sup-
plementary Fig. S1. Furthermore, Cdh8-1, butnot Cdh8-2, shares
a sequence (AAATATCCATGTT) with the truncated Cdh8 iso-
form from rat, suggesting that Cdh8-1 is the chicken orthologue
of this isoform.
TheORFof the three isoformsof Cdh8were obtainedwith the
ORF Finder program at the NCBI website (http://www.ncbi.nlm.
nih.gov/gorf/gorf.html). The putative proteins have the follow-
ing lengths: Cdh8-1 526 aa, Cdh8-2 564 aa, and Cdh8-3 799 aa. An
alignment of the three isoformswas carried outwith the Clustal
X 1.83 program. Results displayed in Supplementary Fig. 2 dem-
onstrate that the two shorter isoforms of chicken Cdh8 each
have aunique13 aa-long sequenceat theC terminus in EC5. The
molecular weight of Cdh8-1, Cdh8-2 and Cdh8-3 is 58.45 kDa,
62.81 kDa, and 88.38 kDa, respectively. The three isoforms have
a similar isoelectric point around pI 4.6 (analyzed with the
DNASTAR Protean program).
A protein blast (http://www.ncbi.nlm.nih.gov/blast) of the
three isoformsofCdh8 indicated thatCdh8-1,Cdh8-2andCdh8-3
show ahigh similarity to humanCdh8 (NP_001787),mouse Cdh8
(NP_031693) and rat Cdh8 (NP_445845; Table 2). Cdh8-3 possesses
all domains of a classic cadherin (5 extracellular repeats, a trans-
membrane domain and a cytoplasmic tail). Cdh8-1 and Cdh8-2
lack the transmembrane domain and the cytoplasmic tail; the
fifth extracellular cadherin domain (EC5) contains only 68 aa
and 30 aa in Cdh8-2 and Cdh8-1, respectively (Fig. 2B and Suppl.
Fig. S2).
Signal peptide analysis was performed with the SignalP 3.0
program (http://www.cbs.dtu.dk/services/SignalP/) and revealedn structure of the three cloned isoforms. Vertical lines
he exons. Cdh8-1 (1) consists of 9 exons and 8 introns, Cdh8-2
12 exons and 11 introns. B. Schematic representation of the
ne domain and cytoplasmic tail and contains a truncated fifth
8-1, but has 68 aa in the truncated EC5. Cdh8-3 (3) is the
Table 1 – The exon and intron sizes of the three isoforms
of chicken Cdh8 and human Cdh8 (H-Cdh8)
Exon (bp) Intron (bp)
Cdh8-1 1 (323) 1 (17052)
2 (446) 2 (43032)
3 (297) 3 (22557)
4 (121) 4 (13924)
5 (172) 5 (3889)
6 (188) 6 (2722)
7 (258) 7 (3497)
8 (140) 8 (16309)
9 (255)
Cdh8-2 1 (323) 1 (17052)
2 (446) 2 (43032)
3 (297) 3 (22557)
4 (121) 4 (13924)
5 (172) 5 (3889)
6 (188) 6 (2722)
7 (258) 7 (3497)
8 (140) 8 (16309)
9 (126) 9 (6873)
10 (697)
Cdh8-3 1 (323) 1 (17052)
2 (446) 2 (43032)
3 (297) 3 (22557)
4 (121) 4 (13924)
5 (172) 5 (3889)
6 (188) 6 (2722)
7 (258) 7 (3497)
8 (140) 8 (16309)
9 (126) 9 (6873)
10 (116) 10 (26635)
11 (253) 11 (1088)
12 (1229)
H-Cdh8 1 (54) 1 (14586)
2 (449) 2 (119663)
3 (300) 3 (44044)
4 (121) 4 (32105)
5 (172) 5 (4067)
6 (188) 6 (3194)
7 (258) 7 (27117)
8 (140) 8 (62134)
9 (123) 9 (13134)
10 (122) 10 (58111)
11 (253) 11 (1366)
12 (773)
Fig. 3 – A. Results from semi-quantitative RT-PCR analysis
showing the expression of the Cdh8 isoforms (1, Cdh8-1; 2,
Cdh8-2, and 3, Cdh8-3) at different stages of chicken
embryonic development (E1.5–E4, whole embryos; E5–E8,
whole head; E10–E20, brain); GAPDH (G) served as an internal
control tomonitor the amount of RNA. Note that the intensity
of the bands of Cad8-1 and Cad8-2 was increased to visualize
the weakest ones (compare the bands of the marker that was
used at the same concentration in all panels). B. The
measured intensity values of the bands are normalized to the
GAPDH value. The error bars represent means +/−s.e.m.
(n=3).
4 B R A I N R E S E A R C H 1 2 0 1 ( 2 0 0 8 ) 1 – 1 4amost likely cleavage site between positionsM29 and A30. This
cleavage position is the same for all three isoforms, suggesting
that theputativeCdh8proteinshaveacommonsignal peptideof
29 aa at the N terminus. Similar results were obtained for
human, mouse and rat Cdh8 (data not shown). The signal
peptide is highlighted by purple color in Supplementary Fig. 2.Table 2 – Percent identity and similarity (positives) between the
rat Cdh8
Human NP_001787
Cdh8-1 Identities 87% (451/513)
Positives 93% (478/513)
Cdh8-2 Identities 88% (485/551)
Positives 93% (515/551)
Cdh8-3 Identities 90% (725/802)
Positives 94% (761/802)2.3. Expression of Cdh8 isoforms during chicken
embryonic development
To study the transcription of the three chickenCdh8 isoforms in
the chicken embryo, we performed semi-quantitative RT-PCR
from E1.5 to E20 (Fig. 3A). Results for Cdh8-3 and GAPDH, which
served as an internal control, were from multiplex RT-PCR.
However,multiplex RT-PCR did notwork for Cdh8-1 andCdh8-2
in conjunction with Cdh8-3 or GAPDH. The bands were quan-
tified by using appropriate software (ImageQuant TL). Thechicken Cdh8 isoforms and human Cdh8,mouse Cdh8, and
Mouse NP_031693 Rat NP_445845
Identities 86% (446/513) Identities 86% (446/513)
Positives 92% (475/513) Positives 92% (475/513)
Identities 86% (479/551) Identities 86% (479/551)
Positives 92% (512/551) Positives 92% (512/551)
Identities 89% (718/799) Identities 89% (717/799)
Positives 94% (758/799) Positives 94% (757/799)
5B R A I N R E S E A R C H 1 2 0 1 ( 2 0 0 8 ) 1 – 1 4measured valueswere normalized to the corresponding GAPDH
values (Fig. 3B). Negative controls (water andnoenzyme)didnot
yield any band (data not shown).
Results showed that Cdh8-3 begins to be transcribedweakly
at E2 in whole embryos. As the embryo develops, the tran-
scriptionof Cdh8-3 increases gradually in the embryosuntil E4.
In the head, expression is relatively high from E4 to E6 and, in
the brain, from E10 to E20. Cdh8-1 and Cdh8-2 are expressed
more weakly than Cdh8-3. Transcript of Cdh8-2 is detected
fromE2.5 and increases until E4 inwhole embryos. In the head,
expression is higher at E8 than at E5 and E6. In the brain,
expression is relatively prominent from E10 to E20. ExpressionFig. 4 – A, C and E. Results from semi-quantitative RT-PCR analy
Cdh8-1; 2, Cdh8-2, and 3, Cdh8-3) in brain at E7 (A), E12 (C) and E
Note that 35 PCR cycles were used for Cdh8-1 and Cdh8-2, but 25
intensity values of the bands are normalized to the GAPDH value
means +/−s.e.m. (n=3). Dienc, diencephalon; Mesenc, mesencep
Rhombenc, rhombencephalon; and Telenc, telencephalon.of Cdh8-1 is similar to Cdh8-2. Transcript is first detected at E3
in whole embryos. Expression in the head peaks at E8 and, in
the brain, it decreases from E10 to E14, and increases again
until E20. These results suggest that the expression of each
of the Cdh8 isoforms is individually regulated during chicken
embryonic development.
2.4. Regional expression of the three isoforms in chicken
embryonic brain
Toanalyze theexpressionof theCdh8 isoforms inbrainby semi-
quantitative RT-PCR at the regional level, brains of E7, E12 andsis for regional expression of the three Cdh8 isoforms (1,
18 (E). The same amount of total RNA was used in each case.
cycles only for Cdh8-3 and GAPDH. B, D and F. The measured
for E7 (B), E12 (D) and E18 (F). The error bars represent
halon; Metenc, metencephalon; Myelenc, myelencephalon;
6 B R A I N R E S E A R C H 1 2 0 1 ( 2 0 0 8 ) 1 – 1 4E18 embryos were separated into telencephalon, diencephalon,
mesencephalon, metencephalon and myelencephalon (for E7
brains, the metencephalon and myelencephalon were not
separated leaving the rhombencephalon intact). GAPDH served
asan internal control. Because expressionofCdh8-1 andCdh8-2
was overall weaker (see Figs. 1C, D and 3A, B), the number of
RT-PCR cycles usedwashigher than that for Cdh8-3 andGAPDH
amplification. For each isoform, regional differences in tran-
scription can be detected. For example, at E7, the expression of
Cdh8-2 and Cdh8-3 is stronger in the rhombencephalon than
telencephalon and mesencephalon (Figs. 4A and B). RegionalFig. 5 – Results from in situ hybridization visualizing Cdh8-3 exp
sections through the rostral diencephalon (A and B), the caudal di
transition area (F) are shown in a rostral-to-caudal sequence. Ab
fourth ventricle; ADP, dorsoposterior nuclear complex of the thala
the midbrain auditory torus; CSh, central shell part of the midbra
the thalamus; DLA, dorsolateral anterior nucleus of the thalamu
dorsomedial anterior nucleus of the thalamus; fp, floor plate; gV
periventricular organ; HT, hypothalamus; IGL, intergeniculate le
aqueduct; LT, lateral terminal nucleus (pretectum); MG, medial g
juxtacommissural nucleus of the pretectum; mPAG, mesenceph
formation; p2Tg, prosomere 2 tegmentum (prerubral field); p3Tg
nucleus; Pe, periventricular stratum; PeCo, periventricular core p
(formerly ventral geniculate nucleus); PrPT, principal pretectal nuc
Rot, rotundus nucleus (thalamus); Rt, reticular nucleus (prethalam
midbrain auditory torus; SCO, subcommissural organ; SCo, supe
medullaris; SPT, subpretectal nucleus; SRot, subrotundus nucleu
prethalamus (ventrolateral nucleus); Tect, tectum; TG, tectal graydifferences in transcription are also seen at E12, especially
for Cdh8-1 and Cdh8-3. For example, the telencephalon
expresses Cdh8-1 more weakly than the metencephalon.
However, the expression of Cdh8-3 is stronger in myelence-
phalon. Cdh8-2 is stably expressed in all brain parts (Figs. 4C
and D). At E18, Cdh8-1 is expressed more weakly in the
mesencephalon than in the telencephalon. Cadh8-3 expression
in the mesencephalon is stronger than in the myelencephalon
(Figs. 4E and F). In conclusion, the expression of the three
isoforms is regulated not only temporally but also regionally in
the embryonic brain.ression in the embryonic day 10 brain of the chicken. Frontal
encephalon (C andD), themidbrain (E) and themid-/hindbrain
breviations: 3, oculomotor nucleus; 3v, third ventricle; 4v,
mus; APT, anterior pretectal nucleus; CCo, central core part of
in auditory torus; DIA, dorsal intermediate anterior nucleus of
s; DLL, dorsal nucleus of the lateral lemniscus; DMA,
, trigeminal ganglion; Hb, habenula; HPO, hypothalamic
aflet; IsV, ventral isthmic nucleus; lraq, lateral recess of the
eniculate nucleus (nucleus ovoidalis); MJC, medial
alic periaqueductal gray; mRtF, mesencephalic reticular
, prosomere 3 tegmentum (Forel's field); PaR, pararubral
art of the midbrain auditory torus; PG, pregeniculate nucleus
leus; RMC, red nucleus,magnocellular part (mesencephalon);
us); RtF, reticular formation; SCo, superficial core part of the
rficial core part of the midbrain auditory torus; sm, stria
s of the thalamus; SubG, subgeniculate nucleus of the
; tt, tectothalamic tract. Scale bar, 500 μm.
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Next, we studied expression of Cdh8 by in situ hybridization.
Expression of Cdh8-1 and Cdh8-2 was too weak to be detected
(no data shown), even with a more sensitive method of in situ
hybridization (tyramide amplification; Van Heusden et al.,
1997). The expression of Cdh8-3 was studied at E8, E10, E12,
E14 and E18 in consecutive series of frontal brain sections.
Representative results are displayed in Fig. 5 for E10, in Fig. 6 for
E12 and in Fig. 7 for E18 (data for E8 and E14 are not shown).
Results indicate that Cdh8-3 expression is restricted to a
specific subset of gray matter structures in all major brain
divisions, from the telencephalon to the hindbrain. At the
regional level, expression is remarkably stable from E8 to E18.
If the expression pattern changes in a given brain region,
these changes usually reflect regional gray matter differen-
tiation. In the following paragraphs, we will describe Cdh8-3
expression on a regional basis in a rostral-to-caudal sequence
for representative stages.
2.5.1. Telencephalon
In themedial pallium,Cdh8-3 is expressed in thehippocampus
(Hi in Fig. 6A) and the parahippocampal area (PHiI, PHiL and
PHiCL in Figs. 6A,B; and 7A,B) at E12. At E18, expression persists
only in the lateral and caudolateral part of the parahippocam-
pal area (PHiL and PHiCL). In the caudolateral parahippocam-
pal area (PHiCL), patches of Cdh8-3 expression are observed in
the superficial layers (Figs. 6B; 7A,B). Similar patches were
described before for Cdh7 expression (Kovjanic and Redies,
2003). In the dorsal pallium, expression in the apical hyper-
pallium (HA in Fig. 6A) is especially prominent. The boundary
between the lateral and ventral pallium, the ventral pallial
lamina, is weakly Cdh8-3 positive (vpl in Fig. 6A). In the ventral
pallium, the caudolateral region of the nidopallium shows
strong Cdh8-3 signal (NCL in Figs. 6A,B,D; and 7D). Other
positive regions include the core nucleus and the interme-
dioanterior nucleus (ACo, AIA in Figs. 7D, and 6B) in the
amygdala (Amy) and the lateral septal area (LS in Figs. 6A–C;
and 7C). Scattered cells in the nuclei of the horizontal and
ventral limb of the diagonal band (HDB in Fig. 6D and VDB in
Fig. 7C) are also positive. In the subpallium, the medial
striatum (MSt in Fig. 6A), the ectopic part of the pallidum
(PalE in Figs. 6B,C) and other pallidal regions (Pal in Figs. 6B–D,
and 7C) express Cdh8-3.
2.5.2. Diencephalon
Cdh8-3 is expressed by a subset of diencephalic nuclei. In the
epithalamus, both the medial and lateral habenular complexes
showstrong signal (Hb in Figs. 5A,B; and 6E;MHb, LHb in Fig. 7E).
In the prethalamus (prosomere 3), expression is especially
prominent in the subgeniculate nucleus (SubG in Figs. 5A,B;
and 6D,E), and the reticular nucleus (Rt, RtD in Figs. 5A; and 6D,
E). In the thalamus (prosomere 2), Cdh8-3 is expressed by a large
portion of the dorsal thalamic nuclei (DMA, DIA, DLA,DP, DSS in
Figs. 5A,B; 6E; and 7E). Moreover, part of the rotundus nucleus
(Rot), the subrotundus nucleus (SRot) and the intrageniculate
leaflet (IGL) show signal (Figs. 5B–D). In the pretectum (pro-
somere 1), the principal pretectal nucleus (PrPT) and the sub-
pretectal nucleus (SPT) are positive, as well as the medial
juxtacommissural nucleus (MJC) and the anterior pretectal nu-cleus (APT). Theperigeniculate nucleus (PG),whichderives from
all three prosomeres, also expresses Cdh8-3 (Figs. 5A–D; 6E,F).
At E10, the tegmental (ventral) area of the diencephalon
showsweak staining inprosomere 2 (p2Tg in Figs. 5C,D). This is
contrasted with much stronger signal in prosomere 3 (p3Tg)
and in prosomere 1 (APT; Figs. 5C,D). In the hypothalamus (HT
in Figs. 5C,D; 6D; and 7E,F), the periventricular organ (HPO in
Figs. 5C,D) expresses Cdh8-3 strongly.
2.5.3. Mesencephalon
Cdh8-3-positive midbrain structures include the oculomotor
nucleus (3 in Figs. 5E; 6G; and 7F), the trochlear nucleus (4 in
Figs. 7G,H), the interfascicular nucleus (IF in Fig. 7F), the
interpeduncular nucleus (IP in Figs. 6G; and 7G), the pedunculo-
tegmental nucleus (PTg in Fig. 6G), the pararubral nucleus (PaR in
Figs. 5E; and 7F), the dorsal nucleus of the lateral lemniscus (DLL
in Fig. 7E), themidbrain reticular formation (mRtF in Figs. 5E; 7F),
the periaquaeductal gray (mPAG in Figs. 5E,F), and the red
nucleus (RMC in Fig. 5E).
In the midbrain auditory torus, the periventricular core part
(PeCo in Figs. 5E; and 6G) and the superficial core part (SCo in
Figs. 5F; and 6G) express Cdh8-3, unlike the central shell and
core parts (CSh, CCo in Figs. 5E,F; and 6G). The tectal gray (TG in
Figs. 5C; and 6F) shows strong signal for Cdh8-3. The tectum
(Figs. 6F,H; 7G) includes scattered Cdh8-3-positive projection
neurons in the stratum griseum centrale (SGC). A deep
sublamina of the stratum griseum et fibrosum superficiale
(SGFS) expresses Cdh8-3 also.
In the (pre-)isthmic region, the ventral isthmicnucleus (IsV in
Fig. 5F) is positive. The isthmic parvicellular nucleus (IsPC in
Fig. 7G) and the magnocellular preisthmic nucleus (MCPI in
Fig. 7G) are negative.
2.5.4. Cerebellum and hindbrain
The cerebellar cortex contains parasagittal domains of Cdh8-
3-positive Purkinje cell clusters; other positive structures in
the cerebellar system are the medial cerebellar nucleus (Med
in Fig. 7I), parts of the lateral and intermediate cerebellar
nuclei and parts of the inferior olivary complex (F. Neudert and
C. Redies, unpublished data). In the hindbrain, a rostral part of
the raphe nucleus (R in Fig. 7H), the reticular formation (RtF in
Figs. 5F; and 7G,H,J,K), the superior olive (OS in Fig. 7J), the
medial pontine nucleus (MPn in Fig. 7J), and the medial ves-
tibular nucleus (MVe in Figs. 7J,K) express Cdh8 more strongly
than their surround. Cdh8-3 is expressed also by a subset of
neurons in the trigeminal ganglion (gV in Fig. 5F).3. Discussion
3.1. Isoforms and gene structure of chicken Cdh8
Cdh8 has been identified in human (Shimoyama et al., 2000),
mouse (Korematsu and Redies, 1997a,b), and rat (Kido et al.,
1998). In this study,wehavesuccessfully clonedthree sequences
of chickenCdh8byRACE; all of themhaveapolyadenylation tail.
After sequence analysis and alignmentwith human,mouse and
rat Cdh8, the three sequences were confirmed as isoforms of
chicken Cdh8. The three isoforms can be all found on chromo-
some11of the chicken genome, a region of synteny to 16q22.1 of
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et al., 1998; Martin et al., 2004). Moreover, most of the 5 end
sequence is identical. These results indicate that the three
isoforms represent splice variants transcribed from a single
gene. The complete sequenceof chickenCdh8 (Cdh8-3) has been
published previously by our group (Luo et al., 2007), but the two
shorter isoforms (Cdh8-1 and Cdh8-2) are described here for the
first time. ChickenCdh8-3 cDNAhashigh similaritywithhuman,
mouse, and rat Cdh8 (80% identities and higher); similarity to
humanCdh8 is highest (Luo et al., 2007). The structural similarity
between theCdh8 genes of these species demonstrates thatCdh8
is a gene highly conserved betweenhigher vertebrates. The even
higher conservation at the protein level (more than 86% identity,
Table 2) between human, mouse, rat and chicken suggests that
Cdh8 has similar functions in these species.
It was reported that, in rat, Cdh8 is expressed in two
isoforms, a complete isoform and a truncated isoform that
lacks the transmembranedomainand thecytoplasmic tail (Kido
et al., 1998). The truncated isoform of rat Cdh8 is terminated
near the N terminus of EC5 with a short unique sequence of 19
aa at the C terminus. Likewise, the two truncated isoforms of
chickenCdh8 both have unique sequences of 13 aa in EC5 at the
C terminus (S2) and are truncated in the same domain (EC5) as
the rat isoform. Cdh8-1 shares four amino acids (NISM) with rat
truncated type at the beginning of the unique sequences.
However, the other residues of the unique sequences differ
from each other in rat and chicken. Isoforms of some other type
II classic cadherins have been reported (see Introduction). The
function of all these short variants of classic cadherins remains
to be investigated.
The cytoplasmic domain is essential for the association of
classic cadherins with catenins. This association plays a crucial
role in the binding of cadherins to the cytoskeleton, which
contributes to cell–cell adhesion, and in signal transduction (for
reviews, see Hirano et al. (2003); and Takeichi (2007)). Conse-
quently, the three isoforms are likely to differ in their adhesive
function and interaction with cytoplasmic proteins. Moreover,
the two shorter isoforms are predicted to represent secretedFig. 6 – Results from in situ hybridization visualizing Cdh8-3 exp
sections through the rostral telencephalon (A and B), the caudal
the rostral diencephalon (E), the caudal diencephalon (F), the mid
in a rostral-to-caudal sequence. The asterisks indicate artefacts.
ac, anterior commissure; ACo, amygdala, core nucleus; AIA, amy
nucleus; csm, corticoseptomesencephalic tract; CCo, central core
anterior nucleus of the thalamus; DLA, dorsolateral anterior nucle
thalamus; DSS, dorsal somatosensory nucleus of the thalamus;
HDB, nucleus of the horizontal limb of the diagonal band; Hi, hipp
lateral forebrain bundle; LPall, lateral pallium; lraq, lateral recess
lateral ventricle; MSt, medial striatum; MV, mesopallium, ventra
nidopallium, caudal part, lateral region; NICe, nidopallium, inter
(intrastriatal) part of pallidum; pch, choroid plexus; Pe, periventri
auditory torus; PG, pregeniculate nucleus (formerly ventral genic
part; PHiL, parahippocampal area, lateral part; PrPT, principal pr
pedunculotegmental nucleus; Rt, reticular nucleus (prethalamus
stratum album centrale; SCo, superficial core part of themidbrain
griseum et fibrosum superficiale; sm, stria medullaris; SPC, supe
subgeniculate nucleus of the prethalamus (ventrolateral nucleus
ventral pallium; vpl, ventral pallial lamina. Scale bar, 500 μm (informs of Cdh8 because they lack the transmembrane domain
and have a truncated EC5 domain. The soluble endogenous
form of another classic cadherin, N-cadherin, is generated by
proteolysis; this soluble form retains its biological function in
promoting cell adhesion and neurite outgrowth (Paradies and
Grunwald, 1993). T-cadherin is the only classic cadherin known
to lack the cytoplasmic and transmembrane domains constitu-
tively (Ranscht and Dours-Zimmermann, 1991).
Shimoyama et al. (2000) have demonstrated that, like other
classic cadherins, the long isoform of Cdh8 regulates cell–cell
binding. The two short isoforms of chicken Cdh8 might also
have adhesive function because the extracellular domain of
classic cadherins serves as the interface for cell–cell binding
and determines binding specificity (Takeichi, 1991). Structural
analysis revealed that the extracellular domains form struc-
tural units whose dimerization is crucial for adhesive activity
(Shapiro et al., 1995; Nagar et al., 1996; Elste and Benson, 2006;
Pokutta andWeis, 2007). Whether the short unique sequences
that are found in the short isoforms at the site of truncation
have a special role in cell adhesion or other functions of Cdh8
remains unclear. For rat Cdh8, Kido et al. (1998) did not
demonstrate an adhesive function for the truncated isoform
because they failed to express it in L cells.
3.2. Expression analysis of chicken Cdh8
In order to explore the possibility that the three isoforms of
chicken Cdh8 have different functions during the embryonic
development, we studied their expression patterns by semi-
quantitative RT-PCR, Northern blotting and in situ hybridiza-
tion, respectively.
First, we designed unique primers to detect separately the
transcript of the three isoforms (Fig. 1A). Second, we con-
firmed the existence of the ORFs corresponding to the three
Cdh8 isoforms by RT-PCR with a different set of unique 3 end
primers (Fig. 1B). Third,weanalyzed the relative amount of each
isoform by Northern blotting. Cdh8-3 is transcribed around 15
times more strongly than Cdh8-1 and Cdh8-2 (Figs. 1C, D).ression in the embryonic day 12 brain of the chicken. Frontal
telencephalon (C), the tel-/diencephalic transition area (D),
-/hindbrain transition area (G), and the tectum (H) are shown
Abbreviations: 3, oculomotor nucleus; 3v, third ventricle;
gdala, intermedioanterior nucleus; APT, anterior pretectal
part of midbrain auditory torus; DIA, dorsal intermediate
us of the thalamus; DMA, dorsomedial anterior nucleus of the
EP, neuroepithelium; HA, apical hyperpallium; Hb, habenula;
ocampus; IP, interpeduncular nucleus; HT, hypothalamus; lfb,
of the aquaeduct; LS, lateral septum; LSt, lateral striatum; lv,
l part; NCcp, nidopallium, caudal part, corticoid plate; NCL,
mediate part, central region; Pal, pallidum; PalE, ectopic
cular stratum; PeCo, periventricular core part of the midbrain
ulate nucleus); PHiCL, parahippocampal area, caudolateral
etectal nucleus; psp, pallial-subpallial boundary; PTg,
); RtD, reticular nucleus, dorsal part (prethalamus); SAC,
auditory torus; SGC, stratum griseum centrale; SGFS, stratum
rficial parvicellular nucleus of the thalamus; SubG,
); Tect, tectum; TG, tectal gray; Tu, olfactory tubercle; VPall,
A-G) and 200 μm (in H).
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Cdh8-1 and Cdh8-2 was too weak to be detected. Fourth, we
analyzed expression levels of the three isoforms by semi-
quantitative RT-PCR in whole embryos, heads and brain (Fig. 3)
and in different brain regions (Fig. 4). The difference in the
temporal and regional expressions between the three isoforms
indicates that the transcription of each isoform is regulated
individually during embryonic development of chicken embryo
and brain. Results confirm that the expression of Cdh8-1 and
Cdh8-2 was considerably weaker than that of Cdh8-3.
Fifth, the expression of the three isoforms was studied by in
situ hybridization. However, the signal for Cdh8-1 and Cdh8-2
was too weak to be detected. The fact that RT-PCR is moresensitive than in situ hybridization (Wakamatsu et al., 2007)
mayexplainwhyCdh8-1 andCdh8-2 canbe revealed byRT-PCR,
but not by in situ hybridization. Nevertheless, because Cdh8-1
and Cdh8-2 may represent soluble forms of Cdh8 (see 2.2 and
3.1), itwill still be interesting toexplore theirpossibleexpression
and function in future studies in detail.
The in situhybridizationstudy revealeda restrictedpatternof
Cdh8 expression in a subset of gray matter structures in the late
embryonic chicken brain (Figs. 5–7). Other classic cadherins are
expressed in a similarly restricted pattern in the embryonic
chickenbrain, for exampleCdh3 (N-cadherin), Cdh4 (R-cadherin),
Cdh6B, Cdh7 (Redies et al., 2000, 2001), and Cdh10 (Fushimi et al.,
1997). The Cdh8-3 expression pattern is different from that of
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some areas. Cdh8 expression in the mouse (Korematsu and
Redies, 1997a,b; Suzuki et al., 1997) is also restricted regionally.
A comparison of the expression patterns in chicken and
mouse brains reveals that a number of brain structures express
this molecule in both species. Examples in the telencephalon
include the hippocampus, the caudolateral parahippocampal
area that likely corresponds to the entorhinal cortex in mouse
(Kovjanic and Redies, 2003), the septal nuclei, the amygdala, the
striatum and parts of the pallidum. In the diencephalon, the
medial and lateral habenula, large parts of the dorsal thalamic
complex, the dorsolateral thalamic nucleus, the reticular nu-
cleus and the anterior pretectal nucleus express Cdh8 in both
species. Additional examples are found in the cerebellar system
(Purkinje cell domains and deep cerebellar nuclei) and in the
mesencephalon (tectum, interpeduncular nucleus, and medial
raphe). In the hindbrain, cross-species expression is observed in
the inferior olive, the pontine nuclei and the vestibular nucleus.
Together, these results suggest a relatively large degree of
phylogenetic conservation of Cdh8 expression between chicken
and mouse.
In summary,Cdh8cancontribute to theadhesive code that is
postulated to regulate morphogenesis and functional differen-
tiation of the chicken brain during embryogenesis (for a review,
seeRedies (2000)). A function of Cdh8 inneural circuit formation
and synaptogenesis has recently been demonstrated in the
somatosensory system of Cdh8-deficient mice (Suzuki et al.,
2007). Their results showed that Cdh8 is essential for establish-
ing the physiological coupling between cold-sensitive sensory
neurons and their target neurons in dorsal horn of the spinal
cord. It will be interesting to analyze the possible functions of
the three Cdh8 isoforms during chicken embryonic develop-
ment by appropriate experimental methods also in chicken, for
example with gene over-expression or knock down in conjunc-
tion with in vivo electroporation.4. Experimental procedures
4.1. Animals
Fertilized eggs of White Leghorn chicken (Gallus gallus domes-
ticus) were obtained from a farm and incubated in a forced-Fig. 7 – Results from in situ hybridization visualizing Cdh8-3 exp
sections through the caudolateral parahippocampal area (A, B), t
diencephalon (E), themesencephalon (F and G), themidbrain tegm
the superior olive (OS; J) and of the cochlear commissure (xc; K) a
stain of a section adjacent to A. The asterisks indicate artefacts. Ab
third ventricle; 4, trochlear nucleus; 4v, fourth ventricle; ACo, am
cerebellar cortex; DLA, dorsolateral anterior nucleus of the thala
hypothalamus; IF, interfascicular nucleus; IP, interpeduncular nu
nucleus; LHb, lateral habenular nucleus; LS, lateral septum; lv, la
medial cerebellar nucleus; MHb, medial habenular nucleus; MPn
formation; MS, medial septal nucleus; MVe, medial vestibular nu
nidopallium, caudal part, lateral region; OS, superior olive; Pal, p
parahippocampal area; PHiCL, parahippocampal area, caudolate
nucleus; RtF, reticular formation; SAC, stratum album centrale; S
superficial parvicellular nucleus of the thalamus; Tect, tectum; TG
band; xc, cochlear decussation. Scale bars, 200 μm (in A and B) adraft incubator (Ehret, Emmendingen, Germany) at 37 °C and
65% humidity. Embryos were studied at embryonic day 1.5
(E1.5), E2, E2.5, E3, E4, E5, E6, E7, E8, E10, E12, E14, E16, E18, and
E20 (at least 3 embryos for each stage). After deep anesthesia
was inducedby coolingon ice, the embryoswere removed from
the eggs. For RT-PCR analysis, the embryos, heads or brains
were put directly into liquid nitrogen and stored at −80 °C. For
regional analysis by RT-PCR, brains of E7, E12, and E18 embryos
were cut into different parts and washed with phosphate-
buffered saline (PBS). Specimens were immersed in liquid
nitrogen and stored at −80 °C. For in situ hybridization,
embryos were fixed in 4% formaldehyde solution on ice
for 6 to 24 h, depending on the size of the embryos. Speci-
mens were embedded in TissueTec O.C.T. compound (Science
Services, München, Germany), frozen in liquid nitrogen and
stored at −80 °C, as described previously (Redies and Takeichi,
1993).
4.2. RNA isolation, RT-PCR and RACE reaction
Total RNA from whole chicken embryos or embryonic brains
was prepared using TRIzol reagent according to the manufac-
turer's instruction (Invitrogen,Karlsruhe,Germany). For E1.5, E2,
E2.5, E3 and E4, total RNAwas isolated fromwhole embryos; for
E5, E6 and E8, total RNAwas extracted from the heads only; and
for E10, E12, E14, E16, E18 and E20, total RNAwas extracted from
isolated brains. To analyze the regional expression of the three
isoforms of Cdh8 in chicken, the brains of E12 and E18 embryos
were separated into telencephalon, diencephalon, mesence-
phalon,metencephalon andmyelencephalon. For E7 brains, the
metencephalon and myelencephalon were not separated
(rhombencephalon). The quality of total RNA was examined
by ethidiumbromide-stained denature agarose gel electrophor-
esis and its concentration determined by a spectrophotometer
for the following experiments.
To obtain the full-length sequences of chicken Cdh8, 5 and 3
end RACE reactions were performed with the SMART RACE
cDNA Amplification Kit (Clontech, Saint-Germain-en-Laye,
France). The selection of the specific primers for RACE was
based on the sequence of a PCR-fragment of chicken Cdh8
obtained previously (Luo et al., 2007), according to the instruc-
tions of the RACE Kit User Manual. Touch-down PCR for 5 and 3
end RACE amplification was performed using the 5 and 3 endression in the embryonic day 18 brain of the chicken. Frontal
he septal area (C), the amygdaloid complex (D), the rostral
entum (H), the cerebellum (I), and the hindbrain at the level of
re shown in a rostral-to-caudal sequence. B shows a thionin
breviations: 3, oculomotor nucleus; 3n, oculomotor nerve; 3v,
ygdala, core nucleus; Amy, amygdala; Cb, cerebellum; CbC,
mus; DLL, dorsal nucleus of the lateral lemniscus; HT,
cleus; ir, infundibular recess; IsPC, isthmic parvicellular
teral ventricle; MCPI, magnocellular preisthmic nucleus; Med,
, medial pontine nucleus; mRtF, mesencephalic reticular
cleus; NCIF, nidopallium, caudal part, island field; NCL,
allidum; PaR, pararubral nucleus; pch, choroid plexus; PH,
ral part; PHiL, parahippocampal area, lateral part; R, raphe
GC, stratum griseum centrale; sm, stria medullaris; SPC,
, tectal gray; VDB, nucleus of the ventral limb of the diagonal
nd 500 μm (in C-K).
11B R A I N R E S E A R C H 1 2 0 1 ( 2 0 0 8 ) 1 – 1 4RACE PCR primers (Cdh8-antisense-1 for 5 end RACE; Cdh8-
sense-1 for 3 end RACE) together with the Universal Primer Mix.
For the first 5 cycles, the touch-downPCRwasperformedat94 °C
for 30 s and at 72 °C for 3min. The next 5 cycleswere performed
at 94 °C for 30 s, 70 °C for 30 s and 72 °C for 3min. At last, another
27 cycleswere performed at 94 °C for 30 s, at 68 °C for 30 s and at
72 °C for 3 min. To obtain more specific bands, nested PCR was
performed following the touch-down PCR for 5 and 3 end cDNA
amplification with the primers (Cdh8-antisense-2 for 5 end
RACE; and Cdh8-sense-2 for 3 end RACE) together with the
Nested Universal Primer, respectively. The PCR templates were
denatured for 1 min at 95 °C, followed by 20 cycles of am-plification (denaturing for 30 s at 95 °C, and annealing and
extension for 3min at 68 °C). The PCRproductswere cloned into
pCR II-TOPOvector (Invitrogen) and sequenced by a commercial
company (MWG, Ebersberg, Germany). After combining the
RACE sequences with the previously obtained RT-PCR fragment
sequence, two sequences similar to Cdh8 were obtained, but
they were much shorter than the complete Cdh8 cDNAs
obtained in other species. The complete sequence of chicken
Cdh8wasobtainedbyRACEaswell (Luoet al., 2007).Theprimers
for 5 end RACE PCR were as follows: Cdh8-antisense-1: 5′-
GAATGTTGGCTGCTTCTACCTTCAGAG-3′, and Cdh8-antisense-
2: 5′-GGCTTCTCTGTCCATGTTGGGAAGAGC-3′. The primers used
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CAGAGTCTGTATC-3′; and Cdh8-sense-2: 5′-GAACCACAGT-
CAAGTGTCCCGGGTGC-3′.
4.3. Bioinformatic analysis of the three full-length
sequences of Cdh8
Sequence alignments were performed with the Clustal X 1.83
program. ORF finding, translation and molecular mass calcula-
tion of the predicted protein of the full-length sequences for the
three isoforms were carried out with the Lasergene software
(DNASTAR, Madison, WI) and the ORF Finder (http://www.ncbi.
nlm.nih.gov/gorf/gorf.html). BLASTwas done at theNCBI server
for nucleotide, protein, and genome analysis (http://www.ncbi.
nlm.nih.gov/blast), while structural analysis of the predicted
proteins for the three isoformswas carried out by the SignalP 3.0
program at the following website: (http://www.cbs.dtu.dk/
services/SignalP/).
4.4. Cloning of the unique nucleotide sequences and the
ORFs of the three isoforms
To clone the unique sequences of the three isoforms of Cdh8,
appropriate primerswere chosen from the unique sequences of
the 3 ends, respectively. For the shortest Cdh8 isoform (Cdh8-1),
the forward primer was 5′-ATGTTGTATAATTTAGAGTGTTAG-
3′ and the reverse primer was 5′-AATTATCTTAGAAAAGTGAG-
TAAG-3′ (expected fragment length 466 bp). For the short Cdh8
isoform (Cdh8-2), the forward primer was 5′-AGATATAAAATG-
TATGTAATATGTG-3′ and the reverse primer was 5′-ACTGTG-
CATGAAATTCCACTTC-3′ (expected fragment length 575 bp).
For the long Cdh8 isoform (Cdh8-3), the forward primer was 5′-
CATAATGGATTCAGTCGGCAG-3′ and the reverse primer was
5′-CAACTGAGTAAAGTTCTCCAAG-3′ (expected fragment
length 697 bp). The three unique sequences (466 bp, 575 bp
and 696 bp) amplified with the above primers were all intron-
spanning (see Suppl. Fig. S1 and Table 1). The one step RT-PCR
reaction was performed first at 50 °C for 30 min for reverse
transcription and at 95 °C for 15min for denaturing, followed by
30 cycles of amplification (denaturing for 45 s at 94 °C, annealing
for 45 s at 56 °C [for Cdh8-1 andCdh8-2] or 59 °C [for Cdh8-3], and
extension for 1.5 min at 72 °C). The RT-PCR fragments were
analyzed on 1.5% agarose gels. The PCR fragments of the three
isoforms obtainedwere cloned into pCR II-TOPOvectorwith the
TA-cloning kit (Invitrogen) for synthesis of unique probes for
each isoform.
To clone the open reading frame (ORF) of the three types of
Cdh8, primers that included the start codon or stop codon,
which was derived from the full-length sequences of the three
isoforms, were chosen. The forward primer was same for the
three sequences: 5′-ATGCCAGAAAGACTAACGGAAATG-3′. The
lower primer for Cdh8-1 was 5′-CATTCTAACACTCTAAATTA-
TACAAC-3′; for Cdh8-2 5′-ATTCAGGTAAATATTACACATAT-
TAC-3′; and for Cdh8-3 5′-TCAAGTTTCTTTGTCACTTTCTCC-3′.
The expected length of the sequences was 1585 bp, 1697 bp and
2400 bp, respectively. First strand cDNAwas synthesized invitro
with the SuperScript First-Strand Synthesis System (Invitrogen)
from chicken E10 brain total RNA. The first strand cDNA served
as the PCR template and was denatured for 2 min at 94 °C,
followed by 35 cycles of amplification (denaturing for 20 s at94 °C, annealing for 30 s at 62 °C, and extension for 2 min at
68 °C). After the last cycle, the reaction product was extended
finally for 15minat 68 °C. TheRT-PCR resultswere visualized on
1% agarose gel.
4.5. Semi-quantitative RT-PCR
Semi-quantitative RT-PCR was performed using the One Step
RT-PCR Kit (Qiagen, Hilden, Germany). Samples with water only
or without reverse transcriptase (RT) were served as negative
controls. The same amount of total RNA was used for each
reaction. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was used as an internal control to monitor the amount of RNA.
The forward primer for GAPDH was 5′-GGGCTCATCTGAAGGG-
TGGTGCTA-3′ and the reverse primer was 5′-GTGGGGGAGACA-
GAAGGGAACAGA-3′ (expected length 810 bp). The one step RT-
PCR reaction was performed first at 50 °C for 30 min for reverse
transcription and at 95 °C for 15min for denaturing, followed by
30 cycles of amplification (denaturing for 45 s at 94 °C, annealing
for 45 s at 56 °C [for Cdh8-1 and Cdh8-2] or 59 °C [for Cdh8-3 and
GAPDH], and extension for 1.5 min at 72 °C). For brain regional
semi-quantitative RT-PCR, 35 PCR cycles were used for Cdh8-1
and Cdh8-2, and 25 cycles for Cdh8-3 and GAPDH. Cdh8-3 and
GAPDH were amplified by multiplex RT-PCR with the One Step
RT-PCR Kit (Qiagen) following the instructions suppliedwith the
kit. The ratio between the primer concentrations for Cdh8-3 and
GAPDH was 5:1. This and multiple other ratios were used for
multiplex RT-PCR with Cdh8-1 or Cdh8-2 primers but did not
yield any bands. The RT-PCR fragments were analyzed on 1.5%
agarose gels.
4.6. In situ hybridization
Digoxigenin-labeled sense and antisense cRNA probes were
transcribed in vitro from the purified plasmids containing
the unique fragments of the three isoforms, according to
the manufacturer's instructions for probe synthesis (Roche,
Mannheim, Germany). Sense cRNA probes were used as a
negative control for in situ hybridization. In situ hybridiza-
tion on cryosection was performed according to Redies and
Takeichi (1993). In brief, cryostat sections of 20 μm thickness
were fixed with 4% formaldehyde in PBS and were then
pretreated with proteinase K and acetic anhydride. Sections
were hybridized overnight with cRNA probe at a concentra-
tion of about 3 ng/μl at 70 °C in hybridization solution (50%
formamide, 3× SSC, 10 mM EDTA, 10% dextran sulfate, 1×
Denhardt's solution, 42 μg/ml yeast transfer RNA and 42 μg/
ml salmon sperm DNA). After the sections were washed and
the unbound cRNA was removed by RNase, the sections
were incubated with alkaline phosphatase-coupled anti-
digoxigenin Fab fragments (Roche) at 4 °C overnight. For vi-
sualization of the labeled mRNA, a substrate solution of
nitroblue tetrazolium salt and 5-bromo-4-chloro-3-indoyl
phosphate was added. The sections were viewed and photo-
graphedunder a transmission lightmicroscope (OlympusBX40,
Hamburg, Germany) equipped with a digital camera (Olympus
DP70). Photomicrographs, including those for gels, were
adjusted in contrast and brightness by the Photoshop software
(Adobe, Mountain View, CA) for optimal display of the staining
patterns in the figures. For identification and terminology of
13B R A I N R E S E A R C H 1 2 0 1 ( 2 0 0 8 ) 1 – 1 4neuroanatomical structures, the atlas by Puelles et al. (2007)
was followed.
Fluorescent in situ hybridization with tyramide amplifica-
tion was performed according to the protocol by Van Heusden
et al. (1997).
4.7. Northern blot analysis
Northern blot analysis was performed according to the protocol
by Sambrook and Russell (2001), with some modifications. In
brief, 20μg eachof total RNA fromE7, E12 andE18 chickenbrains
were electrophoresed in denaturing 1.5% agarose formaldehyde
gel, and transferred onto Hybond nylonmembrane (Amersham
Biosciences, Freiburg, Germany). The same digoxigenin-labeled
antisense cRNA probes as used for in situ hybridization (see 4.6)
were hybridized to the membrane at 65 °C. After washing, the
membrane was reacted with a substrate solution containing
nitroblue tetrazolium salt and 5-bromo-4-chloro-3-indoyl phos-
phate (see 4.6), until mRNA bands were clearly visible.
4.8. Statistical analysis
The intensityof individualbands fromsemi-quantitativeRT-PCR
and Northern blotting was quantified using the software
ImageQuant TL (Amersham Biosciences). The intensity value of
each band was normalized to the value of the corresponding
GAPDH band. Each experimentwas repeated at least three times
(n=3). In the figures, all data are shownwith the standard error of
themean (s.e.m). Statistical analysis was performed by one-way
analysis of variance (ANOVA) and two-tailed t test using PRISM 4
software (GraphPad, San Diego, CA, USA). A value of pb0.05 was
considered significantly different.Acknowledgments
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                                  Abbreviations used in the figures1
3 oculomotor nucleus 
3n oculomotor nerve 
3v third ventricle 
4 trochlear nucleus 
4v fourth ventricle 
6C abducens nucleus, caudal part 
10 dorsal motor nucleus of the vagus nerve 
AA anterior amygdaloid area 
ac anterior commissure 
ACo amygdala, core nucleus 
AHi amygdalohippocampal area 
Ang angular cochlear nucleus 
APT anterior pretectal nucleus 
aq mesencephalic aqueduct 
ATn amygdaloid taenial nucleus 
BCS brachium of the superior colliculus 
Bv blood vessel 
Cb cerebellum 
cc central canal 
CDL caudodorsolateral pallium (dorsolateral corticoid area) 
chp choroid plexus 
csm corticoseptomesencephalic tract 
DA dorsal anterior nuclei of thalamus 
Di diencephalon 
DLG dorsal lateral geniculate nucleus (lateroanterior nucleus) 
DP dorsal posterior nuclei of thalamus 
DR dorsal raphe nucleus 
draq dorsal recess of the mesencephalic aqueduct 
EA extended amygdala 
EGL external granular layer 
ET epithalamus 
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EW Edinger-Westphal nucleus 
Fl flocculus 
fp floor plate 
GP globus pallidus (paleostriatum primitivum) 
Gr granule cell layer of the cerebellum 
HA apical hyperpallium 
Hb habenula 
HBr hindbrain 
Hi hippocampus 
HPO hypothalamic periventricular organ 
HT hypothalamus 
InP intrapeduncular nucleus (central part of striatopallidal area) 
IO inferior olivary nucleus 
IPC interpeduncular nucleus, caudal subnucleus 
IsO isthmooptic nucleus 
IsPC isthmic parvicellular nucleus 
Lat  lateral cerebellar nucleus 
LP lateral pallium 
lr4v lateral recess of fourth ventricle 
lraq lateral recess of the mesencephalic aqueduct 
LS lateral septal nucleus 
lv lateral ventricle 
LVe lateral vestibular nucleus 
M mesopallium 
MCC magnocellular cochlear nucleus 
MCPI magnocellular preisthmic nucleus 
Me5 mesencephalic trigeminal nucleus 
mes mesenchyme 
MG medial geniculate nucleus (nucleus ovoidalis) 
MJC medial juxtacommissural nucleus of the pretectum 
ML molecular layer 
mlf medial longitudinal fasciculus  
MnR median raphe cells 
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MP medial pallium 
mr median raphe 
MS medial septal nucleus 
MSO medial superior olivary nucleus (laminaris nucleus) 
MT medial terminal nucleus (nucleus of the basal optic root) 
MV mesopallium, ventral part 
MVe medial vestibular nucleus 
NC nidopallium, caudal part 
NCcp nidopallium, caudal part, corticoid plate 
NCIF nidopallium, caudal part, island field 
NCL nidopallium, caudal part, lateral region 
ne neuroepithelium 
NF frontal nidopallium 
NICe nidopallium, intermediate part, central region 
NIS nidopallium, intermediate part, superficial region 
opt optic tract 
p1 prosomere 1 (pretectum) 
p1Tg prosomere 1 tegmentum 
p2 prosomere 2 (thalamus) 
p3 prosomere 3 (prethalamus) 
pc posterior commissure 
Pal pallidum 
PalV ventral pallidum 
Pe periventricular stratum 
PG pregeniculate nucleus (ventral geniculate nucleus) 
PHi parahippocampal area 
PHiI parahippocampal area, intermediate part 
PHiM parahippocampal area, medial part 
Pi pineal gland 
Pk Purkinje cell layer of the cerebellum 
PO preoptic nucleus 
Pr5 principal sensory trigeminal nucleus 
PrPT principal pretectal nucleus 
3. Publications—Publication 4                                                                                            58  
psp pallial-subpallial boundary 
r raphe 
RG retrogeniculate nucleus (retroovoidal nucleus) 
ro roof 
Rot rotundus nucleus 
Rt reticular nucleus 
SAC stratum album centrale of the tectum 
SCO subcommissural organ 
Se septum 
SGC stratum griseum centrale of the tectum 
SGFS stratum griseum et fibrosum superficiale of the tectum 
SLu semilunar nucleus 
sm stria medullaris 
SMi superficial microcellular nucleus of the thalamus 
SP subpallium 
SpL lateral spiriform nucleus 
SpM medial spiriform nucleus 
SpVe spinal vestibular nucleus 
SRot subrotundus nucleus of the thalamus 
SSp supraspinal nucleus 
St striatum 
StAm strioamygdaloid transition area 
STh subthalamic nucleus 
StPal striopallidal area 
SubG subgeniculate nucleus (ventrolateral nucleus) 
SuVe superior vestibular nucleus 
Tect optic tectum 
Tel telencephalon 
TGS tectal gray, superficial stratum 
ToSc torus semicircularis, central part  
ToSpe torus semicircularis, periventricular part  
VisCo visual nidopallial nucleus, core region 
VMH ventralmedial hypothalamic nucleus 
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VP ventral pallium 
vpl ventral pallial lamina 
xc cochlear decussation 
xs supraoptic decussation 
1 Alternative (traditional) terms are given in italic type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Publications—Publication 4                                                                                            60  
Abstract 
ADAMs (a disintegrin and metalloprotease) are a family of trans-membrane multi-domain   
metalloproteases with multiple functions. So far, more than 35 ADAM family members 
have been identified from mammalian and nonmammalian sources. Although some 
functions of ADAMs have been elucidated, their expression patterns remain poorly 
investigated, especially during CNS development. Here, we cloned the open reading 
frames or full-length cDNAs of ADAM9, ADAM10, ADAM12, ADAM22 and ADAM23 
from chicken embryonic brain, analyzed their evolutionary relationship, and mapped their 
expression in the embryonic chicken brain by in situ hybridization for the first time. In 
general, each of the five ADAMs shows a spatially restricted and temporally regulated 
expression profile. However, the types of tissues and cells, which express each of the five 
ADAMs, differ from each other. ADAM9 is predominantly expressed in the choroid 
plexus and in the ventricular layer. ADAM10 is expressed by developing blood vessels, 
oligodendrocytes, and subsets of neurons and brain nuclei. ADAM12 is expressed by very 
few brain nuclei, cerebellar Purkinje cells, restricted regions of the neuroepithelium, and 
some neurons in the deep tectal layers. ADAM22 expression is strong in some brain nuclei 
and in the pineal gland. ADAM23 is expressed by most gray matter regions and the 
choroid plexus. The differential expression patterns suggest that the five ADAMs play 
multiple and versatile roles during brain development. 
 
Key words: in situ hybridization, blood vessel, pineal gland, choroid plexus, 
neuroepithelium, oligodendrocytes. 
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Members of the ADAM (a disintegrin and a metalloprotease) family are type I trans-
membrane proteins. Another acronym for this protein family is MDC, which denotes their 
metalloproteinase-disintegrin-cysteine-rich domains (Wolfsberg et al., 1995; Black and 
White, 1998; Schlondorff and Blobel, 1999). ADAMs possess a multi-domain structure 
with a signal peptide, a prodomain, a metalloprotease domain, a disintegrin domain, a 
cysteine-rich domain, an epidermal growth factor (EGF)-like domain, a transmembrane 
domain and a cytoplasmic tail. The disintegrin domain can bind integrins or other receptors 
(Lu et al., 2007). The metalloprotease domain contains a consensus active-site sequence 
for a zinc-dependent metalloprotease; some ADAMs have been shown to be catalytically 
functional. In relation to these multiple domains, ADAMs were proposed to be involved in 
proteolysis, adhesion, cell fusion and cell signaling (Blobel, 2002, 2005; White, 2003). 
Specific biological processes, in which ADAMs have been implicated, include sperm-egg 
fusion, somatic cell-cell adhesion, cell-matrix interaction, ectodomain shedding, myoblast 
fusion, and neurogenesis (Seals and Courtneidge, 2003). Moreover, some ADAMs have 
been implicated in the control of membrane fusion, cytokine and cytokine receptor 
shedding, growth factor and their receptor processing, and cell migration, as well as in 
processes such as muscle development, fertilization, and cell fate determination (Huovila 
et al., 1996; Seals and Courtneidge, 2003). Up-regulation or inhibition of expression of 
specific ADAMs has been associated with a number of diseases, including inflammation, 
asthma, arthritis, atherosclerosis and cancer (Wolfsberg et al., 1995; Duffy et al., 2003; 
Moss and Bartsch, 2004). 
The existence of ADAM genes has been confirmed in many animal species, 
including mammals, reptiles and invertebrates, but ADAMs have not been found in lower 
organisms like Escherichia coli and Saccharomyces cerevisiae or in plants (Seals and 
Courtneidge, 2003). So far, more than 35 ADAMs have been cloned from different 
species. For a short description of each member, consult the Cytokines & Cells Online 
Pathfinder Encyclopaedia website (COPE, http://www.copewithcytokines.de/cope.cgi?Key 
=ADAM%20protein%20family).  
Individual members of the ADAM family show variable expression patterns that 
are developmentally regulated. Some ADAMs are expressed in highly restricted patterns in 
specific tissues and organs, whereas others are expressed more widely.  
In the nervous system, ADAMs play a role in cell proliferation, migration, 
differentiation, apoptosis, myelination and axon guidance, as well as in some nervous 
diseases, such as Alzheimer’s disease and inflammatory responses (Novak, 2004; Yang et 
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al., 2006). For example, ADAM10 plays an important role in neurogenesis and axon 
extension; it is required for the formation of the optic projection to the tectum (Chen et al., 
2007). ADAM10 was demonstrated to cleave axon guidance molecules like ephrin and 
cadherins (Janes et al., 2005; Maretzky et al., 2005, 2008; Reiss et al., 2005, 2006; Schulz 
et al., 2008).  
Not much is known about the expression profiles of ADAMs in the CNS. 
Kärkkäinen et al. (2000) identified ten ADAM mRNAs and showed strikingly different 
expression profiles of six ADAM mRNAs in the major parts of the adult mouse brain by 
Northern analysis. Similar results were obtained for ADAM22 and ADAM23 in the human 
brain (Sagane et al., 1998). In situ hybridization with probes for ADAM10 and ADAM17 
showed regional expression of these molecules in different regions of the adult brain 
(Kärkkäinen et al., 2000). However, the spatial and temporal expression patterns of 
ADAMs during vertebrate brain development remain unknown.  
In the present study, we cloned the full-length or open reading frame (ORF) 
sequences of three novel members of the ADAM family from the chicken (ADAM12, 
ADAM22 and ADAM23) and investigated the spatiotemporal expression patterns of these 
and two other ADAMs (ADAM9 and ADAM10) in the embryonic chicken brain in detail. 
Our results reveal a spatially restricted and temporally regulated expression pattern for all 
five ADAMs. The general type of structures that express the individual ADAMs are, 
however, rather different. The results from the present study provide a basis for the 
investigation of possible functions of ADAMs in brain development. 
 
Experimental procedures 
Animals 
Fertilized eggs of White Leghorn chicken (Gallus gallus domesticus) were purchased from 
a local farm and incubated in a forced-draft incubator (Ehret, Emmendingen, Germany) at 
37°C and 65% humidity. Embryos were studied at embryonic day 6 (E6), E8, E10, E12, 
E14, E16, E18, and E19 (at least 3 embryos for each stage). Embryos were removed from 
the eggs after induction of deep anesthesia by cooling on ice. The brain was dissected 
carefully and fixed in formaldehyde solution (4% in Hepes-buffered salt solution; HBSS) 
on ice for 6 to 24 hours, depending on the stage. Older embryos (E14, E16, E18 and E19) 
were prefixed with 4% formaldehyde solution by intracardial perfusion. After fixation, the 
brains were immersed in graded sucrose solutions (12%, 15% and 18% in HBSS). 
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Specimens were embedded in TissueTec O.C.T. compound (Science Services, München, 
Germany), frozen in liquid nitrogen and stored at -80°C, as described previously (Lin et al., 
2008). 
 
RNA extraction and cDNA cloning 
Total RNA from whole E12 brain was prepared using the TRIzol reagent, according to the 
manufacturer’s instruction (Invitrogen, Karlsruhe, Germany). First-strand cDNA was 
synthesized in vitro using the SuperScript First-Strand Synthesis System (Invitrogen) with 
E12 brain total RNA. The ORF of ADAM9, ADAM10 and ADAM23 were cloned by RT-
PCR. The full-length sequences of chicken ADAM12 and ADAM22 were cloned using the 
SMART RACE cDNA Amplification Kit (Takara Bio Europe/Clontech, Saint-Germain-
en-Laye, France) and confirmed by sequencing (to be submitted to Genbank). Based on to 
the RACE results, the ORFs of ADAM12 and ADAM22 were cloned by One Step RT-
PCR Kit (Qiagen, Hilden, Germany). The RT-PCR reaction was performed first at 50°C 
for 30 min for reverse transcription and at 95°C for 15 min for denaturation, followed by 
30 cycles of amplification. The primers and PCR parameters are shown in Table 1. Finally, 
all of the obtained sequences were cloned into pCR-II vector (Invitrogen) and sequenced 
by a commercial company (MWG-Biotech AG, Ebersberg, Germany) with M13 forward, 
reverse and specific internal primers. The obtained sequences were compared to those of 
other published ADAM genes and were blasted against the chicken genome with the NCBI 
BLAST program (http://www.ncbi.nlm.nih.gov/BLAST). The nucleotide similarities and 
evolutionary relationships of the different ADAMs were analyzed using the Lasergene 
MegAlign program (DNASTAR, Madison, WI). 
 
Probe synthesis and in situ hybridization 
Digoxigenin-labeled sense and antisense cRNA probes were transcribed in vitro from the 
purified pCR-II plasmids containing the ORF of the different ADAMs, according to the 
manufacturer's instructions for probe synthesis (Roche, Mannheim, Germany). Sense 
cRNA probes were used as a negative control for in situ hybridization. Probes were 
purified by sodium acetate or LiCl/EtOH precipitation and by using Quick Spin Columns 
(Roche). Incorporation of label and correct size was verified by RNA formaldehyde 
denaturing gel electrophoresis, blotting, and detection of membrane-bound probes using 
alkaline phosphatase-conjugated anti-digoxigenin Fab fragments (Roche). 
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In situ hybridization on cryosection was performed according to Redies et al. 
(1993). In brief, cryostat sections of 20 µm thickness were fixed with 4% formaldehyde in 
PBS and pretreated with proteinase K and acetic anhydride. Sections were hybridized 
overnight with cRNA probe at a concentration of about 3 ng/µl at 70oC in hybridization 
solution (50% formamide, 3× SSC, 10mM EDTA, 10% dextran sulfate, 1× Denhardt’s 
solution, 42 µg/ml yeast transfer RNA and 42 µg/ml salmon sperm DNA). After the 
sections were washed and the unbound cRNA was removed by RNase, the sections were 
incubated with alkaline phosphatase-coupled anti-digoxigenin Fab fragments (Roche) at 
4oC overnight. For visualization of the labeled mRNA, a substrate solution of nitroblue 
tetrazolium salt and 5-bromo-4-chloro-3-indoyl phosphate was added.  
 
Immunohistochemistry 
In selected cases, sections adjacent to those used for in situ hybridization were processed 
for galactocerebroside (Galc) immunohistochemistry following the immunostaining 
protocol by Redies et al. (1993). In brief, the sections were fixed in ice-cold 4% 
formaldehyde in HBSS for 20 min and washed in Tris-buffered saline (TBS, pH 7.4) 
supplemented with 1 mM CaCl2 and 1 mM MgCl2. Endogenous peroxidase activity was 
suppressed by incubation with 0.3% H2O2 in methanol for 30 min. Unspecific binding of 
antibodies was blocked by incubating the sections with 5% skim milk powder in TBS for 
30 min. A mouse monoclonal antibody against galactocerebroside (hybridoma supernatant; 
kind gift of B. Ranscht; Ranscht et al., 1982) was appropriately diluted in blocking solution 
(1:2). Sections were incubated with this solution at 4°C overnight. Three washing steps in 
TBS were followed by incubation of the sections with biotinylated goat anti-mouse 
secondary antibody (Jackson ImmunoResearch, Cambridgeshire, UK) for 30 min at RT. 
The sections were then incubated with avidin-biotin-horseradish peroxidase complex 
(ABC Kit, Vector Laboratories, Burlingame, CA, USA) and reacted with 0.03% 3,3´-
diaminobenzidine, 0.04% NiCl2 and 0.01% H2O2 as a substrate, according to the 
manufacturer's instructions.  
 
Image analysis 
For neuroanatomic orientation, sections adjacent to those used for in situ hybridization and 
immonohistochemistry were stained with thionine acetate for Nissl substance (Redies et 
al., 1993). All sections were viewed and photographed under a transmission light 
microscope (Olympus BX40, Hamburg, Germany) equipped with a digital camera 
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(Olympus DP70). Photomicrographs were adjusted in contrast and brightness by the 
Photoshop software (Adobe, Mountain View, CA) for optimal display of the staining 
patterns in the figures. For identification of neuroanatomical structures, the atlas by Puelles 
et al. (2007) was followed. 
 
Results 
Cloning and phylogenetic analysis of the five ADAM cDNAs from chicken 
Based on the published sequences of chicken ADAM9 and ADAM10, and the predicted 
sequence of chicken ADAM23, we cloned their ORF by RT-PCR. For ADAM12 and 
ADAM22, the full-length sequences were obtained by the RACE method. The accession 
numbers of the sequences will be/were submitted to GenBank and are listed in Table 1. 
The analysis of the evolutionary relationship amongst all eight known chicken 
ADAMs indicates a relatively high similarity for ADAM22 and ADAM23, and for 
ADAM9 and ADAM12, respectively, whereas ADAM10 and ADAM17 are more distant 
from the other ADAMs (Fig. 1).  
 
Expression patterns in the embryonic brain 
In general, each of the ADAMs investigated shows a spatially restricted and temporally 
regulated expression pattern. Strikingly, the type of tissues, cell types and the 
neuroanatomical structures, which express individual ADAMs, differ from each other 
(Table 2). Expression patterns are shown in Fig. 2 (ADAM9), Figs. 3 and 4 (ADAM10), 
Fig. 5 (ADAM12), Fig. 6 (ADAM22) and Fig. 7 (ADAM23). In the figures, the panels are 
arranged according to their developmental stage (early to late). For a negative control, 
sense RNA probes were used (Figs. 2L, 3P). With few exceptions, the nomenclature of 
Puelles at al. (2007) was used. Alternative (traditional) terms are given in the list of 
abbreviations used in the figures. 
 
ADAM9 
At E6 and E8, ADAM9 is expressed in the ventricular (neuroepithelial) layer (ne) of 
several brain regions, for example, in the hindbrain, the medial part of the tectal vesicle, 
the diencephalon (Di in Fig. 2A), the telencephalon and the roof (ro) of the third ventricle 
(3v in Fig. 2A). In addition, at E8, ADAM9 transcript is found in the ependymal layer of 
the primordial choroid plexus (chp) in the lateral ventricles (lv in Fig. 2B). Some blood 
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vessels express ADAM9 weakly. In the diencephalon and mesencephalon, expression in 
the ventricular layer is weak and more widespread at E8 than at E6. 
 At E10, expression is strong in the ependymal layer (ne), the hindbrain floor plate 
(fp) and the mesencephalic roof (ro in Fig. 2C). In addition, weak homogeneous staining is 
seen in the hindbrain (HBr) and cerebellar gray matter (Cb in Fig. 2D). The accessory 
oculomotor nucleus of Edinger-Westphal (EW in Fig. 2C) shows moderate staining. 
Expression by the mantle layer of the mid- and forebrain remains very weak. Moderate 
staining of blood vessel (Bv in Fig. 2E) is observed throughout the brain. 
 From E12 to E16, very strong expression in the choroid plexus (chp) of all 
ventricles predominates (Fig. 2F). Weak expression in almost all gray matter regions and 
moderate expression in blood vessels persists (Fig. 2G,H). In the diencephalon, the 
rotundus nucleus (Rot), the anterior pretectal nucleus (APT), and the dorsal anterior 
nuclear complex (DA) show moderate expression (Fig. 2H). In the mesencephalon and 
isthmic region (Fig. 2G), the magnocellular preisthmic nucleus (MCPI), the isthmic 
parvicellular nucleus (IsPC), the semilunar nucleus (SLu), the tectal gray matter (TGS in 
Fig. 2H) and the tectum (Tect) are also moderately positive. 
At the prehatching stage (E19), the expression in the choroid plexus and the 
regionalized expression in the ependymal lining are weaker than at earlier stages. Blood 
vessels are no longer positive. Gray matter expression is also weaker and more 
heterogeneous. Purkinje cells (Pk) show relatively strong expression throughout the 
cerebellum (Fig. 2K). The supraspinal nucleus (SSp), the dorsal complex of the vagal 
nerve (10 in Fig. 2M,N), neurons of the hindbrain reticular formation, the lateral vestibular 
nucleus (LVe in Fig. 2I,J), and the nucleus rotundus show slightly stronger signal than 
surrounding gray matter.  
  
ADAM10 
At E6 and E8, the ventricular (neuroepithelial) layer (ne) of all parts of the brain is strongly 
positive, for example in the tectum (Fig. 3A,D,E), in the diencephalon (Fig. 3B) and in the 
hindbrain (Fig. 3C). The mantle layer shows weak to moderate signal; in some areas, for 
example in the dorsal thalamus (p2 in Fig. 3D), expression is stronger than in other 
regions. In the blood vessels throughout the mantle layer, ADAM10 expression is 
especially prominent (arrows in Fig. 3C,E). The choroid plexus (chp in Fig. 3D) also 
expresses ADAM10. At E10 and E12, strong ADAM10 expression by blood vessels 
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persists (arrows in Figs. 3G-K); this expression decreases at later stages and is no longer 
detectable in brain at E19. 
At E12, most gray matter areas exhibit widespread and weak ADAM10 expression 
throughout the brain. Signal in some regions, however, increases to high levels from E8 to 
E14. In the diencephalon, mesencephalon and isthmic region, strongly positive structures 
at E12 include the anterior and posterior dorsal thalamic complex (DA in Fig. 3G; DP in 
Fig. 3H), the medial geniculate (ovoidal) nucleus (MG in Fig. 3H), the principal pretectal 
nucleus (PrPT in Fig. 3I), the intergeniculate leaflet (not shown), the lateral spiriform 
nucleus (SpL in Fig. 3I), the hypothalamic periventricular organ (HPO in Fig. 3H; at E14 
in Fig. 3O,P), the ventromedial hypothalamic nucleus (VMH in Fig. 3H), the central core 
and central shell parts of the midbrain auditory torus (ToS in Fig. 3J), the isthmic 
parvicellular nucleus (IsPC in Fig. 3J), the magnocellular preisthmic nucleus (MCPI in Fig. 
3J), and the semilunar nucleus (SLu in Fig. 3J). In the tectum, most cells in the stratum 
griseum centrale (SGC), the periventricular stratum (Pe) and the neuroepithelial stratum 
(ne) contain strongly positive cells, whereas cells in the stratum griseum et fibrosum 
superficiale (SGFS) are only weakly positive (Fig. 3K,L). 
 In the telencephalon at E14 (Fig. 3M,N), all structures express ADAM10, but at 
different levels ranging from weak to strong staining. The structures that are most strongly 
positive include the apical hyperpallium (HA), the intermediate parahippocampal area 
(PHiI), superficial parts of the mesopallium (M), and most of the nidopallium (NF, NICe, 
NIS, NCIF, NCL, NC) and the amygdala. In the subpallium, signal is weak in the globus 
pallidus (GP) to moderate in the striatum (St). A ventral and a dorsal subregion of the 
lateral septum (LS) express ADAM10 strongly. 
Staining decreases from E14 to E19, with the exception of the telencephalon and 
the cerebellum. In the cerebellum, ADAM10 is expressed strongly by the Purkinje cell 
(Pk) layer and weakly by in the internal and external granule cell layer (EGL; E14 in Fig. 
3Q,R).  
At late stages of embryogenesis (E16-E19), numerous small ADAM10-positive 
cells are found in fiber tracts. For example at E16, ADAM10-positive cells that co-express 
galactocerebroside (Galc), a marker for oligodendrocytes (Ranscht et al., 1982), are 
observed around the auditory nuclei (MCC, magnocellular cochlear nucleus; MSO, medial 
superior olivary nucleus [nucleus laminaris]; Fig. 4A-C) and in the auditory projections 
that cross the midline (xc). Other structures that contain similar ADAM10-positive cells 
include the root of the oculomotor nerve (3n in Fig. 4D,E), the brachium of the superior 
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colliculus (BCS in Fig. 4F) and the medial longitudinal fasciculus (mlf in Fig. 4G-I). 
Finally, the pineal gland (Pi) expresses ADAM10 at E18 (Fig. 4J,K).  
 
ADAM12 
At E6 and E8, ADAM12 signal in the telencephalon is restricted to a few weakly labeled 
cells in the mantle layer of the medial pallium (MP in Fig. 5A). Regional expression in the 
ventricular layer is observed in the mesencephalic vesicle (Tect), except for the caudal 
regions, in the pretectum (p1) and in the epithalamus (ET in Fig. 5B). The dorsal thalamus 
(p2) contains ADAM12-positive cells in the mantle layer. There are also some dispersed 
ADAM12-positive cells in the mantle layer of the pretectum (arrow in Fig. 5B). 
 At E10, the mesencephalic ventricular layer is still positive (Fig. 5C). In addition, 
dispersed cells are seen in the deeper strata of the developing tectal mantle layer (arrows in 
Fig. 5C). The ependymal lining of the aqueduct (aq), including its dorsal recess (draq), 
expresses ADAM12 strongly, but the subcommissural organ (SCO) is negative (Fig. 5D). 
In the isthmus, the parvicellular nucleus expresses ADAM12 strongly (IsPC in Fig. 5C), 
but none of the other isthmic nuclei is positive. In the cerebellum (Fig. 5E), clusters of 
Purkinje cells (Pk) express ADAM12 in the flocculus (Fl). Also, the midline granule cell 
raphe (mr) and some cells in the external granular layer are positive in the vermal region 
(Fig. 5E). In the hindbrain, all parts of the floor plate (fp) and the median raphe cells 
(MnR) express ADAM12 (Fig. 5F). 
In the E12 telencephalon, the visual core region of the nidopallial nucleus expresses 
ADAM12 (VisCo in Fig. 5G). ADAM12-positive cells are also found in the periventricular 
stratum (Pe) of the medial pallium (MP in Fig. 5G). In the dorsal thalamus, the superficial 
microcellular nucleus (SMi in Fig. 5I), the dorsal anterior nuclear complex (DA in Fig. 5I), 
the medial geniculate (ovoidal) nucleus (MG in Fig. 5J), the perirotundic area, and the 
intergeniculate leaflet are positive (not shown). More caudally, in the pretectum, the 
medial terminal nucleus expressed ADAM12 (MT in Fig. 5K). In the tectum, there are a 
few dispersed ADAM12-positive cells in the stratum griseum centrale (SGC in Fig. 5M). 
In their large size and deep position within SGC, these cells resemble the magnocellular 
SGC neurons described by Martinez-de-la-Torre et al. (1987). The isthmic parvicellular 
nucleus remains strongly positive (Fig. 5L). 
At E14 and E16, the expression of ADAM12 is similar to E12. Strong staining is 
still seen in the tectum, the parvicellular isthmic nucleus, and the core nucleus of the 
nidopallium. Expression in the other structures has decreased. In the cerebellum, the 
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innermost (premigratory) sheet of the external granular layer (EGL) is positive, as well as 
almost the entire Purkinje cell (Pk) layer, except for a few small gaps (arrowheads in Fig. 
5N). At E16, ADAM12 is expressed in the dorsal (motor) nucleus of the vagus nerve (10 in 
Fig. 5O). The floor plate is still positive (fp in Fig. 5O). 
At E19, the staining observed at E16 persists. In addition, very small ADAM12-
positive cells are seen almost everywhere. These cells are especially numerous in fiber 
tracts, for example in the brachium of the superior colliculus (BCS in Fig. 5P). The 
distribution and size of these cells is reminiscent of oligodendrocytes, which have been 
shown to express ADAM12 in the human and rat (Bernstein et al., 2004). Cerebellar 
Purkinje cells are now ubiquitously positive (not shown). 
 
ADAM22 
At E6, ADAM22 is expressed by the mesenchyme surrounding the brain (mes in Fig. 6A). 
In the brain, the neuroepithelial layer (ne) is negative except for some weak staining in the 
pretectal and basal mesencephalic region. The mantle layer shows diffuse and weak to 
moderate staining in some areas, for example, in the diencephalon (p2, p3 in Fig. 6A). 
 Expression at E8 is similar to that at E6, but the ventricular signal has become 
stronger in some areas, for example, in the mesencephalon and some diencephalic regions. 
The tectal midline (arrowhead in Fig. 6B), the neuroepithelium of the epithalamus (ET) 
and the roof of the third ventricle (3v) show very strong ADAM22 signal (Fig. 6B). 
 From E10 onwards, staining in gray matter is heterogeneous. Many gray matter 
structures express relatively high levels of ADAM22 while others are negative or show 
low signal. The expression patterns are relatively stable between E10 and E19. In the 
following paragraphs, expression patterns will be described for the fore- and midbrain at 
E10-E14 (Fig. 6C-J) and for the hindbrain at E16-E19 (Fig. 6K-P). 
Telencephalic structures that express high levels of ADAM22 include superficial 
layers of the hippocampus (Hi in Fig. 6F), the medial parahippocampal area (PHiM in Fig. 
6G), the caudodorsolateral pallium (CDL in Fig. 6F), the visual nidopallium, the anterior 
amygdaloid area (AA in Fig. 6F), the amygdaloid subnuclei surrounding the core nucleus 
of the amygdala (ACo in Fig. 6G), the amygdalohippocampal area (AHi in Fig. 6G), the 
amygdaloid taenial nucleus (ATn in Fig. 6G), the extended amygdala (EA in Fig. 6F), the 
lateral septum (LS in Fig. 6C), the medial septal nucleus (MS in Fig. 6G), the striatum (St 
in Fig. 6C,F), the intrapeduncular nucleus (InP in Fig. 6C) and the striopallidal area (StPal 
in Fig. 6C). In the diencephalon (Fig. 6I), the following nuclei show especially strong 
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ADAM22 expression: the superficial microcellular nucleus, the anterior dorsal thalamic 
complex, the posterior dorsal thalamic complex (DP), the reticular nucleus, the rotundus 
nucleus (Rot), the subrotundic nucleus (SRot), the perigeniculate nucleus (PG), and the 
anterior pretectal area (APT). The pineal gland (Pi), but not the choroid plexus (chp), 
expresses ADAM22 strongly (Fig. 6H).  
In the mesencephalon, the mesencephalic nucleus of the trigeminal nerve (Me5 in 
Fig. 6D), the prosomere 1 tegmentum (p1Tg in Fig. 6D) and the trochlear nucleus (4 in 
Fig. 6E) are positive. In the tectum (Fig. 6J), the vast majority of cells in the stratum 
griseum centrale (SGC), a few cells in the stratum album centrale (SAC), and the 
neuroepithelial layer (ne) express ADAM22. 
In the cerebellum, clusters of Purkinje cells (Pk) express ADAM22 at E14 and E16 
while granule cells show weak expression (Fig. 6K). At E19, both Purkinje cells and 
granule cells express ADAM22 relatively strongly and ubiquitously (not shown). The deep 
cerebellar nuclei also express ADAM22, for example the lateral cerebellar nucleus (Lat in 
Fig. 6N). 
Heterogenous expression of ADAM22 is also observed in the late embryonic 
hindbrain. In the isthmic region, the semilunar nucleus (SLu in Fig. 6E,L) expresses very 
high levels of ADAM22 throughout development. Other strongly positive hindbrain 
structures include the isthmooptic nucleus (IsO in Fig. 6L), the raphe nuclei (R in Fig. 6L), 
the reticular formation (Rt in Fig. 6L,M,O,P), the magnocellular cochlear nucleus (MCC in 
Fig. 6M), the medial superior olivary (laminar) nucleus (MSO in Fig. 6M), the lateral 
cerebellar nucleus (Lat in Fig. 6N), the lateral vestibular nucleus (LVe in Fig. 6N), the 
medial vestibular nucleus (MVe in Fig. 6O), and the inferior olivary nucleus (IO in Fig. 
6P). 
 
ADAM23 
At E6, almost the entire mantle layer shows moderate signal, with some minor regional 
variations in staining intensity (Fig. 7A). The ventricular layer is stained weakly, if at all. 
The roof plate of the third ventricle is positive (ro in Fig. 7A). 
 At E8, staining of the mantle layer persists throughout the brain. There is also 
regional expression of ADAM23 in the periventricular layer of the lateral ventricles (Pe in 
Fig. 7B,C). The choroid plexus of the lateral ventricles shows strong staining (chp in Fig. 
7B), but that of the third ventricle is stained weakly or not at all. The pineal gland is 
negative throughout development (Table 2). 
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 At E10, the labeling of the mantle layer structures is still heterogeneous, but very 
widespread. Some nuclei are more strongly labeled than others (for example, see the gray 
matter of the mesencephalon and hindbrain in Fig. 7D,E). In the tectum, only the deep 
layers are positive (Tect in Fig. 7D). 
 From E12 to E19, the gray matter retains its heterogeneous and widespread 
expression (Fig. 7F-P). The most strongly labeled gray matter structures include, in the 
telencephalon, the hippocampus (Hi in Fig. 7H,N), the parahippocampal area (PHi in Fig. 
7F,H), the strioamygdaloid transition area (StAM in Fig. 7F), the ventral mesopallium 
(MV in Fig. 7H), the caudal nidopallium, the amygdaloid complex, the 
amygdalohippocampal area, parts of the striatum (St in Fig. 7F,H,N), dispersed cells in the 
globus pallidus (GP in Fig. 7H,N), and the lateral septum (LS in Fig. 7F,H,N). The choroid 
plexus of the lateral ventricle (chp in Fig. 7F,H) remains positive, with regional variations 
in signal intensity. The lateral ventricle (lv) is bordered ventrally by an ADAM23-positive 
ependymal surface, but not dorsally (Fig. 7F,H). In the prethalamus of the diencephalon 
(Fig. 7G), strongly ADAM23-positive nuclei include the subgeniculate nucleus (SubG) and 
the pregeniculate nucleus (PG). In the thalamus (Fig. 7G,I,L), the dorsal anterior nuclear 
complex (DA), the dorsal lateral geniculate nucleus (DLG), the rotundus nucleus (Rot), the 
subrotundic nucleus (SRot), the medial geniculate nucleus, the retrogeniculate nucleus 
(RG) express ADAM23 strongly. In the pretectum, the medial juxtacommissural nucleus 
(MJC in Fig. 7L) and the medial spiriform nucleus (SpM in Fig. 7I) are strongly ADAM23 
positive. 
 In the mesencephalon, the oculomotor complex (3 in Fig. 7J; see also 3 and EW in 
Fig. 7D for E10) and the trochlear nucleus (4 in Fig. 7J) exhibit strong signal. In the torus 
semicircularis (inferior colliculus), the periventricular part (ToSpe) is more strongly 
stained than the core part (ToSc), as already seen at E10 (Fig. 7D). The neurons of the 
mesencephalic nucleus of the trigeminal nerve (Me5 in Fig. 7L) express ADAM23 very 
strongly. In the deep layers of the tectum (SAC and SGC in Fig. 7M), most neurons show 
strong signal. In the superficial layers (SGFS), only a few cells are positive. The 
magnocellular preisthmic nucleus is more strongly positive than the isthmic nuclei. 
 The Purkinje cells of the cerebellum (Pk in Fig. 7P) express ADAM23 strongly and 
homogeneously while the expression in the internal granular layer (Gr) is weaker. All of 
the deep cerebellar nuclei exhibit very strong signal. 
 In the hindbrain, most nuclei are weakly to moderately positive. The nuclei that 
express high levels of ADAM23 mRNA include the magnocellular cochlear nucleus (MCC 
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in Fig. 7J,O), which shows a prominent gradient from low levels caudolaterally to high 
levels rostromedially (insert in Fig. 7O). The other cochlear nuclei (MSO and Ang in Fig. 
7O), the vestibular nuclei (MVe, LVe, SuVe in Fig. 7J,O) and the principal sensory 
trigeminal nucleus (Pr5 in Fig. 7J) show moderate signal. More caudally, strongly positive 
nuclei include the motor nucleus of the trigeminal nerve, the nucleus of the lateral 
lemniscus and the motor nucleus of the vagal complex (data not shown). The entire 
hindbrain reticular formation (Rt in Fig. 7O), in particular in the gigantocellular neurons, 
show prominent signal. 
 
Discussion 
Although the function of some members of the ADAM family is well studied (see below), 
their expression pattern during vertebrate brain development is poorly understood. For the 
chicken embryo, only a few studies on the expression or function of ADAMs have been 
published. The chicken is an excellent animal model to study embryonic development. The 
complete sequencing of the chicken genome and the availability of the in vivo 
electroporation technique for genetic manipulation (Muramatsu et al., 1997; Luo and 
Redies, 2005) have enhanced the usefulness of the chicken embryo in developmental 
biology. Hall and Erickson (2003) reported that chicken ADAM10 is expressed in 
epithelial tissues and plays a role in their morphogenesis. The expression of ADAM13 in 
the chicken embryo was shown to be temporally and spatially regulated in different organs 
and tissues (Lin et al., 2007). ADAM17, a main proteolytic protease during embryonic 
development, was implicated in the non-amyloidogenic processing of beta-amyloid 
precursor protein in the chicken (Carrodeguas et al., 2005). Watabe-Uchida et al. (2004) 
reported that ADAM35 (also called meltrin-ε) is expressed in epithelial tissues during 
chicken embryogenesis. From the work in chicken and other species, it has become clear 
that ADAMs have diverse functions in many developmental processes, like cell adhesion, 
neurogenesis, axon guidance, protein shedding, signal transduction etc. (Seals and 
Courtneidge, 2003; Blobel, 2005). In order to propose and test the functional roles of 
ADAMs in brain development, it is necessary to know the precise expression patterns of 
these genes. We therefore cloned five ADAMs (ADAM9, ADAM10, ADAM12, ADAM22 
and ADAM23) and analyzed their expression during chicken embryonic brain 
development for the first time. ADAM9, ADAM10 and ADAM12 have metalloprotease 
activity, whereas ADAM22 and ADAM23 do not. Our results show that the expression 
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patterns of the ADAMs are strikingly different, both at the level of brain regions (Figs. 2-
7) and neural cell types (Table 2). 
 
ADAM9 
ADAM9 can mediate cell adhesion through binding to integrin α6β1 by the disintegrin 
domain (Nath et al., 2000). ADAM9 has been shown to cleave the insulin B-chain, pro-
TNF-alpha, gelatin, beta-casein, fibronectin and APP (Roghani et al., 1999; Schwettmann 
and Tschesche, 2001; Asai et al., 2003). It appears that other members of the ADAM 
family may functionally replace ADAM9 because knock-out mice develop into fertile 
adults without major abnormalities (Weskamp et al., 2002). In the chicken embryo, 
ADAM9 is expressed by blood vessels, the choroid plexus, by parts of the neuroepithelium 
and in regions of differentiating gray matter, suggesting that ADAM9 plays multiple 
unknown roles during brain development. 
 
ADAM10 
ADAM10, named Kuzbanian in Drosophila (Rooke et al., 1996) is essential to embryonic 
development and controls neurogenesis and axon extension in the CNS (Fambrough et al., 
1996; Pan and Rubin, 1997; Chen et al., 2007). ADAM10-deficient mice developed only to 
E9.5 with multiple defects in the CNS, somites and cardiovascular system (Hartmann et 
al., 2002). Also, ADAM10 has been confirmed as a candidate alpha-secretase responsible 
for shedding proteins as diverse as APP, heparin-binding EGF (HB-EGF), EGF receptor, 
E-cadherin, N-cadherin, protocadherin C3 and VE-cadherin (Yan et al., 2002; Sahin et al., 
2004; Maretzky et al., 2005, 2008; Reiss et al., 2005, 2006; Schulz et al., 2008). Our 
results show that ADAM10 is mainly expressed by developing blood vessels as well as in 
restricted neuroepithelial regions and in differentiating gray matter. The latter finding 
suggests that the proposed role of ADAM10 in axon elongation (Chen et al., 2007) is 
confined to specific brain regions and/or fiber tracts. In this context, our novel finding that 
ADAM10 is also expressed by oligodendrocytes at later embryonic stages in many fiber 
tracts is of interest. Whether ADAM10-positive neurites and oligodendrocytes interact 
remains to be investigated. In neuroepithelial cells, growing blood vessels and during 
neurogenesis, ADAM10 may regulate cell differentiation, as proposed previously for other 
systems (Pan and Rubin, 1997). 
 
ADAM12 
3. Publications—Publication 4                                                                                            74  
ADAM12, also called meltrin-α, is a member of meltrin subfamily of ADAMs (Inoue et 
al., 1998). It can mediate cell adhesion by binding to integrin α9β1 (Eto et al., 2000). As 
an active metalloprotease, the potential physiological substrates of ADAM12 include 
insulin-like growth factor binding proteins IGFBP-3 and -5, placental leucine 
aminopeptidase (P-LAP), heparin binding EGF-like growth factor (HB-EGF), EGF, β-
cellulin and S-carboxymethylated transferrin (Jacobsen et al., 2008). Although ADAM12 
appears to play a role in myoblast fusion in embryonic development (Galliano et al., 2000), 
ADAM12-deficient mice, which are viable and fertile, have only minor muscular 
abnormalities (Kurisaki et al., 2003).  ADAM12 is overexpressed in several human tumors 
such as breast carcinoma, colon carcinoma and gastric carcinoma (Iba et al., 1999) and is 
required for mouse prostate tumor progression (Peduto et al., 2006). Interestingly, 
ADAM12 is a marker of trisomy 18 in the first and second trimester of pregnancy (Spencer 
and Cowans, 2007). In quail, ADAM12 was reported to be expressed in dorsal root ganglia 
and the ventral spinal roots (Lewis et al., 2004). In the human and rat, ADAM12 is 
expressed by oligodendrocytes (Bernstein et al., 2004). The present study maps the 
expression of ADAM12 in the vertebrate brain for the first time. ADAM12 is expressed in 
restricted regions of the neuroepithelium, suggesting a role in brain regionalization. 
Especially striking is the highly restricted expression in very few gray matter structures. 
These structures belong to different functional systems, for example, to the visual system 
(visual nidopallial nucleus, tectum, isthmic parvicellular nucleus and medial terminal 
nucleus), the auditory system (medial geniculate nucleus), the cerebellar system (Purkinje 
cells) and the visceral nervous system (nucleus of the vagus nerve). It will be interesting to 
study what common role, if any, ADAM12 plays in these restricted gray matter regions. 
 
ADAM22 and ADAM23 
ADAM22 and ADAM23, which are closely related phylogenetically (Fig. 1), are 
uncatalytical members of the ADAM family. Their gene symbol and alternative names are 
MDC2 and MDC3, respectively (Sagane et al., 1998). Some of the binding partners of the 
two ADAMs are known. For example, the 14-3-3ζ protein can interact with the 
cytoplasmic domain of ADAM22; this interaction is required for cell spreading and cell 
adherence (Zhu et al., 2005). ADAM22 also serves as a receptor for LGI1 that regulates 
synaptic transmission (Fukata et al., 2006).  
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ADAM22-deficient mice show signs of severe ataxia and peripheral nerve 
hypomyelination (Sagane et al., 2005), whereas ADAM23-deficient mice show tremor and 
severe ataxia and die within two weeks of birth (Leighton et al., 2001). These neurological 
defects indicate that the two ADAMs are important for normal development and function 
of the nervous system (Yang et al., 2006). ADAM23 is expressed primarily as a cell-
surface protein that appears to be localized to sites of intercellular contact where it serves 
to mediate cell-cell interactions. ADAM23 also regulates neuronal differentiation within 
the mammalian CNS (Goldsmith et al., 2004; Sun et al., 2007). 
Both molecules are highly expressed in the human brain, as revealed by Northern 
blotting (Sagane et al., 1998). Novak (2004) mentioned unpublished observations that 
ADAM22 is expressed in Purkinje cells of the cerebellum and neurons of the neocortex. 
The present study reveals the complex expression patterns of the two ADAMs in 
developing brain for the first time. Both ADAMs are expressed in restricted regions of the 
neuroepithelium. In all major parts of brain, brain nuclei and layers with large differences 
in their ADAM expression are found adjacent to each other. The expression patterns of the 
two ADAMs in the neuroepithelium and gray matter differ from each other, but overlap 
partially. In some brain structures, for example, the pineal gland and the choroid plexus, 
the expression profile of the two ADAMs is opposite (Table 2). These results suggest that 
the two ADAMs, despite their closely homologous nucleotide sequence, play distinct roles 
in different brain structures. Interestingly, the magnocellular cochlear nucleus displays a 
rostromedial-to-caudolateral gradient of expression (Fig. 7O) that may relate to the 
tonotopic gradient found in this nucleus (Rubel and Parks, 1975). 
 
In summary, the five ADAMs investigated in the present study differ in their regional 
expression in developing brain areas, both in the neuroepithelial domains and in gray 
matter. These results suggest that ADAMs, like many transcription factors and adhesion 
molecules, play a role in brain regionalization (for reviews, see Redies and Puelles, 2001; 
Puelles and Rubenstein, 2003). In addition, we confirm previous results by other groups 
(for reviews, see Novak, 2004; Yang et al., 2006) that the five ADAMs are expressed 
differentially by specific types of tissues and cells in the developing brain, like blood 
vessels, oligodendrocytes, pineal cells, floor plate ependymal cells and neurons (Table 2). 
Together, these results indicate multiple and diverse roles for each ADAM in brain 
development. The present results may provide the basis for studying these roles at the 
experimental level in the future. 
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Legends 
Figure 1. Evolutionary relationships among the eight known chicken ADAMs, based on 
multiple nucleotide sequence alignment of their ORFs. The length of each pair of branches 
represents the distance between sequence pairs, while the units at the bottom of the figure 
indicate the number of substitution events. 
 
Figure 2. ADAM9 expression in the chicken brain at embryonic day (E) 8 (A,B), E10 (C-
E), E14 (F-H) and E19 (I-N). In situ hybridization results are shown for frontal sections, 
except for G that shows a horizontal section. A, diencephalon (Di); B, choroid plexus (chp) 
in the lateral ventricle (lv); C, midbrain; D, cerebellum (Cb) and hindbrain (HBr); E, 
higher magnification of the boxed area in D to show an ADAM9-positive blood vessel 
(Bv); F, pineal gland (Pi) and choroid plexus (chp) in the third ventricle (3v); G, tectum 
(Tect) and isthmic region; H, dorsal thalamus; I, lateral vestibular nucleus (LVe) in 
hindbrain; J, thionine staining of a section adjacent to I; K, cerebellar cortex with 
ADAM9-positive Purkinje cells (Pk); L, negative control (sense probe); M, vagal motor 
complex (10) and supraspinal nucleus (SSp) in the hindbrain; N, thionine staining of a 
section adjacent to M. For other abbreviations, see separate list. Scale bars, 100µm (in E), 
200µm (in A-C,F,I-N), and 500µm (in D,G,H). 
 
Figure 3. ADAM10 expression in the chicken brain at embryonic day (E) 6 (A-C), E8 (D-
F), E12 (G-L) and E14 (M-R). In situ hybridization results are shown for frontal sections, 
except for D, J and N that show horizontal sections. A, neuroepithelium (ne) of the tectum; 
B, dorsal thalamus; C, hindbrain; D, telencephalon (Tel), dorsal thalamus (p2) and tectum; 
E, tectum; F, thionine staining of a section adjacent to E; G-I, sections through the 
diencephalon in a rostral-to-caudal series; J, mesencephalon; K, tectum; L, thionine 
staining of a section adjacent to K; M, frontal section through the telencephalon; N, 
horizontal section through the telencephalon; O, periventricular organ of the hypothalamus 
(HPO); P, negative control (sense probe); Q, granule cell raphe (r) and Purkinje cells (Pk) 
in cerebellum; R, thionine staining of a section adjacent to Q. For other abbreviations, see 
separate list. Arrows point at blood vessels. Scale bars, 100µm (in A-C,E,F,K,L,O-R), and 
500µm (in all other panels). 
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Figure 4. ADAM10 expression (A,D,F,H,J), immunostaining results for 
galactocerebroside (Galc, a marker for oligodendrocytes; B,I), and thionine stains 
(C,E,G,K) in frontal sections through the chicken brain at embryonic day (E) 16 (A-C), 
E18 (D,E,J,K) and E19 (F-I). A-C, medial superior olivary (laminaris) nucleus in the 
hindbrain (adjacent sections); D,E, oculomotor nerve (3n) in the mesencephalon; F, 
brachium of the superior colliculus (BCS) in the tectum; G-I, medial longitudinal 
fasciculus (mlf) in the hindbrain; J,K, pineal gland (Pi). A-C, D/E, G-I and J/K represent 
adjacent sections, respectively. For other abbreviations, see separate list. Scale bars, 
100µm (in D,E), and 200µm (in all other panels). 
 
Figure 5. ADAM12 expression in the chicken brain at embryonic day (E) 8 (A,B), E10 (C-
F), E12 (G-M), E16 (N,O) and E19 (P,Q). In situ hybridization results are shown for 
frontal sections, except for A, B, G, H, K and L that show horizontal sections. A, 
telencephalon (Tel); B, telencephalon, thalamus and tectum (Tect); C, tectum; D, 
mesencephalon; E, cerebellum and hindbrain; F, floor plate (fp) and median raphe nucleus 
(MnR); G, visual nidopallial nucleus, core region (VisCo) of the telencephalon; H, 
thionine staining of a section adjacent to G; I, dorsal thalamus; J, diencephalon at the level 
of the medial geniculate nucleus (MG); K, medial terminal nucleus (MT) in the 
mesencephalon; L, isthmic parvicellular nucleus (IsPC); M, tectum; N, Purkinje cells (Pk) 
in the cerebellum (Cb); O, dorsal motor nucleus of the vagus nerve (10); P, isthmic 
parvicellular nucleus (IsPC) and brachium of the superior colliculus (BCS); Q, thionine 
staining of a section adjacent to P. Arrows in B and C indicate the periventricular stratum 
(Pe). For other abbreviations, see separate list. Scale bars, 200µm (in A,D,F,I-Q), and 
500µm (in all other panels). 
 
Figure 6. ADAM22 expression in the chicken brain at embryonic day (E) 6 (A), E8 (B), 
E10 (C), E12 (D,E), E14 (F-J), E16 (K) and E19 (L-P). In situ hybridization results are 
shown for frontal sections, except for B that shows a horizontal section. A, diencephalon; 
B, telencephalon and tectum (arrowhead indicates the tectal midline); C, telencephalon; D, 
tegmentum of prosomere 1 (p1Tg) and hypothalamus (HT); E, isthmic region and rostral 
hindbrain; F, telencephalon (rostral section); G, telencephalon (caudal section); H, pineal 
gland (Pi) and choroid plexus (chp); I, tectum and diencephalon; J, tectum; K, Purkinje 
cells (Pk) in cerebellum; L, hindbrain; M, magnocellular cochlear nucleus (MCC) and 
medial superior olivary nucleus (MSO) in the hindbrain; N, deep cerebellar and vestibular 
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nuclei; O, hindbrain (rostral section); P, hindbrain (caudal section). For other 
abbreviations, see separate list. Scale bars, 200µm (in A,H,J,K), and 500µm (in all other 
panels). 
 
Figure 7. ADAM23 expression in the chicken brain at embryonic day (E) 6 (A), E8 (B,C), 
E10 (D,E), E12 (F,G), E14 (H-L), E16 (M) and E19 (N-P). In situ hybridization results 
are shown for frontal sections, except for J and K that show horizontal sections. A, 
diencephalon; B, choroid plexus (chp) in the forebrain; C, periventricular stratum (Pe) of 
the telencephalon; D, tectum (Tect) and mesencephalic tegmentum; E, cerebellum and 
hindbrain; F, telencephalon; G, dorsal thalamus; H, telencephalon; I, diencephalon; J, 
hindbrain; K, thionine staining of a section adjacent to J; L, diencephalon; M, tectum; N, 
telencephalon; O, cerebellum (Cb) and hindbrain; the insert shows the ADAM23 
expression gradient in the magnocellular cochlear nucleus (MCC); P, Purkinje cells (Pk) in 
cerebellum. For other abbreviations, see separate list. Scale bars, 200µm (in B,C,M,P), and 
500µm (in all other panels). 
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Table 1. Primers and parameters for PCR and GenBank accession numbers for 
chicken ADAM9, ADAM10, ADAM12, ADAM22 and ADAM23. 
 
Name Primer  PCR parameter GenBank accession No. 
ADAM9 5'- atg gct cgg gcg gcg cgg a -3' 
5'- cta taa gga gtg gta gga cca -3' 
30 sec at 94°C, 30 sec at 60°C, 
3 min at 68°C 
NM_001031396 
ADAM10 5'- atg gat cta gcg agg acg at -3' 
5'- tca atg tct cat atg tcc ca -3' 
30 sec at 94°C, 30 sec at 58°C, 
3 min at 68°C 
AY077631 
ADAM12 5'- atg tca aag cgt ctc ctt gcg -3' 
5'- atc att tca cat cag cag tag c -3' 
45 sec at 94°C, 45 sec at 58°C, 
2.5 min at 72°C 
FJ188468 
ADAM22 5'- atg aat gct aca tca cag aag ttt g -3' 
5'- gca gaa cag cct tgt cac gtc c -3' 
45 sec at 94°C, 45 sec at 60°C, 
2.5 min at 72°C 
FJ188469 
ADAM23 5'- atg ccg cag aaa gac tac aa -3' 
5’- tta ctt aaa gcc cca tcc tg -3’ 
30 sec at 94°C, 30 sec at 55°C, 
2.5 min at 68°C 
FJ188470 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Publications—Publication 4                                                                                            87  
Table 2. Comparison of the expression of ADAM9, ADAM10, ADAM12, ADAM22 and 
ADAM23 in tissues and cell types of the embryonic chicken brain*
 
 ADAM9 ADAM10 ADAM12 ADAM22 ADAM23 
Blood vessels ++1 +++1 -  -  -  
Oligodendrocytes  -  ++2 +2 -  -  
Pineal gland +  + -  +++  -  
Choroid plexus +++  +3 +3 -  +++3
Neuroepithelium  +++3 ++ ++3 ++3 +3
Gray matter3 ++ ++ -  ++ ++ 
Floor plate ++ +  +++ -  -  
 
* -, negative, +, weakly positive; ++, moderately positive; +++, strongly positive. The table 
lists the highest expression levels observed. 
1 negative at older stages 
2 positive from E16 to E19 
3 regional expression 
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Figure 1. Evolutionary relationships among the eight known chicken ADAMs, based on 
multiple nucleotide sequence alignment of their ORFs 
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Figure 2. ADAM9 expression 
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Figure 3. ADAM10 expression (1) 
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Figure 4. ADAM10 expression (2) 
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Figure 5. ADAM12 expression 
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Figure 6. ADAM22 expression 
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Figure 7. ADAM23 expression 
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4. ADDITIONAL RESULTS  
 
Overexpression of ADAM17 remodels blood vessels in the developing chicken tectum 
 
Introduction 
A detailed account on the expression and roles of ADAMs is given in Chapter 1.3. In brief, 
ADAM proteins possess multiple domains that are potentially involved in proteolysis, 
adhesion, cell fusion and cell signalling (Blobel, 2002, 2005). Altered expression of some 
members of the ADAM family has been associated with a number of diseases including 
inflammation, asthma, arthritis, Alzheimer’s disease, atherosclerosis and cancer (Duffy et 
al., 2003; Vincent, 2004). In the brain, ADAMs play a role in neural development, axon 
guidance and some nervous diseases (Yang et al., 2006).  
ADAM17, also named TACE (TNF alpha converting enzyme), is the best-
characterized member of the ADAM family. In the nomenclature of CD antigens, 
ADAM17 has been given the designation CD156b. ADAM17 protein is a major sheddase 
that releases the extracellular domain of many proteins, including receptors and preforms 
of cytokines and growth factors (Novak, 2004). ADAM17 is up-regulated in human colon 
carcinoma (Blanchot-Jossic et al., 2005). In the brain, ADAM17 mRNA is expressed 
ubiquitously. Proteolytic cleavage of the neural cell adhesion molecule (N-CAM) by 
ADAM17 has an effect on neurite outgrowth (Kalus et al., 2006). ADAM17 is also 
involved in human CNS inflammation (Kieseier et al., 2003), and in the cleavage of 
amyloid precursor protein (APP) in Alzheimer's disease (Asai et al., 2003). During chicken 
embryonic development, ADAM17 has been implicated in the non-amyloidogenic 
processing of beta-amyloid precursor protein as a main proteolytic protease (Carrodeguas 
et al., 2005). Mice that are catalytically deficient of ADAM17 have been generated. 
Heterozygous mice developed normally and were fertile; however, the homozygous 
siblings were underrepresented at birth and most died within 24 hours (Peschon et al., 
1998). Moreover, the inhibition of ADAM17 expression reduces hypoxia-induced brain 
tumor cell invasiveness (Zheng et al., 2007). 
The blood-brain barrier (BBB) of the brain vasculature segregates the CNS milieu 
from the systemic blood circulation and helps to maintain the delicate homeostasis of the 
CNS environment (Lai and Kuo, 2005). The BBB is a highly regulated membranous 
barrier of the CNS capillaries; it is composed of endothelial cells and pericytes 
(Engelhardt, 2003; Lai and Kuo, 2005). Endothelial cells with their tight junctions 
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constitute the main element of the BBB. The surrounding pericytes are essential toward the 
microvascular endothelial wall for the formation, maturation, and maintenance of the 
normal microvascular structure and function. The molecular mechanisms regulating BBB 
permeability are poorly understood. 
In this study, we analyzed the effect of ADAM17 overexpression on blood vessel 
formation in the chicken embryonic brain. We chose the midbrain tectum for 
electroporation because it is easily accessible for ex ovo electroporation, as shown by 
previous studies from our laboratory (Treubert-Zimmermann et al., 2002; Luo and Redies, 
2005). In the present study, the cDNA of chicken ADAM17 was cloned and its expression 
was analyzed during chicken embryonic development for the first time. Results from semi-
quantitative RT-PCR suggest that expression levels are similar at different stages, except 
for somewhat lower expression at later stages (E16-E20). In situ hybridization (ISH) 
results revealed that ADAM17 is expressed widely throughout the developing brain. In the 
optic tectum, ADAM17 is expressed strongly in the neuroepithelium and the 
periventricular stratum (Pe), moderately in the stratum griseum centrale (SGC), and 
weakly in the stratum griseum et fibrosum superficiale (SGFS). Expression is low or 
absent in the stratum album centrale (SAC) and blood vessels. Furthermore, by in vivo (ex 
ovo) electroporation, we overexpressed ADAM17 in the developing chicken tectum and 
analyzed the resulting morphological changes by fluorescence immunostaining and 
transmission electron microscopy (TEM). Compared to wild-type blood vessels, the 
morphology of blood vessel in the electroporated tecta is dramatically changed; the 
thickness of the blood vessel walls is increased in parallel to the number of pericytes. 
Together, our results indicate that the overexpression of ADAM17 remodels the 
morphology of the developing vasculature, possibly through an ADAM17-induced change 
in the extracellular matrix environment of the brain vasculature. 
 
Materials and Methods 
 
Animals 
Chicken embryos were obtained and prepared as described in Publications 1-4.   
 
RNA isolation and cDNA cloning 
Total RNA from whole chicken embryos or embryonic brains were prepared using TRIzol 
reagent according to the manufacturer’s instruction (Invitrogen, Karlsruhe, Germany). For 
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embryos at 1.5 days' incubation (E1.5), E2, E2.5, E3 and E4, total RNA was isolated from 
whole embryos; for E5, E6 and E8, total RNA was only extracted from the heads; and for 
E10, E12, E14, E16, E18 and E20, total RNA was extracted from isolated brains. The 
quality of total RNA was examined by ethidium bromide-stained denaturing agarose gel 
electrophoresis and RNA concentration determined by a spectrophotometer. 
First strand cDNA was synthesized in vitro using the SuperScript First-Strand 
Synthesis System (Invitrogen) with total RNA from E12 brain. Then the full-length cDNA 
and a partial cDNA sequence of ADAM17 were cloned by PCR. The PCR reaction was 
performed first for 2 min at 94°C for denaturing, followed by 30 cycles of amplification 
(denaturing for 30 sec at 94°C, annealing for 30 sec at 59°C, and extension for 2.5 min at 
68°C). The last extension was for 10 min at 68°C. The primers for full-length cDNA of 
ADAM17 were 5’-ATGAGACTCCGGCTGTGG-3’ (upper) and 5’-
TCAGCACTCCGTCT CCTTGC-3’ (lower). The primers for the partial cDNA sequence 
were 5’-TCCCGCGT GCTAAAGTTCCTCTGG-3’ (upper) and 5’-
GGCACTCGCGCTCCTCTCATCAC-3’ (lower). At last, the sequences were cloned into 
pCR-II vector (Invitrogen) and sequenced by a commercial company (MWG-Biotech AG, 
Ebersberg, Germany) with M13 forward, reverse and specific internal primers. 
 
Semi-quantitative RT-PCR 
Semi-quantitative RT-PCR was performed using the One Step RT-PCR Kit (Qiagen, 
Hilden, Germany). Samples with water only or without reverse transcriptase served as 
negative controls. The same amount of total RNA was used for each reaction. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control to 
monitor the amount of RNA. The forward primer for GAPDH was 5’-
GGGCTCATCTGAAGGGTGGTGCTA-3’ and the reverse primer was 5’-
GTGGGGGAGACAGAAGGGAACAGA-3’ (expected length 810 bp). The ratio between 
the primer concentrations for ADAM17 (primer for partial sequence, expected length 1070 
bp) and GAPDH was 5:1. The one step RT-PCR reaction was performed in the same tube 
for both ADAM17 and GAPDH first at 50°C for 30 min for reverse transcription and at 
95°C for 15 min for denaturing, followed by 30 cycles of amplification (denaturing for 45 
sec at 94°C, annealing for 45 sec at 59°C [ADAM17 and GAPDH], and extension for 1.5 
min at 72°C). The RT-PCR fragments were analyzed on 1.5% agarose gels. 
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Plasmids and antibodies  
Full-length and partial sequences of ADAM17 were cloned into pCR-II vector (see above) 
for cRNA probe synthesis. Then the full-length sequence of ADAM17 was subcloned from 
pCR-II-ADAM17 into the eukaryotic expression vector pCAGGS that carries a 
CMV/chicken beta-actin promoter as pCAGGS-ADAM17. Full-length GFP cDNA in 
pCAGGS (pCAGGS-GFP) was a kind gift of Dr. H. Ogawa (Momose et al., 1999). All 
plasmids were purified from Topo10 strain of Escherichia coli (Invitrogen) with the Maxi 
Plasmid Purification Kit (Qiagen).  
The following antibodies were used for immunostaining of sections: rat polyclonal 
antibody HT7 that serves as a marker for blood-brain barrier (BBB)-forming endothelial 
cells (dilution 1:200; kind gift of H. Gerhardt, Institute of Pathology, University of 
Tübingen, Germany; Risau et al., 1986; Gerhardt et al., 1996); Cy3-labeled mouse 
monoclonal antibody against smooth muscle actin (SMA), a marker for smooth muscle 
cells or pericytes (1:300, Sigma); rabbit polyclonal antiserum against human fibronectin, 
used as a marker for blood vessels in the brain (1:2000, kind gift of R. Hynes, MIT, 
Cambridge); rabbit polyclonal antibody M12K against alpha-catenin (1:50; kind gift of W. 
Schneider, Max-Planck-Institut for Developmental Biology, Tübingen, Germany; 
Schneider et al., 1993), which is present in brain vasculature (Miskevich et al., 1998); and 
rat monoclonal antibody against CD31 (PECAM-1), a marker for endothelial cell-cell 
interactions involved in angiogenesis  (1:10; Abcam ab7388; DeLisser et al., 1997). 
Primary antibodies were followed by incubation with secondary antibodies (Cy3-labelled 
AffiniPure goat anti-mouse, rat or rabbit IgG antisera, respectively; Jackson 
ImmunoResearch).  
 
In vivo (ex ovo) electroporation 
The method for ex ovo culture was modified after Luo and Redies (2004). The contents of 
fertilized eggs, incubated at 37°C in a forced-draft egg incubator (BSS160, Ehret, 
Germany), were put into petri dishes at E3, and then transferred into an incubator (B6120, 
Heraeus, Germany) for further incubation at 37°C ("shell-less" culture). For ex ovo 
electroporation, E6 embryos were chosen (Momose et al., 1999; Treubert-Zimmermann et 
al., 2002; Luo and Redies, 2005). The vitelline and amnion membranes were torn carefully 
with fine forceps over the tectum. About 0.5-1µl pCAGGS-GFP plasmid in Gey’s buffered 
salt solution (GBSS, Invitrogen, concentration of plasmid about 0.5µg/µl and 2µg/µl), 
together with 0.1% Fast Green (Sigma) and similar amounts of pCAGGS-ADAM17 
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(concentration of plasmid 0.5µg/µl or 2µg/µl, compared to 0.25µg/µl of pCAGGS-GFP 
plasmid) were injected into the right tectal ventricle. Immediately following injection, 
electric pulses (25V, 60 ms pulse length, six pulses, 100 ms intervals) were applied by an 
electroporator (CUY 21, TR Tech, Japan). Transfected embryos were returned to the 
incubator until E8, E10 and E12. Brains with positive GFP signal were isolated, fixed and 
embedded, as described (Publications 1-4). All sections used were cut in frontal plate. 
 
Probe synthesis and in situ hybridization (ISH) 
Digoxigenin-labeled sense and antisense cRNA probes were transcribed in vitro from the 
purified pCR-II plasmids containing the full-length or partial sequence of ADAM17, 
according to the manufacturer's instructions for probe synthesis (Roche, Mannheim, 
Germany). Sense cRNA probes were used as a negative control for ISH. Hybridized probes 
were detected using alkaline phosphatase-conjugated anti-digoxigenin Fab fragments 
(Roche Diagnostics GmbH, Germany). ISH on cryosection was performed according to the 
method described in Publications 1-4. Photomicrographs, including those for gels, were 
adjusted in contrast and brightness by the Photoshop software (Adobe, Mountain View, 
CA) for optimal display of the staining patterns in the figures.  
 
Apoptosis analysis with TUNEL assay  
Apoptosis was compared between transfected and untransfected areas in the same 
electroporated embryos. To detect apoptotic cells, cryostat sections were stained using the 
In Situ Cell Death Detection Kit/TMR Red (Roche) according to the manufacturer’s 
instructions. 
 
Immunohistochemistry 
For immunofluorescence staining, sections adjacent to those used for ISH were 
preincubated with skimmed milk solution (5% skimmed milk, 0.3% Triton X-100, and 
0.04% sodium azide in TBS) at room temperature for 60 min, then incubated sequentially 
with the primary antibodies against HT7, SMA, fibronectin, alpha-catenin or CD31, 
respectively, appropriately diluted in the skimmed milk solution at 4oC overnight, and with 
Cy3-labeled secondary antibody against the IgGs of the appropriate species (1:300 
dilution) at room temperature for 60 min each. Finally, dye Hoechst 33258 (Molecular 
Probes) was used for staining of cell nuclei. Fluorescence was visualized and photographed 
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under a transmission fluorescence microscope (Olympus BX40, Hamburg, Germany) 
equipped with a digital camera (Olympus DP70).  
 
Transmission electron microscopy (TEM) 
Electroporated embryos were perfusion fixed at E12 via the heart with 2.5% 
glutardialdehyde /2% formaldehyde solution for 5 min. The following embryos were used: 
2 embryos for pCAGGS-ADAM17/pCAGGS-GFP co-electroporation, 2 embryos for 
pCAGGS-GFP electroporation alone, and 2 normal embryos without electroporation 
(serving as negative controls). The brains were dissected carefully after perfusion and fixed 
in the above fixative at 4oC overnight. Under a fluorescence stereomicroscope (Leica, 
Mannhein, Germany), the GFP-positive area in each tectum was then dissected and fixed 
further in 1% osmium tetroxide. Vibratom sections were prepared from this specimen, 
dehydrated in ethanol and embedded in Durcupan ACM (Fluka, Switzerland). Ultrathin 
sections were examined in an electron microscope (EM900, Zeiss, Oberkochen, Germany) 
after counterstaining with uranyl acetate and lead citrate (Roberts, 2002). Pictures were 
taken with a CCD camera (FastScan–F 114, TVIPS GmbH, Gauting, Germany). 
 
Morphometry and statistical analysis 
The intensity of individual bands from semi-quantitative RT-PCR was quantified using the 
software ImageQuant TL (Amersham Biosciences). The intensity value of each band was 
normalized to the value of the corresponding GAPDH band. Each experiment was repeated 
three times (n=3). In the figures, all data are shown with the standard error of the mean 
(S.E.M). Statistical analysis was performed by two-tailed t test using PRISM 4 software 
(GraphPad, San Diego, CA, USA). A value of p<0.05 was considered as a statistically 
significant difference for the different experiments in the same experimental group. 
For analysis of the transmission electron microscope images of tectal blood vessels, 
the area occupied by the blood vessel walls was measured from digital images by using the 
NIH image program (ImageJ) and expressed in number of pixels. In the same measured 
areas, the number of cross-sections through pericyte nuclei and endothelial cell nuclei were 
counted, respectively. All calculations were performed with SPSS 11.0 for Windows 
(SPSS Inc., Chicago, IL, USA). Student's t test was used to compare quantitative 
differences between areas of the vessel walls, and between the numbers of pericyte nuclei 
from different samples, respectively. 
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Results and discussion 
To study ADAM17 mRNA expression, semi-quantitative RT-PCR was performed from 
E1.5 to E20. Our results show that ADAM17 began to be transcribed as early as at E1.5 or 
even earlier. Expression is maintained at high levels until E20 (Fig. 5A). A statistic 
analysis of the semi-quantitative RT-PCR results failed to reveal any significant 
differences for the different stages, except for a small decrease at later stages (E16-E20; 
Fig. 5B). Overall, results demonstrate a relatively stable expression of ADAM17 
throughout the chicken embryonic development. 
The results from in situ hybridization indicate that ADAM17 (AM17) expression is 
visualized in the deep layers of the tectum at E8 (Fig. 5C). At E10 and E12, ADAM17 is 
expressed strongly in the neuroepithelium (ne in Fig. 5D,E) and the periventricular stratum 
(Pe), moderately in the stratum griseum centrale (SGC), weakly in the stratum griseum et 
fibrosum superficiale (SGFC), and absent in the stratum album centrale (SAC in Fig. 5D). 
ADAM17 sense probe was taken as a negative control (Fig. 5F). 
To study the function of ADAM17 during tectal development, ADAM17-
containing plasmid (ADAM17-pCAGGS) was injected and electroporated into the tectum 
at E6 to induce ADAM17 overexpression. Positive specimens were collected at E8, E10 
and E12. ADAM17 overexpression changed the morphology of the tectum at E10 and E12 
(Fig. 5I and Figs. 6,7). Control electroporation experiments (GFP alone) did not result in 
morphological changes in the tectum (Fig. 5G). To study whether the thinning of the tectal 
layers observed with ADAM17 overexpression was due to apoptosis, a TUNEL essay was 
performed. A comparison of the number of apoptotic cells between ADAM17 
overexpression and control specimens revealed a very low number of apoptotic cells in 
both cases (Fig. 5H,J). We conclude that the change in tectal morphology induced by 
ADAM17 overexpression did not result from a marked increase in apoptosis. 
Figure 6A shows that GFP-positive control cells can be visualized in the tectum 
(Tect) under the fluorescence microscope. ISH with ADAM17 antisense probe (AM17 in 
Fig. 6) was performed on sections from E8 embryos (Fig. 6B), E10 embryos (Fig. 6C), and 
E12 embryos (Fig. 6D). Results show that ADAM17 was successfully overexpressed in the 
GFP-positive tectal area at all three stages (Fig. 6B-D). At E10 and E12, the thickness of 
the tectum was decreased and the gross morphology of tectal blood vessels was altered in 
the electroporated area (Fig. 6C,D). 
In this study, I focus on the morphology of the blood vessels. To define the 
morphological change induced by overexpression of ADAM17 in the developing tectum in 
4. Additional Results                                                                                                          102 
more detail, I used different blood vessel markers. HT7 is a marker for blood-brain barrier 
(BBB)-forming endothelial cells (Gerhardt, 1996). Compared to the non-electroporated 
area, the ADAM17/GFP-positive area showed a similar staining pattern for HT7 (Fig. E-
G’). Fig. 6G and G’ display the merged images for the HT7 staining (red), Hoechst 33258 
(nuclear) staining (blue) and GFP staining (green) in the same section. Moreover, the 
following additional markers were used: alpha-smooth muscle actin (SMA) is a marker for 
smooth muscle cells or pericytes (Fig. 6H-K); fibronectin (Fn) is a marker for basement 
membranes in the blood vessels (O’Shea, 1987) (Fig. 6L-O); alpha-catenin is a general 
marker for vasculature in the brain (Miskevich et al., 1998) (Fig. 6P-S); and PECAM-
1/CD31 is a marker that mediates endothelial cell-cell interactions involved in 
angiogenesis (DeLisser et al., 1997) (Fig. 6T-W). From the immunostaining of these four 
antibodies, we can see that the size of the blood vessels in the ADAM17/GFP-positive area 
is much larger than that in the non-electroporated area. The inserts at the lower left side of 
Figure 6H,L,P,T (for E10) and Figure 6J,N,R,V (for E12) show magnifications of the areas 
boxed in these figures. Figure 6I,M,Q,U (for E10) and Figure 6K,O,S,W (for E12) 
represent the merged images for GFP (green) and Cy3 (red) fluorescence staining with the 
respective antibodies. A comparison of the results for HT7 (endothelial marker) and SMA 
(pericyte marker) suggest that the hypertrophy of the blood vessels in the ADAM17/GFP-
positive area is due to a change in the number and size of pericytes, but not of endothelial 
cells. 
To study the change in the pericytes in more detail, transmission electron 
microscope (TEM) experiments were performed. In the regions where the tectum 
overexpressed ADAM17, the number of pericytes in the wall of the vessels was increased 
(Fig. 7B), compared to control samples of the non-electroporated adjacent areas or the 
areas that were electroporated with GFP alone (Fig. 7A). In Figure 7A,B, arrowheads show 
the endothelial cells, and arrows show the pericytes. For quantification of this result, we 
measured the areas occupied by the brain vessel wall in tectal regions with pCAGGS-
ADAM17/pCAGGS-GFP co-expression  samples (ADAM17/GFP, n=55) and the two 
types of controls, i.e. non-electroporated adjacent regions (ØADAM17/ØGFP, n=26) and 
electroporation with GFP alone (GFP, n=20). A t test showed a significant difference of the 
mean values for the vessel walls between the experimental group and both control groups 
(p<0.05 and p<0.02, respectively; Fig. 7C). There was also a significant difference in the 
number of the pericyte nuclei between experimental and control groups (p<0.02 and 
p<0.01, respectively; Fig. 7D). However, there was no significant difference in the number 
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of the endothelial cell nuclei between all three groups (data not shown). The cell-cell 
contact between endothelial cells and pericytes was not investigated in this study. 
However, it is known that reciprocal interactions between pericytes and endothelial cells 
regulate the development, stabilization, maturation and remodeling of vasculature (Choi 
and Kim, 2008). 
During CNS development, the vascular system in the brain is derived from the 
leptomeningeal blood vessels through angiogenesis. The capillaries from the perineural 
vascular plexus penetrate neural tissue and form the brain microvessels.  The walls of 
typical angiogenic microvessels are composed of two types of cells, endothelial cells and 
pericytes. Endothelial cells form the inner lining of the vascular tube; pericytes form an 
outer sheath around the endothelium (Risau, 1997). Also, pericytes are in active 
communication with the cells of the neurovascular unit and make fine-tuned regulatory 
adjustments in response to stress stimuli in the brain (Dore-Duffy, 2008). Disruption of the 
extracellular matrix (ECM) is combined with an enhanced BBB permeability in 
pathological states (Rosenberg et al., 1993; Rascher et al., 2002). In vitro experiments 
support that differentiation of pericytes in culture is accompanied by changes in the 
extracellular matrix (Schor et al., 1991). Matrix metalloproteases (MMPs) were shown to 
regulate the structure and function of ECM molecules under normal and pathological 
conditions (Sternlicht and Werb, 2001). ADAM17 has been hypothesized to regulate 
angiogenesis based on its proteolytic activity in matrix degradation, although it has not yet 
been investigated sufficiently (van Hinsbergh et al., 2006). Based to the above results, I 
speculate that the increase in the number of pericytes in the developing tectum is due to a 
change in the ECM environment of the blood vessels in the areas of ADAM17 
overexpression.  
Furthermore, ADAM17 mRNA is strongly present in the ventricular layer 
(neuroepithelium) that is composed of radial glial cells whose processes span the entire 
thickness of the neural tube wall. Because of the lack of antibodies against ADAM17, I 
was unable to study whether the radial glial processes express ADAM17. This question 
remains to be answered in a future study. 
 
Conclusion 
My results show that ADAM17 is expressed at relatively high levels throughout embryonic 
brain development. Overexpression of ADAM17 leads to an increase in the thickness of 
the blood vessel wall, due to an increase in the number of pericytes. The mechanism of this 
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change remains unknown. Here, I speculate that the overexpression of ADAM17 remodels 
the developing brain vasculature through a change in the ECM environment of the brain 
blood vessels. 
 
Legends for the additional figures 
Fig. 5. ADAM17 expression in the embryonic chicken brain. 
A. Result from semi-quantitative RT-PCR analysis showing the expression of ADAM17 at 
different stages of chicken embryonic development (upper bands; E1.5-E4, whole 
embryos; E5-E8, whole heads; E10-E20, brain). GAPDH (lower bands) served as an 
internal control to monitor the amount of RNA.  
B. The measured intensity values of the ADAM17 bands shown in A were normalized to 
the GAPDH value. The error bars represent means +/- S.E.M. (n=3). 
C-F. Results from in situ hybridization (ISH) with ADAM17 antisense probe on cross-
sections through the tectum at E8 (C), E10 (D), and E12 (E). ISH with ADAM17 sense 
probe served as a negative control (F). 
G-J. TUNEL assay on cross-sections through the E12 tectum. G,I. GFP signal in a 
specimen electroporated with GFP plasmid alone (control; GFP), and co-electroporated 
with ADAM17 plasmid (AM17/GFP), respectively. H,J. TUNEL assays showing the 
apoptotic cells (red points) in the same sections as in G and I, respectively. Scale bars, 
200µm in F for D-F, in J for C and G-J.  
 
Fig. 6. ADAM17 overexpression mediated by in vivo (ex ovo) electroporation in the 
developing tectum. All specimens were electroporated at E6. 
A. Fluorescence microphotographs of an embryonic chicken tectum at E8 (whole mount 
preparation). B-C. Results from ADAM17 in situ hybridization (ISH) showing ADAM17 
overexpression in the electroporated area at E8 (B), E10 (C), and E12 (D). 
E-G’. Fluorescence photomicrographs of HT7 immunoreactivity at E12. E. HT7 
immunostaining. F. GFP fluorescence of the same section as E. G. Merged images for HT7 
(red), GFP (green) and nuclear stain Hoechst 33258 (blue). G’ shows a higher 
magnification of the electroporated area. 
H-K. Fluorescence photomicrographs of alpha-smooth muscle actin (SMA) 
immunoreactivity at E10 (H,I) and at E12 (J,K). H,J. SMA immunoreactivity; I,K. Merged 
images for SMA immunoreactivity (red) and GFP fluorescence (green) for the same 
sections as shown in H and J, respectively. 
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L-O. Fluorescence photomicrographs of fibronectin (Fn) immunoreactivity at E10 (L,M) 
and at E12 (N,O). L,N. Fibronectin immunoreactivity. M,O. Merged images for fibronectin 
immunoreactivity (red) and GFP fluorescence (green) for the same sections as shown in L 
and N, respectively. 
P-S. Fluorescence photomicrographs of alpha-catenin immunoreactivity at E10 (P,Q) and 
at E12 (R,S). P,R. Alpha-catenin immunoreactivity. Q,S. Merged images for alpha-catenin 
immunoreactivity (red) and GFP fluorescence (green) for the same sections as shown in P 
and R, respectively. 
T-W. Fluorescence photomicrographs of PECAM-1/CD31 immunoreactivity at E10 (T,U) 
and at E12 (V,W). T,V. CD31 immunoreactivity. U,W. Merged images for CD31 
immunoreactivity (red) and GFP fluorescence (green) for the same sections as shown in T 
and V, respectively. 
The inserts in H,J,L,N,P,R,T and V are higher magnifications of the areas boxed in the 
respective figures. Scale bars, 100µm in the insert of V for all of the inserts; 200µm in B 
and in W (for all other panels, except A). 
 
Fig. 7. Results from transmission electron microscopy and the statistical analysis. 
A,B. Results from transmission electron microscopy at E12. A, GFP electroporation alone 
(control); B, ADAM17 overexpression sample. The arrowheads show the nuclei of 
endothelial cells, and the arrows show the nuclei of the pericytes. Scale bars, 4µm in A for 
B as well. 
C,D. Results of the statistical analysis. C shows for the mean values for the area occupied 
by the blood vessels walls in the electroporated area or wild type (n=55 for ADAM17/GFP 
co-electroporation; n=20 for electroporation of GFP alone; and n=26 for the wild type 
control).  
D shows for the mean values for the number of the pericyte nuclei in the blood vessels 
walls in the electroporated area or wild type (n=55 for ADAM17/GFP co-electroporation; 
n=20 for electroporation of GFP alone; and n=26 for the wild type control).  
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Figure 5. ADAM17 expression in the embryonic chicken brain 
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Figure 6. ADAM17 overexpression mediated by in vivo (ex ovo) electroporation in the 
developing tectum. All specimens were electroporated at E6. 
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Figure 7. Results from transmission electron microscopy and the statistical analysis. 
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5. DISCUSSION 
 
As outlined in the Introduction section, cell adhesion molecules have various functions 
during embryonic development. Cadherins, one of the best investigated families of cell 
adhesion molecules, were first cloned and studied in chicken embryos (Hatta and Takeichi, 
1986; Napolitano et al., 1991). Like cadherins, ADAMs play important roles during 
embryonic development (Blobel, 2005; Yang et al., 2006), but few studies were performed 
in the chicken system to date. There are still many unexplored questions with regard to the 
temporal and spatial expression and functions of cadherins and ADAMs during the 
vertebrate development and evolution. The cloning and expression analysis of different 
cadherins or ADAMs during chicken embryogenesis will be a first step to answer these 
questions. Based on the expression patterns of cadherins and ADAMs, hypotheses about 
their functions can be formulated and tested experimentally. In my doctoral study, I firstly 
cloned the full-length cDNA sequences of five new chicken genes, ADAM12, ADAM13, 
ADAM22, Cdh8 and Cdh19, using the method of rapid amplification of cDNA ends 
(RACE). Results from mapping the expression of these genes show that  
• ADAM13 is expressed in a well-defined spatiotemporal pattern during chicken 
embryonic development (Publication 1); 
• eight classical cadherins (N-Cdh, R-Cdh, Cdh6, Cdh7, Cdh8, Cdh11, Cdh19 and 
Cdh20) are expressed in spatially restricted expression patterns in the developing 
chicken cochlea (Publication 2); 
• Cdh8 has three isoforms in chicken embryonic system and each isoform shows a 
spatiotemporal expression profile (Publication 3); 
• ADAM9, ADAM10, ADAM12, ADAM22 and ADAM23 all are expressed in the 
developing chicken brain, and each of the five members has its own restricted 
expression pattern in specific types of tissues and cells (Publication 4); and 
• overexpression of ADAM17 remodels blood vessels in the developing chicken 
tectum by increasing the number of pericytes (Additional Results).  
Together, these results indicate multiple and diverse roles for each ADAM and cadherin in 
embryonic development. 
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5.1 Expression of ADAMs in the developing chicken embryo 
The existence of ADAM genes has been confirmed in many animal species, including 
mammals, reptiles and invertebrates (Seals and Courtneidge, 2003). Individual members of 
the ADAM family show variable expression patterns that are developmentally regulated. 
Some ADAMs are expressed in highly restricted patterns in specific tissues and organs, 
whereas others are expressed more widely. Most studies about ADAMs investigated 
human, mouse or rat. Only a few papers reported the functions or expression profiles of 
ADAMs in avian species. In this study, seven ADAMs (ADAM9, ADAM10, ADAM12, 
ADAM13, ADAM17, ADAM22 and ADAM23) were cloned, and their expression patterns 
were analyzed during embryonic development of the chicken brain. ADAM13 was also 
studied in organs other than the brain (Publication 1). Each member has its own expression 
pattern in the developing brain, though the expression patterns of some ADAMs display 
varying degrees of overlap (Publication 4). Moreover, to obtain insight into the function of 
ADAMs in brain development, ADAM17 was overexpressed in the developing tectum. As 
a result, the morphology of blood vessels in the developing chicken tectum was remodelled 
through an increase in the number of pericytes (Additional Results). These findings will be 
discussed in more detail in the following sections. 
 
5.1.1 ADAM13 expression during chicken embryonic development 
Based on the predicted chicken ADAM13 sequence, a full-length sequence, which encodes 
947 amino acids, was obtained by RACE method. This chicken cDNA sequence was 
analyzed from different aspects, such as sequencing, BLAST, deduced protein structure 
analysis, and the evolutionary relationship analysis with other known ADAMs. The 
obtained chicken gene shares the highest similarity with Xenopus ADAM13, and a 
relatively high identity with human and mouse ADAM33. It can therefore be considered as 
the orthologous gene of Xenopus ADAM13 or human and mouse ADAM33. The obtained 
molecule was designated as chicken ADAM13 (Publication 1).  
From semi-quantitative RT-PCR result, ADAM13 began to be transcribed weakly 
at E1.5. As embryo develops, the transcription of ADAM13 increased gradually and 
reached the highest at E10, then decreased sequentially and was still detectable at E20. 
This result suggested that the expression of ADAM13 is temporally changed during 
chicken embryonic development.  
The results from the section and whole mount in situ hybridization indicate that 
ADAM13 is expressed strongly in the chicken embryo, but only in specific regions. Firstly, 
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ADAM13 is expressed in structures derived from the cranial neural crest. The expression 
of ADAM13 in cranial neural crest cells suggests that ADAM13 might play a role in 
guiding cranial neural cells to their destination during migration. Secondly, ADAM13 is 
expressed strongly in the mesenchyme around the brain that will form the meninges later in 
development. Interestingly, the expression in the meninges or the prospective meninges 
decreases gradually from earlier to older stages, but can be still seen until E10 at least. 
Thirdly, ADAM13 is expressed in the somites and its derived structures. The expression of 
ADAM13 in somitic mesoderm was also described in Xenopus, but only at early stages of 
development and not in somite-derived structures (Alfandari et al., 1997). Extending these 
results, I described the expression of ADAM13 also at relatively late stages. Forthly, 
ADAM13 is expressed strongly in the dorsal aorta and the developing kidney. Note that 
the expression of ADAM13 in the glomeruli is associated with the vascular tuft. It will be 
of interest to study whether ADAM13 expression in the mesenchyme around the 
mesonephric tubules and the nephric duct also reflects expression by vascular cells. Fifthly, 
ADAM13 is expressed in digestive organs, such as the esophagus, the proventriculus, the 
gizzard, and the intestines. Together, these results extend previous results from Xenopus 
for early stages of development (Alfandari et al., 1997, 2001) and show in detail that 
ADAM13 is expressed also at later stages of development and in organs that were not 
previously known to express ADAM13. For example, at E10, ADAM13 mRNA was 
transcribed widely in muscles, e.g., of the limbs, the thorax, and the abdominal wall, as 
well as in condensed sheets of chondroblasts around cartilage, e.g., around the vertebrae, 
the ribs and the sternum (Publication 1).  
Like Xenopus ADAM13, chicken ADAM13 has a molecular structure similar to 
members of the meltrin subfamily of ADAMs, which comprises ADAM9, ADAM12, 
ADAM19 and ADAM35. These genes are involved in muscle development (Yagami-
Hiromasa et al., 1995; Weskamp et al., 2002; Lewis et al., 2004; Watabe-Uchida et al., 
2004). The expression of some members of the meltrin subfamily has been described in 
avian embryos (Lewis et al., 2004; Watabe-Uchida et al., 2004). In the quail, ADAM12 is 
expressed in the cranial ganglia, in the mesenchyme of the limb bud, and in the 
mesenchyme surrounding the dorsal aorta, whereas ADAM19 is expressed in the cranial 
and dorsal root ganglia and in the allantois (Lewis et al., 2004). ADAM35 is expressed in 
the chicken myotome and several epithelial tissues, such as the otic vesicles and gut 
epithelia (Watabe-Uchida et al., 2004). The full-length sequence of chicken ADAM9 was 
reported, but its expression pattern has not been described to date (Caldwell et al., 2005). It 
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will be interesting to investigate the functional relation between chicken ADAM13 and 
other members of the meltrin subfamily during the embryonic development. 
 Some functional studies on the roles of ADAM13 have been published. For 
example, the migration of cranial neural crest cells requires the metalloprotease activity of 
ADAM13 in Xenopus (Alfandari et al., 2001). ADAM13 cleaves fibronectin in vitro and 
remodels a fibronectin substrate in vivo; furthermore, its disintegrin and cysteine-rich 
domains can bind the second heparin-binding domain of fibronectin (Gaultier et al., 2002). 
However, other roles of ADAM13 during chicken embryonic development remain 
unexplored. According to my present results, the migration of the neural crest cells in 
chicken embryos may also require the metalloprotease activity of ADAM13. Last but not 
least, strong expression of ADAM13 by other types of tissues and cells, for example the 
developing meninges, dorsal aorta, kidney, muscle and digestive organs, suggests that 
ADAM13 may play multiple roles during embryonic chicken development. 
As mentioned, the gene orthologous to chicken ADAM13 in human and mouse is 
ADAM33, which has been confirmed as a susceptibility gene for asthma (Holgate et al., 
2006). The restricted expression of ADAM33 in mesenchymal cells and its association 
with bronchial hyperresponsiveness and accelerated decline in lung function strongly 
indicate that ADAM33 is involved in the structural airway components of asthma. Chicken 
ADAM13 is also expressed by the bronchial mesenchyme in the developing lung. It 
remains obscure whether ADAM expression is associated with avian respiratory disease. 
 
5.1.2 ADAM expression in the CNS 
Only little was known about the expression profiles of ADAMs in the CNS. Kärkkäinen et 
al. (2000) identified ten ADAM mRNAs and showed strikingly different expression 
profiles of six of these mRNAs in the major parts of the adult mouse brain by Northern 
analysis. Similar results were obtained for ADAM22 and ADAM23 in the human brain 
(Sagane et al., 1998). In situ hybridization with probes for ADAM10 and ADAM17 
showed regional expression of these molecules in the adult mouse brain (Kärkkäinen et al., 
2000). However, the spatiotemporal expression patterns of ADAMs during brain 
development remain largely unknown. 
Results from my study (Publication 4) show that, in the developing brain, the 
general types of structures that express individual ADAMs are rather different. ADAM9 is 
predominantly expressed in the choroid plexus and in the ventricular layer; ADAM10 is 
expressed by developing blood vessels, oligodendrocytes, and subsets of neurons and brain 
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nuclei; ADAM12 is expressed by a few brain nuclei, cerebellar Purkinje cells, restricted 
regions of the neuroepithelium, and deep layer of tectum; ADAM22 expression is strongly 
in some brain nuclei and pineal gland, but negative in choroid plexus; and ADAM23 is 
expressed by most gray matter regions and the choroid plexus.  
These results differ from the expression patterns of other families of adhesion 
molecules. For example, the expression patterns of individual classic cadherins in the 
developing chicken brain are less variable (Redies, 2000; Redies et al., 2005). Although 
each classic cadherin shows a regionally restricted pattern that differs from that of other 
cadherins, most classic cadherins are expressed in the same types of tissues (ventricular 
layer, subsets of neurons and brain nuclei, and specific fiber tracts). Very few classic 
cadherins are known to be expressed by oligodendrocytes and blood vessels (for example, 
VE-cadherin in blood vessels). Moreover, the expression of cadherins is regionally 
restricted in general, while that of some ADAMs (for example, ADAM10 and ADAM23) 
is more widespread. These results suggest that most cadherins play similar roles but at 
different locations in the brain. In contrast, the relatively variable expression patterns of 
ADAMs suggest that they play versatile roles in different types of brain tissues, either in 
highly restricted brain regions (for example, ADAM12 in brain nuclei) or more widespread 
throughout the brain (for example, ADAM10, ADAM22 and ADAM23).  
As mentioned in the Introduction, possible roles for ADAMs in brain development 
include cell proliferation, migration, differentiation, apoptosis, myelination, as well as 
axon guidance (Novak, 2004; Yang et al., 2006). The expression patterns revealed in my 
study (Publication 4) will provide a basis for further experimental studies that investigate 
the functional role of ADAMs during brain development. 
 
5.1.3 ADAM17 overexpression enlarges the blood vessel wall through increasing the 
number of pericytes in the developing optic tectum 
ADAM17 has been well investigated in human and mouse. Results from my study 
(Additional Results) show that it is expressed widely in the developing chicken brain with 
relatively little differences at different developmental stages, except for slightly weaker 
expression at later stages (E16-E20). In the chicken optic tectum, ADAM17 is expressed 
strongly in the neuroepithelium and the periventricular stratum and moderately in the 
neurons of the stratum griseum centrale, but weakly or not at all in the other more 
superficial tectal strata and in blood vessels. 
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When ADAM17 was overexpressed in the chicken developing optic tectum by ex 
ovo electroporation (gain-of-function study), the morphology of blood vessel dramatically 
changed compared to the wild-type. We showed that the observed thickening of the blood 
vessel wall was due to a significant increase in the number of pericytes surrounding the 
endothelial cells. My results indicate that ADAM17 overexpression can change the 
morphology of blood vessels and, as a consequence, possibly remodel the blood-brain 
barrier (BBB) in the developing tectum. Because ADAM17 is a protease for many 
substrates, it is conceivable that the overexpression of ADAM17 might change the 
extracellular matrix environment of the CNS blood vessels, which, in turn, may result in 
the observed hypertrophy of the blood vessel wall. Of course, additional experiments will 
have to confirm this hypothesis. 
Pericytes have an important role in the formation of the BBB, a highly regulated 
membranous barrier of CNS capillaries (Engelhardt, 2003; Lai and Kuo, 2005). The main 
function of the BBB is to protect the brain from the intrusion of harmful substances. 
Changes in the BBB are observed in different kinds of nervous system diseases. 
Endothelial cells with their tight junctions constitute the main component of the BBB. 
However, pericytes are essential for the formation, maturation, and maintenance of the 
normal microvascular structure of the endothelial wall and its function. The molecular 
mechanisms, which regulate BBB permeability, remain poorly understood. My results 
suggest that ADAM17 may be a candidate molecule to contribute to the formation of the 
BBB. 
Not only ADAM17, but also ADAM10 and ADAM15 are known to be involved in 
angiogenesis (van Hinsbergh et al., 2006). For example, ADAM15 is strongly expressed in 
endothelial cells; however, there is no major developmental defect or pathological 
phenotype in ADAM15-deficient mice, which prompted an evaluation of its role in 
neovascularization (Horiuchi et al., 2003, 2005). My results have confirmed that ADAM9 
and ADAM10 are both expressed in blood vessels of the developing brain, but not in the 
mature brain (Publication 4). It will be interesting to investigate the angiogenetic function 
of these additional ADAM members. 
 To study gene function, the overexpression (gain-of-function) strategy was used 
successfully in our group in the electroporated chicken embryo (Treubert-Zimmermann et 
al., 2002; Luo and Redies, 2004, 2005; Luo et al., 2004, 2006). Analysis of loss-of-
function experiments is a more common approach to study gene function. For example, in 
our group, Gänzler-Odenthal and Redies (1998) blocked successfully the function of N-
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cadherin in the embryonic chicken brain with a specific antiserum, but this method 
depends on the availability of a functionally blocking antibody. Luo and Redies (2004) 
tried the plasmid-mediated antisense expression of Cdh6 and Cdh7 by electroporation as 
well, but they did not find a striking difference in mRNA levels between the wild type and 
the antisense expression. Recently, double-stranded RNA (dsRNA) has been shown to 
mediate sequence-specific post-transcription gene silencing. This methodology has become 
well known as RNA interference (RNAi; Caplen, 2002; Hannon, 2002). Recently, RNAi 
has been established as a convenient tool to analyze the function of genes of interest in 
invertebrates and vertebrates (Sato et al., 2004). Most RNAi experiments are being 
performed at the cellular level in combination with cell culture. As described in the 
Introduction, chicken embryos provide an ideal model system to investigate vertebrate 
embryogenesis. Thus, the establishment of RNAi in chicken embryos in combination with 
in vivo electroporation would provide a powerful method to analyze the function of genes 
expressed during embryogenesis. Small interfering RNA (siRNA) as a quick and simple 
method has been used for silencing the exogenous and endogenous gene expression in 
chicken embryogenesis (Rao et al., 2004). Vector-based RNAi has been used in different 
reports (Katahira and Nakamura, 2003; Chesnutt and Niswander, 2004; Dai et al., 2005; 
Das et al., 2006). Virus-based RNAi, using the replication-competent avian splice (RCAS) 
retrovirus, was successfully applied to the developing chicken retina (Harpavat and Cepko, 
2006). In the future, these or similar plasmid-based RNAi approaches combined with in 
vivo electroporation will provide a powerful tool to investigate gene function in the 
chicken embryo. 
 
5.2 Cadherins are markers to analyze functional pattern formation in the nervous 
system 
The precise and complicated structure of the CNS is intimately associated with its mature 
functions and requires a multitude of cell-cell interactions. Many cell recognition 
molecules that mediate cell-cell interactions are implicated in neural development. 
Therefore, isolating and understanding these cell adhesion molecules will help us to 
elucidate the mechanisms of brain development. Cadherins are one of the largest and best-
investigated families of cell adhesion molecules. As surface glycoproteins, which are 
critical to normal embryonic development, cadherins are directly involved in a wide 
variety of processes such as cell adhesion, cell sorting, cell survival, morphogenesis, 
formation of intercellular junctions, maintenance of tissue integrity and tumorigenesis. 
5. Discussion                                                                                                                      116 
Both reduced and inappropriate expression of cadherins has been associated with abnormal 
tissue formation in embryos and tumorigenesis in mature organisms (Takeichi, 1991; 
Hirano et al., 2003; Redies et al, 2005).  
The expression of the various cadherin family members is regulated in a complex 
pattern during embryogenesis. For example, Kim et al. (2007) examined the spatiotemporal 
distribution of mRNAs for 12 delta-protocadherins (non-clustered Pcdhs) in rat brain using 
in situ hybridization. Some of them (Pcdh1, Pcdh7, Pcdh9, Pcdh10, Pcdh11, Pcdh17, and 
Pcdh20) showed region-dependent expression patterns in the brain during the early 
postnatal stage. Hertel et al. (2008) analyzed the expression patterns of 12 different classic 
cadherins and delta-protocadherins in the basal ganglia of the postnatal and adult mouse by 
in situ hybridization, and their results suggest that cadherins provide a code of potentially 
adhesive cues, which specify not only patch and matrix compartments but also multiple 
molecular gradients within the mouse basal ganglia. Krishna et al. (2008) cloned 16 
members of the classic cadherin and delta-protocadherin subfamilies from ferret brain. 
They demonstrated that almost all of these molecules are expressed in spatiotemporally 
restricted profiles throughout visual cortical development. Differential expression was 
observed not only in the layers of the developing visual cortex but also in subsets of 
neurons within the cortical layers. 
In chicken embryos, the expression patterns and possible functions of N-Cdh, R-
Cdh, Cdh6, Cdh7, Cdh8, Cdh10, Pcdh7 and Pcdh10 have been investigated in the CNS by 
several groups, including our own group (Redies et al., 2002a,b; Treubert-Zimmermann et 
al., 2002; Heyers et al., 2003, 2004; Becker and Redies, 2003; Müller et al., 2004; Luo et 
al., 2004; Luo and Redies, 2004; Neudert and Redies, 2008; Publication 3). Chicken Cdh20 
(MN-cadherin) is expressed exclusively in lateral motor column of lumbar region in the 
spinal cord from E4 to E10 (Shirabe et al., 2005). In the spinal cord, chicken Pcdh10 (OL-
protocadherin) was specifically expressed in motor neurons, and the protein was 
distributed along motor nerves (Nakao et al., 2005). For a few cadherins, their regulation 
by gene regulatory factors has also been studied. For example, the regionalized expression 
of Cdh7 in a restricted region of the spinal cord neuroepithelium is regulated by Shh and 
Pax7 during development (Luo et al., 2006). However, there are still some members of 
cadherin family that are poorly understood at both the expression level and the functional 
level in the CNS. 
 In conclusion, the regionally restricted expression of individual cadherins in the 
developing brain is well established. Other organs, such as the kidney, also express 
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multiple cadherins in differential patterns, but in different types of tissues (Perantoni, 
1999). In this work, I mapped the expression of multiple cadherins in an organ that 
undergoes a highly complex morphogenesis during its development, the inner ear. 
Although some cadherins have been shown to be expressed during inner ear development, 
my study is the first to systematically compare the expression patterns of multiple 
cadherins in the inner ear (Publication 2). My results show that the neural tube and the ear 
vesicle, which both derive from the ectoderm, are subject to a similarly complex 
spatiotemporal regulation of expression. In another project, I asked whether three isoforms 
of a classic cadherin (Cdh8) also differ in their spatiotemporal regulation in the developing 
brain and possibly contribute to nervous system complexity (Publication 3). The answer to 
this question, however, was negative. 
 
5.2.1 Cadherin expression in the developing chicken cochlea 
The expression of the eight classic cadherins (N-Cdh, R-Cdh, Cdh6B, Cdh7, Cdh8, Cdh11, 
Cdh19 and Cdh20) was investigated in the developing chicken cochlea (Publication 2). 
Respectively, the expression of Cdh6B and N-Cdh was demonstrated in the hair cells, 
while Cdh8, Cdh11, and N-Cdh mRNAs were present in the supporting cells of the basilar 
papilla. Hair cells and supporting cells share a common progenitor cell during chicken 
cochlear development (Weisleder et al., 1995; Fekete et al., 1998). Supporting cells can 
differentiate into hair cells when hair cells are destroyed by acoustic noise or ototoxic 
drugs (Girod et al., 1989; Adler and Raphael, 1996; Roberson et al., 2004; Yamagata et al., 
2006). It is remarkable that N-Cdh signalling can induce cell proliferation of both hair cells 
and supporting cells. The blocking of N-Cdh function results in an inhibition of the 
proliferation of hair cells and supporting cells (Warchol, 2002). Therefore, the expression 
of cadherins in the supporting cells and the hair cells may have an effect on the 
differentiation of the supporting cells and the hair cells during normal chicken cochlear 
development. 
However, R-Cdh and Cdh11 were exclusively expressed by the homogene cells of 
the chicken cochlea, which are involved in the formation of the tectorial membrane during 
chicken cochlear development (Tanaka and Smith, 1975; Cohen and Fermin, 1985). The 
temporal profile of R-Cdh and Cdh11 expression in the homogene cells may relate to the 
generation of the tectorial membrane. Interestingly, Cdh7, Cdh19, and Cdh20 were 
expressed in an overlapping manner during cochlear development in the chicken. Cdh19 
was transcribed by the spindle-shaped cells, Cdh20 in the acoustic ganglion cells, and 
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Cdh7 in both of them. This result suggests that the regulation of gene expression for these 
three closely related cadherins, which are located at the same chromosomal location of the 
human genome (Kools et al., 2000), is only partially diverged in the cochlea and may 
coregulate the development of the spindle-shaped cells and the acoustic ganglion cells. In 
the cochlea, the projection of peripheral receptive regions onto auditory structures of the 
CNS is tonotopically organized. The guidance of the nerve fibres mediating this tonotopic 
projection is therefore of special interest. Several CAMs have been found to be involved in 
the guidance of the extension of the neurites from the acoustic ganglion to their target hair 
cells (Richardson et al., 1987; Kajikawa et al., 1997). The present study reveals that R-
Cdh, N-Cdh, and Cdh7 are coexpressed by the neurites of the acoustic ganglion axons and 
that N-Cdh and R-Cdh are also coexpressed in the areas of contact between the neurite 
terminals and the hair cells. Previous studies have demonstrated that R-Cdh, N-Cdh, and 
Cdh7 play an important role in neurite outgrowth and fasciculation, in synaptogenesis 
and/or in synaptic plasticity during embryonic development (Redies et al., 1992, Redies, 
1995; Fannon and Colman, 1996; Riehl et al., 1996; Tanaka et al., 2000; Treubert-
Zimmermann et al., 2002). Therefore, the three cadherins may be involved in the guidance 
of neurites from the acoustic ganglion to the sensory epithelium and in synaptogenesis with 
the target cells. Together, the expression of the eight classic cadherins in the developing 
cochlea suggests a role for cadherins in the genesis of the auditory system, for example, in 
the formation of hair cells and in the guidance of the neurites of acoustic ganglion to their 
target hair cells. 
 
5.2.2 Cadherin 8 expression in the embryonic chicken brain 
Cdh8 has been identified in human (Shimoyama et al., 2000), mouse (Korematsu and 
Redies, 1997a, b), and rat (Kido et al., 1998). The complete chicken Cdh8 cDNA sequence 
(Cdh8-3) was published in Publication 2. Chicken Cdh8-3 cDNA has high similarity with 
human, mouse, and rat Cdh8 (80% identities and higher); similarity to human Cdh8 is 
highest. The structural similarity between the Cdh8 genes of these species demonstrates 
that Cdh8 is a gene highly conserved between higher vertebrates. From RACE results, I 
found that chicken Cdh8 has two other isoforms (Cdh8-1 and Cdh8-2) generated by 
alternative mRNA splicing. It has been reported previously that Cdh8 is expressed in two 
isoforms in rat, a complete isoform and a truncated isoform that lacks the trans-membrane 
domain and the cytoplasmic tail (Kido et al., 1998). Isoforms of some other type II classic 
cadherins have also been reported (PB-Cdh, Sugimoto et al., 1996; Cdh11, Kawaguchi et 
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al., 1999; and Cdh7, Kawano et al., 2002). The function of all these short variants of 
classic cadherins remains to be investigated. Shimoyama et al. (2000) demonstrated that, 
like other classic cadherins, the long isoform of Cdh8 regulates cell-cell binding. The two 
short isoforms of chicken Cdh8 might also have adhesive function because the 
extracellular domain of classic cadherins serves as the interface for cell-cell binding and 
determines binding specificity (Takeichi, 1991).  
Structural analysis revealed that the extracellular domains form structural units 
whose dimerization is crucial for their adhesive activity (Shapiro et al., 1995; Nagar et al., 
1996; Elste and Benson, 2006; Pokutta and Weis, 2007). Whether the short unique 
sequences of the short isoforms at the site of truncation have a special role in cell adhesion 
or other functions of Cdh8 remains unclear. For rat Cdh8, Kido et al. (1998) did not 
demonstrate an adhesive function of the truncated isoform. 
The complete Cdh8 isoform (Cdh8-3) is expressed in the supporting cells of the 
basilar papilla in the chicken developing cochlea (Publication 2), and expression is 
temporally and spatially regulated also in the embryonic brain (Publication 3). The in situ 
hybridization study revealed a restricted pattern of Cdh8-3 expression in a subset of gray 
matter structures in the late embryonic chicken brain. Other classic cadherins are expressed 
in a similarly restricted pattern in the embryonic chicken brain, for example N-Cdh, R-
Cdh, Cdh6B, Cdh7 (Redies et al., 2000, 2001), and Cdh10 (Fushimi et al., 1997). The 
Cdh8-3 expression pattern is different from that of these other cadherins, although there is 
a partial overlap in some areas. According to the expression pattern of chicken Cdh8 in the 
developing brain, Cdh8 can possibly contribute to the adhesive code that is postulated to 
regulate morphogenesis and functional differentiation of the chicken brain during 
embryogenesis. 
The two shorter isoforms (Cdh8-1 and Cdh8-2) are expressed weakly compared to 
the long isoform (Cdh8-3). Although some evidence for a differential regulation of the 
three isoforms in the major brain regions was obtained by semi-quantitative RT-PCR, I 
could not observe a differential expression of the two shorter isoforms at the regional level 
by in situ hybridization because expression levels of Cdh8-1 and Cdh8-2 were too low to 
be detected by this method. Consequently, it remains unclear whether all three isoforms 
contribute to the adhesive code of developing brain structures to the same degree or in a 
similar way.  
A function of Cdh8 in neural circuit formation and synaptogenesis has been 
demonstrated in the somatosensory system of Cdh8-deficient mice (Suzuki et al., 2007). 
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Their results showed that Cdh8 is essential for establishing the physiological coupling 
between cold-sensitive sensory neurons and their target neurons in dorsal horn of the spinal 
cord. There is a relatively large degree of phylogenetic conservation of Cdh8 expression 
between chicken and mouse. It will be interesting to analyze the possible functions of the 
three Cdh8 isoforms during chicken embryonic development by appropriate experimental 
methods also in chicken. Suitable methods of investigation would be gain-of-function or 
loss-of-function studies of these isoforms in conjunction with in vivo electroporation. 
 
5.3 Interaction between ADAMs and cadherins 
The main identified functions of ADAMs are substrate shedding through the 
metalloprotease domain and cell-cell or cell-matrix adhesion mediated by the disintegrin 
domain (Blobel, 2005; Lu et al., 2007). For the function of cadherins, the release of their 
extracellular domain containing the homophilic binding cites is important to regulate cell 
adhesion, cell migration, and neurite outgrowth (Paradies and Grunwald, 1993; Nakagawa 
and Takeichi, 1998). For N-Cdh, this ectodomain cleavage is inhibited by tissue inhibitors 
of metalloproteinases (TIMPs). Furthermore, TIMPs promote fibroblast adhesion through 
stabilization of focal adhesion contacts. This stabilization was correlated with an increase 
of N-Cdh expression (Ho et al., 2001). Recently, it has been found that ADAM10 is 
responsible for the shedding of different cadherins (Reiss et al., 2005, 2006; Maretzky et 
al., 2005, 2008; Schulz et al., 2008). The knock-down of ADAM10 expression by different 
methods (in ADAM10-deficient mice, or with siRNA or a specific inhibitor) results in an 
increase of cell adhesion. As mentioned in the Introduction, ADAM10 can not only shed 
N-Cdh to decrease cell adhesion, but also affect its distribution in fibroblasts (Reiss et al., 
2005). ADAM10 is also responsible for E-Cdh cleavage, which regulates epithelial cell 
adhesion and migration and affects E-Cdh subcellular localization (Maretzky et al., 2005). 
Maretzky et al. (2008) also revealed that ADAM10 is involved in regulating E-Cdh cell-
surface expression in the diseased human skin. An increase in the level of active ADAM10 
leads to a loss of E-Cdh from the cell surface and decreases keratinocyte cohesion. In 
another experimental study, ADAM10 inhibitor and siRNA transfection both were able to 
block the constitutive shedding of gamma-Pcdh C3 and modulated the cell adhesion (Reiss 
et al., 2006). Moreover, through the shedding of VE-Cdh, ADAM10 can regulate the 
endothelial permeability and T-cell transmigration (Schulz et al., 2008). Interestingly, it is 
ADAM10, not ADAM9, ADAM15 or ADAM17, that sheds these cadherins and regulates 
cell adhesion. Because half of all members of the ADAM family display metalloprotease 
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activity, we must ask whether other ADAMs have the same or a similar function as 
ADAM10, or if ADAM10 can shed other cadherins. The present results on the distribution 
of ADAMs in the developing chicken brain and similar expression data on cadherins may 
help to put forward specific hypotheses on possible interactions between members of the 
two gene families and the role of these interactions in regional brain development. 
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6.  SUMMARY 
 
Introduction: Cell adhesion molecules (CAMs) play various roles during embryonic 
development. Cadherins are a large superfamily of CAMs that mediate cell-cell adhesion 
and signaling transduction by a calcium-dependent mechanism. The ADAM family of 
genes can also be considered a family of CAMs, because their disintegrin domain binds 
integrin to mediate cell-cell or cell-matrix interactions, and their cysteine-rich domain and 
epidermal growth factor-like domain both are able to modify cell-cell adhesion. Moreover, 
many ADAMs are metalloproteases that shed different trans-membrane proteins, such as 
cadherins. However, the expression patterns and potential functions of most ADAMs and 
some cadherins remain poorly understood. In the present thesis, I cloned seven members of 
the ADAM family and a multiple cadherins from the chicken embryo, and investigated 
their molecular characteristics and expression profiles during chicken embryonic 
development. 
 
Methods: Fertilized eggs were incubated in a forced-draft incubator at 37°C and 65% 
humidity until the embryos reached the desired stage. Total RNA was isolated from 
different stages and partial or full-length cDNAs of the ADAMs and cadherins of interest 
were cloned by RT-PCR or RACE. The temporal expression profiles of each gene were 
analyzed with semi-quantitative RT-PCR during chicken embryonic development. 
Northern blot was performed to determine the amount and size of chicken cadherin-8 
isoforms as well. Results from semi-quantitative RT-PCR and Northern blot were further 
analyzed by appropriate statistic methods. The temporal and spatial expression patterns of 
the cloned molecules were investigated using in situ hybridization of sections or whole 
mount specimens. Appropriate protein markers helped to confirm the identity of expression 
areas by immunostaining. To investigate the function of chicken ADAM17, an 
overexpression (gain-of-function) experiment was performed using in vivo (ex ovo) 
electroporation of the embryonic chicken tectum.  
 
Results: I obtained the novel full-length sequences of chicken ADAM12, ADAM13, 
ADAM22, Cdh8 and Cdh19. The expression pattern of ADAM13 was investigated in 
detail in the chicken embryo throughout the developing organism. The expression patterns 
of eight chicken cadherins (N-Cdh, R-Cdh, Cdh6, Cdh7, Cdh8, Cdh11, Cdh18 and Cdh20) 
were analyzed in the developing cochlea at older embryonic stages. I confirmed that 
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chicken Cdh8 possesses three isoforms from mRNA alternative splicing and analyzed their 
temporal and spatial expression in the chicken embryonic brain. Five ADAMs investigated 
(ADAM9, ADAM10, ADAM12, ADAM22, ADAM23) show different types of expression 
patterns in the developing chicken brain. Finally, ADAM17 overexpression (gain-of-
function) resulted in a morphological change of the blood vessels in the developing tectum. 
This change coincided with an increase in the number of pericytes.  
 
Conclusions: Our results indicate that chicken ADAM13 is expressed more widely during 
embryonic development than was previously known for Xenopus ADAM13. In the 
developing cochlea, different classic cadherins show restricted expression patterns, similar 
to their expression in the brain. Cdh8 has three transcript variants from mRNA alternative 
splicing, all of which show temporal and spatial expression profiles during chicken 
embryonic brain development by RT-PCR, but only the long isoform was expressed in 
amounts high enough to be detected by in situ hybridization. Unlike cadherins, the five 
investigated ADAMs exhibit general spatiotemporal expression patterns in brain tissue that 
are rather different for each ADAM, suggesting various roles for different ADAMs in brain 
development. Additionally, I show that ADAM17 overexpression increases the wall 
thickness of the blood vessels in the tectum by increasing the number of pericytes. I 
speculate that the observed increase in the number of pericytes is caused by a remodeling 
of the extra-cellular matrix environment of vascular cells due to ADAM17-induced 
changes in cell-matrix interactions, matrix protein shedding, or cell signal transduction. 
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7. ZUSAMMENFASSUNG 
 
Einleitung: Zelladhäsionsmoleküle (CAMs) spielen in der Embryonalentwicklung 
vielfältige Rollen. Cadherine, eine Großfamilie der CAMs, vermitteln in Abhängigkeit von 
Calciumionen Zell-Zell-Adhäsion und Signaltransduktion. Die ADAM-Gen-Familie kann 
ebenfalls als eine Familie der CAMs angesehen werden, da ihre Disintegrin-Domäne durch 
Bindung an Integrin Zell-Zell-Adhäsion und Zell-Matrix-Adhäsion vermittelt. Mit Hilfe 
ihrer Cystein-reichen Domäne und der Epidermal-Growth-Factor-Domäne können 
ADAMs die Zell-Zell-Adäsion auch modulieren. Die überwiegende Anzahl von  ADAMs 
sind Metalloproteinasen, die verschiedene transmembranäre Proteine, wie zum Beispiel 
Cadherine, spalten können. Jedoch sind die Expressionsmuster und mögliche Funktionen 
der meisten ADAMs und einiger Cadherine nicht gut erforscht. Daher klonierte ich in 
meiner Dissertation sieben Mitglieder der ADAM-Familie und mehrere Cadherine aus dem 
Huhnembryo und untersuchte ihre molekularen Eigenschaften und Expressionsprofile 
während der embryonalen Entwicklung des Huhns. 
 
Methoden: Befruchtete Hühnereier wurden in einem Frischluftinkubator bei 37°C und 
65% Luftfeuchtigkeit inkubiert, bis die Embryonen das gewünschte Altersstadium erreicht 
hatten. Die gesamte RNA wurde für unterschiedliche Stadien isoliert und cDNA-
Fragmente oder cDNAs gesamter Länge von ADAM-Molekülen und Cadherinen wurden 
mit RT-PCR oder RACE kloniert. Das zeitliche Expressionsprofil jedes isolierten Genes 
wurde mit semi-quantitativer RT-PCR bestimmt. Mit der Northern-Blot-Methode wurde 
für Cadherin-8 auch die Menge und Länge der im Huhn auftretenden Isoformen bestimmt. 
Die Ergebnisse der semi-quantitativen RT-PCR und der Northern-Blots wurden mit 
geeigneten statistischen Methoden ausgewertet. Das zeitlich-räumliche Expressionsmuster 
der klonierten Moleküle analysierte ich mittels In situ-Hybridisierung sowohl auf 
Gewebeschnitten als auch an kompletten Embryonen. Verschiedene molekulare Marker 
dienten dazu, die Identität von anatomischen Strukturen zu verifizieren. Um die Funktion 
von ADAM17 zu untersuchen, wurde dieses Gen im Huhnembryo durch In vivo-(Ex ovo-
)Elektroporation im Tectum des Huhnembryos überexprimiert. 
 
Ergebnisse: Ich klonierte bisher unbekannte cDNA-Sequenzen gesamter Länge von 
ADAM12, ADAM13, ADAM22, Cdh8 und Cdh19 des Huhns. Das Expressionsmuster von 
ADAM13 untersuchte ich im Detail während der gesamten Entwicklung des 
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Huhnembryos. Die Expressionsprofile acht  verschiedener Cadherine (N-Cdh, R-Cdh, 
Cdh6, Cdh7, Cdh8, Cdh11, Cdh18 und Cdh20) wurden in der sich entwickelnden Cochlea 
in späten Entwicklungsstadien des Huhns näher betrachtet. Ich bestätigte, dass es im Huhn 
drei Isoformen von Cdh8 gibt, die aufgrund von alternativem mRNA-Splicing entstehen, 
und untersuchte deren räumlich-zeitliche Expression im Gehirn des Huhnembryos. Fünf 
von mir untersuchte ADAMs (ADAM9, ADAM10, ADAM12, ADAM22 und ADAM23) 
wiesen unterschiedliche Expressionsprofile im Gehirn des Huhnembryos auf. Die 
Überexpression von ADAM17 im sich entwickelnden Tectum des Huhns resultierte in 
einer morphologischen Veränderung der Blutgefäßwände, die mit einer Vermehrung von 
Perizyten einherging. 
 
Schlussfolgerungen: Die Ergebnisse zeigen, dass ADAM13 im Huhnembryo in mehr 
Organen exprimiert wird, als bisher für ADAM13 in der Xenopus-Entwicklung bekannt 
war. In der sich entwickelnden Cochlea des Huhns weisen verschiedene klassische 
Cadherine räumlich beschränkte Expressionsmuster auf und ähneln darin den 
Expressionsmustern im Gehirn. Cdh8 kommt in drei verschiedenen mRNA-Transkripten 
vor, die alle spezifische räumlich-zeitlich beschränkte Expressionsmuster im embryonalen 
Gehirn des Huhns aufweisen, wobei allerdings nur die lange Isoform so stark exprimiert 
ist, das es für den Nachweis mit der In situ-Hybridisierung ausreicht. Anders als die 
Cadherine besitzen die fünf untersuchten ADAMs zeitlich-räumliche Expressionsmuster, 
die sich voneinander generell unterscheiden, was auf unterschiedliche Funktionen dieser 
ADAMs bei der Gehirnentwicklung hinweist. Des weiteren konnte ich durch die 
Überexpression von ADAM17 zeigen, dass die morphologische Veränderung in den 
Wänden der Blutgefäße auf eine größere Anzahl von Perizyten zurückzuführen ist. Dieser 
Anstieg lässt sich möglicherweise auf Veränderungen der extrazellulären Matrix in der 
Umgebung der Blutgefäße zurückführen, welche wiederum durch ADAM17-induzierte 
Modifikationen der Zell-Matrix-Interaktionen, Matrix-Proteinspaltung oder 
Signaltransduktion hervorgerufen sein können. 
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